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Conclusion : There is a significant difference in left ventricular dyssynchrony pattern 
in pts with right ventricular paced versus native LBBB. This should be taken into 
consideration when assessing these patients for dyssynchrony and left ventricular lead 
site placement.
9:30 a.m.
810-5	 Effect	of	Mitral	Regurgitation	on	Response	to	Cardiac	
Resynchronization	Therapy
David DeLurgio, Imran Niazi, Jill Schafer, Adam Hoyhtya, Emory Crawford Long 
Hospital, Atlanta, GA
Background:	Severity of baseline mitral regurgitation (MR) is reported to be positively 
correlated with lack of response to cardiac resynchronization therapy (CRT). In this 
retrospective analysis on the DECREASE-HF database, we hypothesized that patients 
(pts) with less baseline MR experience greater LV size reduction, and pts whose MR 
worsens respond less than patients whose MR improves.
Methods: Pts participating in the DECREASE-HF Study were included. The primary 
endpoint is a composite, SCORE=5*ΔPeakVO2-ΔLVESD. Peak VO2 is maximum oxygen 
capacity and LVESD is left ventricular end-systolic dimension. 306 pts were implanted 
with CRT-D and followed 6 months.
Results:	 61.3% (130/212) of pts with baseline MR grade 0-1 experienced LVESD 
reduction ≥ 5mm compared to 46.6% (27/58) of pts with moderate to severe baseline MR 
(grade 2-3) (p	=	0.04, using Chi-squared test). Table 1 presents outcomes by change in 
MR grade from baseline to 6 months (improved, no change, or worsened MR). Adjusting 
for multiple tests, paired t-tests show a larger ΔLVESD and SCORE for pts with Improved 
vs Worsened MR. The No Change MR responses were numerically but not statistically 
less than the Improved MR group. 
Table	:	6-month	outcomes	by	3	MR	grade	categories,	all	patients
Improved No	Change Worsened
Variable N Mean	±	SD N
Mean	±	
SD N
Mean	±	
SD P-value
Change in Peak VO2 (ml/
kg/min) 64 1.8 ± 2.7 153 1.4 ± 2.7 20 0.6 ± 2.1 0.16
Change in LVESD (mm) 74 -8.6 ± 8.3 172 -6.5 ± 6.8 24 -3.2 ± 7.4 0.01
Composite SCORE 64 17.5 ± 15.0 152
13.7 ± 
15.3 20 5.8 ± 14.0 0.01
Conclusions:	In this retrospective analysis, both baseline MR and change in MR affected 
response to CRT. A lower percent of pts with baseline MR 3-4 experienced a reduction in 
LVESD compared to those with no or little MR (grade 0-1). Also, pts whose MR improved 
had significantly better outcomes compared to pts whose MR worsened.
9:45 a.m.
810-6	 Interatrial	Conduction	Measured	During	Biventricular	
Pacemaker	Implantation	Accurately	Predicts	Optimal	
Paced	Atrioventricular	Intervals
Vadim Levin, Margit Nemeth, Ilyas Colombowala, Ali Massumi, Abdi Rasekh, Jie 
Cheng, James A. Coles, Jr., Michael R. Ujhelyi, Mehdi Razavi, Lehigh Valley Hospital, 
Allentown, PA, Texas Heart Institute/St. Luke’s Episcopal Hospital, Houston, TX
Background: Optimizing the atrioventricular (AV) delay following biventricular (BiV) 
pacemaker implantation can require substantial resources. We hypothesized that 
interatrial conduction time (IACT), measured at the time of BiV device implant, could be 
a surrogate value for the optimal paced AV delay (PAV). Methods:	Consecutive subjects 
(N=25; age= 66 ± 10 yo; M/F: 17/8) undergoing BiV pacemaker implantation and in sinus 
rhythm were included. A quadripolar electrophysiology catheter was inserted via a guiding 
sheath into the posterolateral coronary sinus (CS) to measure left atrial depolarization. 
The IACT was calculated as the interval between right atrial stimulation artifact and 
earliest deflection on the coronary sinus catheter electrogram. Subsequently, during atrial 
pacing the PAV was determined using transmitral pulsed wave doppler echocardiography 
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810-3	 Predictive	Value	of	Combined	Longitudinal	and	
Radial	Dyssynchrony	for	Response	to	Cardiac	
Resynchronization	Therapy
John Gorcsan, III, Matthew S. Suffoletto, Gabe B. Bleeker, Nini C. Thomas, Masaki 
Tanabe, Samir Saba, Laurens F. Tops, Martin J. Schalij, Jeroen J. Bax, University of 
Pittsburgh, Pittsburgh, PA, University of Leiden, Leiden, The Netherlands
Background: Dyssynchrony plays a role in response to cardiac resynchronization 
therapy (CRT), but dyssynchrony patterns may be complex and the optimal quantitative 
approach remains unclear.
Methods: We studied 173 NYHA III-IV heart failure patients (pts) undergoing CRT 
(ejection fraction (EF) 23±7% and QRS 168±27ms) before and 6±3 months after CRT. 
Dyssynchrony was assessed in 2 planes: Longitudinal: tissue Doppler (TDI) measures 
of velocity (2-site data in 109, and 12-site data in 64) with opposing wall delay > 65 
ms and Radial: speckle tracking radial strain with difference > 130 ms. Response was 
defined as end-systolic volume (ESV) decrease > 10% or EF increase > 15%.
Results: Of 173 pts, 119 were EF responders (69%) and 54 EF non-Responders (31%). 
If pts had both radial and longitudinal dyssynchrony, 93% were EF responders. If pts 
had neither radial nor longitudinal dyssynchrony, 24% were EF responders using 2-
site TDI and only 15% were EF responders using 12 site TDI (figure) (p<0.05). Pts with 
heterogeneous dyssynchrony: either/or (not both) radial or longitudinal dyssynchrony had 
mixed results with 53% EF responders.
Conclusions: Combined patterns of longitudinal and radial dyssynchrony appear 
additive to predict response to CRT. Uniform patterns have high positive and negative 
predictive value, while heterogeneous patterns are less predictive. These observations 
have potential clinical implications. 
9:15 a.m.
810-4	 Differing	Left	Ventricular	Contraction	Patterns	in	
Patients	With	Right	Ventricular	Paced	Versus	Native	
Left	Bundle	Branch	Block:	A	2D	Strain	Study
Ajay Shah, Eftekhari Hossein, Rawa Sarji, Walter J. Pierce, Donna Macmillan-Marotti, 
Bilal Ayub, Arti Shah, Joseph DeRose, Farooq A. Chaudhry, Jonathan S. Steinberg, St 
Luke’s Roosevelt Hospital Center, Columbia University, New York, NY
Background	and	Objective: Paced left bundle branch block (LBBB) induced by right 
ventricular pacing (RVP) and native LBBB are generally managed in a similar fashion 
with cardiac resynchronization therapy (CRT). The differences in left ventricular (LV) 
contraction pattern between RVP versus native LBBB are not well defined. We evaluated 
differences in LV contraction pattern in these cohorts using the novel technique of 2 D 
Speckled Tracking Radial Strain (STRS).
Methods:	We studied 33 consecutive pts with either RVP or native LBBB referred to 
the echocardiography laboratory for baseline dyssynchrony assessment prior to CRT. 
The LV activation was studied in mid short axis view using 2D STRS. The time to peak 
contraction was assessed for 6 LV walls namely anterior, inferior, lateral, posterior, inferior 
septal and anteroseptal.
Results: Of the 33 pts (66 ± 13yrs; 77% male; LVEF :17 ± 5); 14 pts (42%) had right 
ventricular paced and 19 pts (58%) had native LBBB (QRS 144 ± 11 vs 152 ± 16 ms; 
p=NS). As shown in figure, pts with paced LBBB had significantly delayed activation 
in their inferior wall (50%; 412 ± 60 ms) compared to pts with native LBBB who had 
predominantly delayed activation in their lateral wall (61%; 309 ± 106 ms).
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(iterative method). The relationship between paced IACT and PAV was then determined. 
Results: The mean ± SD paced IACT and PAV were 126 ± 25 msec and 157 ± 23 
msec, respectively. There was a strong positive correlation between the paced IACT and 
PAV (r = 0.73, p < 0.001). The equation describing the relationship was PAV = 0.68 * 
(IACT + 104) msec. Conclusions: The paced IACT has a strong correlation with the echo 
derived optimal PAV. This method may be used to program PAV intervals without need for 
echocardiography in patients undergoing BiV pacemaker implantation. 
10:00 a.m.
810-7	 The	Effects	of	QRS	Duration	and	Atrial	Pacing	
on	Atrioventricular	Optimization	of	Cardiac	
Resynchronization	Therapy
Michael R. Gold, Imran Niazi, Michael Giudici, Yinghong Yu, Shantha Arcot-
Krishnamurthy, Medical University of South Carolina, Charleston, SC
Most CRT studies were performed in atrial sense mode. Yet in practice, CRT devices are 
often programmed in DDD(R) mode, which increases atrial pacing. This study compared 
AV delay (AVD) optimization methods for CRT during atrial overdrive pacing to maximize 
the acute hemodynamic response.
Methods: We studied 25 patients (pts) (age: 67±11yrs, QRS: 151±35 ms, 96% NYHA III, 
LVEF: 25±7%) with AV sequential (DDD) pacing at rates 10-20 bpm above the intrinsic rate 
at 4 AVDs. Changes in LV dP/dt from sinus baseline were measured for each AVD and the 
maximum was calculated from a third order polynomial fit of the data. Comparisons were 
made between fixed AVDs of 100 or 120 ms and an electrogram-based AV optimization 
(EEHF+). Subgroup analysis was performed prospectively based on QRS width.
Results: Wide QRS (>150 ms) pts had significantly shorter optimal AVDs (P=0.01) 
and larger LV dP/dt (p<0.001) than moderate QRS pts (120-150 ms). EEHF+ AVD 
was significantly closer to the optimal AVD than both 100 and 120 ms (p’s <0.01). 
EEHF+ provided markedly better LV dP/dt than both fixed AVDs in moderate QRS pts 
(p<0.00001).
Conclusions: Optimal paced AV delays are much longer than are traditionally programmed 
in CRT devices. QRS width affects both hemodynamic response and the optimal AV delay. 
The electrogram-based algorithm provided paced AV delays much closer to optimal values 
than commonly used AV delays, which resulted in improved hemodynamic performance. 
AVD %Change in LVdP/dt
Moderate QRS Wide QRS Moderate QRS Wide QRS
Opt AVD 227.6±53.8 176.6±56.3 10.6±6.7 27.2±12.9
EEHF+ 193.3±34.1* 169.9±41.3* 8.4±8.0* 24.5±14.1
120 ms 120 120 1.9±8.8 23.4±14.6
100 ms 100 100 -0.4±8.4 21.6±14.4
* EEHF+ significantly greater than 100 ms and 120 ms (p<0.01)
10:15 a.m.
810-8	 Effect	of	Three	Cardiac	Resynchronization	Therapy	
Modalities	on	Mitral	Regurgitation
Imran Niazi, David DeLurgio, Adam Hoyhtya, Jill Schafer, St. Luke’s Medical Center, 
Milwaukee, WI
Background:	DECREASE-HF compared three cardiac resynchronization therapy (CRT) 
modalities: simultaneous BiV (SIM), LV pacing (LV), and sequential BiV (SEQ; LV paced 
before RV). Based on the primary composite endpoint, SEQ was equivalent to SIM, while 
LV was not equivalent to SIM. We hypothesized that worsening mitral regurgitation (MR) 
in a subset of LV patients (pts) resulted in worse overall outcomes.
Methods: This is a retrospective analysis of DECREASE-HF. After implant of CRT-D, 306 
patients (NYHA III/IV, EF ≤ 35%, QRS ≥150ms, LBBB) were randomized to SIM, SEQ, or 
LV, in a 1:1:1 ratio and followed 6 months (mos). In all pts, atrioventricular (AV) timing was 
set using electrogram-based AV optimization, with RV paced after LV in SEQ pts.
Results:	No differences existed between groups in baseline MR (p=0.08). The table 
presents outcomes of pts with no or little baseline MR (grade 0 or 1). After 6 months, a 
higher percent of LV pts had worsening MR ≥ 1 grade compared to SIM (p=.009) or SEQ 
(p=.004). Notably, only in the LV group was worsened MR associated with a significantly 
lower SCORE (p=.002). LV pts whose MR did not worsen experienced outcomes similar 
to SIM and SEQ pts. 
6-Month	Outcomes	for	
Patients	with	Baseline	MR	
Grades	0-1
LV	(N=70) SIM	(N=73) SEQ	(N=70)
N	(%) N	(%) P-value	
vs.	LV N	(%)
P-value	
vs.	LV
Pts	with	worsened	MR 14 (20%) 4 (5%) 0.009
3 
(4%) 0.004
N Mean	±	SD N Mean	±	SD N Mean	±	SD
SCORE	for	pts	with	
worsened	MR 10
-0.9 ± 
15.8 4 12.0 ± 12.7 3 12.9 ± 2.6
SCORE	for	pts	with	no	
change	or	improved	MR 47
16.0 ± 
14.8 65 16.1 ± 15.5 58 11.9 ± 16.2
P-value	-	mean	SCORE	
worsened	vs.	no	change	or	
improved
0.002 0.61 0.92
Primary	Composite	Endpoint:	SCORE	=	5*ΔPeakVO2	-	ΔLVESD
Conclusions:	 In this retrospective analysis, worsening MR in LV pts resulted in worse 
outcomes vs. SIM and SEQ pts. Further studies are warranted to discern why LV 
benefits some pts but worsens MR in others. A possible mechanism is failure to provide 
synchronized papillary muscle activation at the selected AV delay due to variable septal 
conduction time.
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Atrial	Tachycardias	and	Atrial	Flutter:	
Mechanisms	and	Therapies
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11:30 a.m.
623-5	 Stroke	Prevention	Technology	for	Patients	with	
Non-Valvular	AF:	Worldwide	Experience	with	the	
WATCHMAN	LAA	System
Peter B. Sick, Karl-Eugen Hauptmann, Eberhard Grube, Michael R. Mooney, David 
R. Holmes, Gerhard Schuler, Hospital of the Barmherzige Brueder Regensburg, 
Regensburg, Germany, University of Leipzig, Heart Center GmbH, Leipzig, Germany
Background:	Over 50% of patients with non-valvular atrial fibrillation (AF) are at risk 
of ischemic stroke and thromboembolic events. Multiple studies have confirmed the 
presence of thrombus in the left atrial appendage (LAA) in more than 90% of patients 
with AF related stroke.
Methods:	 The WATCHMAN LAA system (Atritech, Inc., Minneapolis, MN) is placed 
in the LAA via transseptal puncture to prevent the occurrence of ischemic stroke and 
systemic thromboembolism. The implant is made of nitinol, has a 160 micron PET porous 
membrane on the proximal face and incorporates a row of fixation barbs around the mid 
perimeter. It is available in 5 sizes (21, 24, 27 and30 and 33 mm). Beginning in August 
2002, a multi-center feasibility trial was started. Patients were assessed at 45 days and 6 
months with TEE and chest x-ray and annual clinical assessments thereafter.	
Results:	In 64 patients the device has been implanted successfully with a mean follow 
up of 714 days. In five additional patients implantation was not possible due to anatomic 
problems. Mean age was 69.7years (47-85), 66% were male. Two patients experienced 
device embolization, both successfully retrieved percutaneously with no further 
embolizations after enhancement of fixation barbs. Two major and 3 minor pericardial 
effusions, one air embolism, all without long term sequelae and one delivery system 
issue (first generation design) have been reported. After 6 months 97.1% of patients had 
ceased device related warfarin therapy. Four patients, however, had flat thrombus noted 
on the atrial face of the implant at 6 months, one of these patients developed a transient 
ischemic attack (TIA). Coumadin was restarted in these patients. Two patients, one with 
a history of TIA experienced a TIA without LAA-thrombus visible, however there was 
no stroke or systemic embolism. One patient died after 9 months due to an ascending 
aortic dissection, another due to bowel operation. Autopsy documented a stable, well 
endothelialized device.	
Conclusions:	Preliminary data suggest the WATCHMAN LAA system to be safe and 
feasible. Further randomized study is ongoing to determine the long term effect of this 
technology on stroke reduction in comparison with coumadine.
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Exercise	and	Provocative	Testing
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2:00 p.m.
818-3	 Autonomic	Effects	on	the	Spectral	Analysis	of	Heart	
Rate	Variability	After	Exercise
Jason Ng, Sri Sundaram, Alan H. Kadish, Jeffrey J. Goldberger, Northwestern 
University, Evanston, IL
Background: Validation of the physiologic origins of spectral characteristics of heart rate 
variability (HRV) during recovery from exercise has not been studied.
Methods: Normal subjects (N=28, 53±7 yrs, 17 male) underwent submaximal bicycle 
testing on 4 separate days. On the 1st day, baseline (BASE) recordings were made. On 
the 2nd and 3rd day, atropine (0.04 mg/kg) to achieve parasympathetic blockade (PB) 
or propranolol (0.2 mg/kg) to achieve beta adrenergic blockade (BB) was administered 
during exercise. On the 4th day, double blockade (DB) was given. HRV was measured 
as the power in the low frequency (LF) band (0.04 to 0.15 Hz), the high frequency (HF) 
band (0.15 to 0.4 Hz), and ratio (LF/HF) for detrended 1 minute segments of RR intervals 
in the first 5 minutes.
Results: The peak RR intervals for BASE, BB, PB and DB were 470±72 ms, 631±47 
ms, 400±27 ms, and 569±44 ms, respectively, and increased steadily over 5 minutes to 
640±100 ms, 849±117 ms, 468±37 ms, and 691±85 ms, respectively. LF and HF were 
significantly higher during BASE and BB than during PB and DB (p<0.0001). However, 
there was no difference between BASE and BB and between PB and DB. LF in the 5th 
min. was higher than the 1st min for BASE (p<0.05) and BB (p<0.02). LF/HF was higher 
in the 5th min than in the 1st min for BASE (p<0.01) and PB (p<0.05).
Conclusions: In this first 5 min. of recovery, both LF and HF power are mediated by 
parasympathetic effects. The LF/HF ratio does not provide an index of sympathetic 
withdrawal that occurs in the recovery period.
2:15 p.m.
818-4	 Heart	Rate	Recovery	After	Exercise	Testing	and	Risk	of	
Cardiovascular	Events	and	Mortality	in	Stable	Coronary	
Patients
Illena Antonetti, Wojciech Zareba, Ronald J. Krone, Arthur J. Moss, University of 
Rochester, Rochester, NY, Jewish Hospital, St. Louis, MO
Background: Abnormal heart rate recovery (HRR) after exercise stress testing has 
been associated with increased risk of cardiac death in cohorts of healthy subjects or 
patients suspected of ischemic heart disease. The aim of this study was to determine 
the association between HRR and risk of ischemic cardiac events and death in stable 
patients after a recent acute coronary event.
Methods: 757 stable coronary patients underwent exercise stress testing an average 2.7 
months after acute coronary syndrome. The heart rate was measured at baseline, peak 
during exercise and at 2 minutes into recovery. HRR was the difference between peak 
heart rate and the heart rate at 2 minutes.
Results: During mean 2-year follow-up, 133 (18%) patients reached combined endpoint 
of unstable angina requiring hospitalization, nonfatal MI, or cardiac death; 45 (6%) 
patients experienced the latter two events, and 11 (1.5%) died. None of the heart rate 
parameters was predictive for combined endpoints. All heart rate parameters were 
predictive for cardiac death when added one at a time in the multivariate Cox model 
(Table: hazard ratios expressed per 1 beat per minute increase). When these heart 
rate parameters were included simultaneously, HRR was the only heart rate parameter 
significantly associated with cardiac death. Dichotomizing the HRR at ≤ 26bpm (lowest 
quintile) gave a hazard ratio of 4.64 for cardiac death.
Conclusions: Heart rate recovery at 2 minutes is a significant predictor of cardiac death 
in stable coronary patients.
Heart Rate Parameters Predicting Death
Heart Rate 
Variables
Hazard Ratio - parameters 
added one at a time
P 
value
Hazard Ratio - parameters 
added simultenously
P 
value
Peak HR 1.03 0.039 1.02 0.398
Baseline to 
Peak HR 1.05 0.026 1.02 0.326
HR recovery 1.06 0.002 1.05 0.021
2:30 p.m.
818-5	 Different	Biological	Pattern	in	Adenosine	Sensitive	
Syncope	and	Tilt-Induced	Vasovagal	Syncope
Sébastien Prévôt, Frédéric Franceschi, Régis Guieu, Zouher Ibrahim, Victor Cuello, 
Jean-Claude Deharo, CHU La Timone, Cardiology Department, Marseille, France
Adenosine plasma levels (APL) have been shown to be elevated in patients with syncope 
and positive head-up tilt (HUT) test. ATP and HUT-tests identify different populations of 
syncope patients with distinct clinical characteristics. The aim of this study was: 1/ to 
investigate whether patients with positive ATP or HUT-test have different baseline APL; 2/ 
to correlate APL with the length of the ventricular pause when ATP-test is positive.
Methods: Twenty-six consecutive patients (58.2±13.6 y., 11 females) referred for 
unexplained syncope underwent baseline APL measurement followed by ATP and HUT-
tests. APL were determined by High Performance Liquid Chromatography method on 
venous blood samples obtained in resting patients. ATP test consisted of the intravenous 
bolus injection of 20 mg ATP. HUT test was performed at 60° for 45 min and, if negative, 
the test continued for 20 min after administration of sublingual nitroglycerin.
Results: Ten patients had positive ATP-test (4 with positive ATP-test alone); 16 patients 
had positive HUT test (10 with positive HUT-test alone). APL were lower in patients with 
positive ATP test alone than in patients with positive HUT test alone (0.68±0.27µmol/L vs 
2.07±1.51 µmol/L, p<0.05); they were not different in patients with positive ATP test and 
in patients with negative ATP test (1.80 ±1.27 µmol/L vs 1.54±1.53 µmol/L, p=NS). There 
was no statistical correlation between APL and the length of the ventricular pause induced 
by the ATP test (r=-0.29, p=NS).
Conclusion: Lower baseline adenosine plasma levels were observed in patients with 
adenosine sensitive syncope than in patients with tilt induced vasovagal syncope. 
Therefore ATP and HUT test identify 2 distinct populations of patients presenting with a 
different biological pattern at baseline.
2:45 p.m.
818-6	 Cornell	Voltage	Product	in	ECG	Relates	to	Left	
Ventricular	Mass	in	Subjects	Prone	to	Develop	
Hypertension	Over	20	Years
Arne Strand, Helga Gudmundsdottir, Ingrid Os, Gunnar Smith, Reidar Bjørnerheim, 
Sverre E. Kjeldsen, Ulleval University Hospital, Oslo, Norway
Background: Left ventricular hypertrophy (LVH) in hypertension is an independent risk 
factor of cardiovascular morbidity and mortality and related to blood pressure (BP) and 
neuro-hormonal factors. To our knowledge no study relates ECG markers of LV size 
and in particular Cornell Voltage Product through 20 years in homogenous groups of 
normotensives and hypertensives. Tissue Doppler imaging (TDI) is a promising technique 
to assess LV function.
Methods: In a 20-year prospective study of middle-aged men, sustained hypertensives 
(HT) (n=22), new hypertensives (new HT) (n=17) and sustained normotensives (NT) 
(n=17) were compared at baseline (42 yrs) and follow-up (62 yrs). Subjects defined as 
normotensive in 1984 and developed hypertension (New HT) through follow-up had either 
24-h BP > 125/80 mm Hg or antihypertensive drugs. Relationships between ECG and LV 
parameters were investigated. TDI was used to assess LV diastolic function.
Results: LVM was significantly higher, and more subjects had echo LVH
(LVMI > 116 g/m2) in hypertensive groups. There were linear trends in Cornell voltage 
product 2004 (p=0.026) and 1984 (p=0.138). E/E’M (p=0.002) and E/E’L (p=0.003) 
differentiated diastolic function. (Table)
Conclusions: Cornell voltage product at baseline might indicate that subjects prone to 
develop hypertension have a higher baseline LV mass despite of normal BP and indicates 
the importance of neurohormonal factors in development of LVH. TDI differentiated LV 
diastolic function between the groups.
Characteristics of groups (n=56)
Variable	(+/-	SD) Controlsn=17 New	hypertensivesn=17 Hypertensivesn=22 Anovap
LV mass index (g/m2) 2004 102 ± 17 111 ± 25 114 ± 20 0.071
LV mass (g)2004 200 ± 29 227 ± 62 233 ± 39§ 0.025
Echo LVH (n) 1 6 10 0.025
Cornell Voltage Product 
2004 (mm·mS) 996(534) 1193 (450) 1410 (619) 0.026
Cornell Voltage Product 
1984 (mm·mS)
986
(381) 1159 (405) 1215 (552) 0.138
SysLat (cm/s) 7.0 ± 2.2 7.0 ± 1.8 6.0 ± 1.3 0.086
ELat (cm/s) 8.7 ± 2.1 7.2 ± 2.1 6.8 ± 1.3 0.005
E/E’Lat 8.1 ± 2.3 10.6 ± 3.7 11.5 ± 2.5 0.002
3:00 p.m.
818-7	 Deceleration	Capacity	In	Post-MI	Patients	on	and	off	
Beta-Blockers
Petra Barthel, Marek Malik, Axel Bauer, Raphael Schneider, Georg Schmidt, Deutsches 
Herzzentrum & 1. Med. Klinik, Munich University of Technology, Munich, Germany
Background: Established post-infarction risk factors perform poorly in patients on beta-
blockers. Deceleration Capacity (DC) is newly established risk predictor in post MI-patients. This 
study assessed risk stratification performance of DC in patients on and off beta-blockers.
Methods:The study was performed in patients of the EMIAT trial. Out of a total of 1,170 
patients, 518 were on beta-blockers and 652 were off beta-blockers. Primary endpoint 
was total mortality, median follow up was 22 months.
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DC was determined in a 24-hour Holter ECG taken 2 weeks after the index infarction 
according to the published methodology (DC categories: 0 (DC >4.5 ms), 1 (DC 2.5 - 4.5 
ms), 2 (DC <2.5 ms).
A Cox-proportional hazards analysis was performed with respect to age, mean heart rate, 
HRV index, history of previous MI, LVEF and DC, all with prospectively set dichotomy limits.
Results: In patients on and off beta-blockers, 2-year mortality was 10% and 18 % 
respectively. In patients off beta-blockers, DC, history of previous infarction, Diabetes 
mellitus, and LVEF were independent predictors of mortality while in patients on beta-
blockers, DC and age were the only independent predictors (see Table for the results of 
the multivariate analysis - only significant factors are shown).
Conclusions: In post MI-patients on and off beta-blockers, DC is a strong risk stratifier.
off beta-blockers on beta-blockers
Variable Relative hazard p Relative hazard p
Age - - 2.0 <0.05
Diabetes mellitus 2.2 <0.0001 - -
Previous MI 2.3 <0.0001 - -
LVEF 1.6 <0.05 - -
DC 1 3.0 <0.0001 2.8 <0.01
DC 2 4.6 <0.0001 3.7 <0.001
3:15 p.m.
818-8	 Isoproterenol	Increases	QT	Dynamicity	in	the	
Conscious	Rabbit	With	Chronic	Heart	Failure
Mari A. Watanabe, Tomofumi Kimotsuki, Martin N. Hicks, Michael Dunne, Stuart M. Cobbe, 
St. Louis University, St. Louis, MO, Glasgow Royal Infirmary, Glasgow, United Kingdom
Background: Experimental studies in animals and man show that greater QT dynamicity 
(slope of QT vs RR plot) is arrhythmogenic, but post-infarction patients in the EMIAT 
study with sudden cardiac death were recently found to have smaller QT dynamicity over 
the day than those without. Greater QT dynamicity during adrenergic activation in failing 
hearts might explain this unexpected finding.
Methods: New Zealand White rabbits underwent coronary ligation (n=7) or sham surgery 
(n=7), and implantation of a pacemaker lead in the right ventricle. Eight weeks after 
surgery, ECGs were recorded from unsedated rabbits using the pacemaker lead. 1.0~2.0 
ml of 1 micromol/l isoproterenol (Iso) solution was given intravenously. The slope of Q_
Tpeak interval vs RR interval plot (QT/RR) was calculated.
Results: The ligated rabbits had lower LVEF (41±1.6 (s.e.m.) vs 68±2.1 %, p<0.0001) and 
higher heart rate (265±6.8 vs 305±12.2 ms, p<0.05) than sham rabbits. Their Iso-induced 
RR shortening was smaller (67±6.5 vs 106±15.3 ms, p<0.05) as was RR shortening per time 
(-4.1±0.73 vs -8.2±0.72, p<0.005), but QT/RR in response to Iso was greater (0.59±0.12 vs 
0.29±0.045, p<0.05) in spite of this. We also observed more instances of biphasic QT-RR 
relation (in 5/7 vs 2/7) and greater QT/RR hysteresis in the ligated rabbits.
Conclusion: Greater QT/RR, greater hysteresis, and biphasic QT-RR relation are 
all theoretically arrhythmogenic, and could underlie the propensity of failing hearts to 
arrhythmia and sudden cardiac death.
ACC.ORAL CONTRIBUTIONS
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Clinical	Issues	With	Atrial	Fibrillation
Monday, March 26, 2007, 2:00 p.m.-3:30 p.m.
Room 278-281
2:00 p.m.
819-3	 Asians	Are	Less	Susceptible	to	Atrial	Fibrillation:		
A	Meta-Analysis
Gian M. Novaro, Craig R. Asher, Sergio L. Pinski, Deepak L. Bhatt, Cleveland Clinic 
Florida, Weston, FL, Cleveland Clinic, Cleveland, OH
Background: Development of atrial fibrillation (AF) in cardiac patients (pts) is 
multifactorial, including not well defined genetic factors. We sought to determine if Asian 
race was associated with the development of AF in pts with coronary disease.
Methods: We conducted a meta-analysis of 7 prospective randomized clinical trials 
coordinated by the Cleveland Clinic Clinical Coordinating Center that prospectively 
collected data on the development of AF: 4 trials in patients with acute myocardial 
infarction (GUSTO I, IIb, III, V), and 3 trials in pts with acute coronary syndromes 
(PURSUIT, IMPACT II, PARAGON A). Follow-up periods ranged from 6-12 months.
Results: A total of 94,785 pts were identified (93,050 white, 1735 Asian). At baseline, 
Asian pts were younger, had a lower body mass index, a lower prevalence of prior 
angioplasty and bypass surgery, and a greater prevalence of male gender and diabetes 
compared to white pts. Development of AF was lower in Asian than in white pts (4.7% 
vs. 7.6%; p<0.001), while rates of ventricular tachycardia/fibrillation were similar in both 
groups. In multivariate logistic analysis, Asian race was associated with significantly lower 
rates of AF (OR 0.65; 95% CI 0.50-0.84; p=0.001) compared to white race (see Table).
Conclusions:	Similar to prior studies showing a lower prevalence of AF in blacks, Asian 
race appears to be protective against the development of AF. Further study is needed to 
investigate the mechanisms and potential genetic underpinning behind this association.
Multivariate logistic model for incident atrial fibrillation
Variable Odds Ratio (95% CI) P
Age 1.060 (1.057-1.063) <.001
Female 0.908 (0.854-0.965) .002
BMI 1.008 (1.002-1.014) .006
Hx of MI 1.101 (1.030-1.176) .005
Hx of HTN 1.223 (1.157-1.294) <.001
Asian race 0.647 (0.496-0.843) .001
2:15 p.m.
819-4	 Is	Rhythm	Control	Superior	to	Rate	Control	in	New	
Onset	Atrial	Fibrillation?
Leonardo Tamariz, Marco Gonzalez, Howard Willens, Julio Chirinos, Bernardo Lopez-
Sanabria, Gordon Chen, Ana Palacio, Robert Mcnamara, University of Miami, Miami, FL
Background: Rate control has been shown to be a reasonable management strategy for 
many patients with atrial fibrillation (AF). However, the majority of patients enrolled in the 
clinical trials had persistent AF. We aimed to compare health care utilization and stroke 
rates between rate and rhythm control in new onset atrial fibrillation.
Methods: We analyzed data from a retrospective cohort of a large health benefits 
company with new onset AF, defined as having no claims for AF in the 12 months prior 
to the occurrence of the first AF claim. We stratified all individuals into two categories 
using pharmacy utilization codes: rate control only and rhythm (antiarrhytmics) control. 
Cox proportional hazard models were used to estimate the relative hazard (RH) of stroke 
and hospitalization. Additionally, we measured adjusted health care costs for each group 
during a 12-month follow-up using generalized linear models.
Results: We identified 19,341 subjects with new onset AF with a mean age of 70.9±12.8 
years and 46% females. The cohort consisted of 14,093 subjects in the rate control group 
and 5,248 subjects in the rhythm control group. During follow-up 7160 patients were 
hospitalized and 2347 had a stroke.
The RH of hospitalization for those subjects in the rhythm control group was 1.12; 95% 
CI 1.07-1.18 when compared to those in the rate control adjusted for demographics, 
congestive heart failure, myocardial infarction, hypertension, diabetes, abnormal lipids, 
peripheral vascular disease. The RH of stroke for those subjects in the rhythm control 
group was 1.16; 95% CI 1.05 - 1.29 when compared to those subjects in the rate control 
group adjusted for the same covariates plus the use of warfarin.
The adjusted one-year total health care costs were higher for the rhythm control group ($ 
37828; 95% C.I. 36575-39080) when compared to the rate control group ($ 31902; 95% 
C.I. 31141-32664).
Conclusions: Rate control was the most frequently used therapy for AF. Rhythm control 
was associated with higher health care utilization and stroke incidence when compared 
to rate control in new onset AF.
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819-5	 Is	Rhythm	Control	Superior	to	Rate	Control	in	Patients	
With	Atrial	Fibrillation	and	Diastolic	Heart	Failure?
Melissa S. Kong, Sana M. Al-Khatib, Linda K. Shaw, Robert M. Califf, Christopher M. 
O’Connor, Duke University Medical Center, Durham, NC
Background Although no clinical trial evidence exists on the optimal management of atrial 
fibrillation (AF) in patients with isolated diastolic heart failure, it has been hypothesized 
that rhythm-control is more advantageous due to the dependence of these patients’ left 
ventricular filling on atrial contraction. We aimed to determine whether such patients 
survive longer with rhythm- vs. rate-control.
Methods The Duke Cardiovascular Database (1995-2005) was queried for patients 
with EF>50% and discharge diagnoses of AF and heart failure. We compared baseline 
characteristics and survival of patients managed with rate- vs. rhythm-control. Using a 
60-day landmark view to assess medication usage, Kaplan-Meier curves were generated 
and results adjusted for baseline patient differences using Cox proportional hazards 
modeling.
Results 471 patients met inclusion criteria (338 treated with rate-control and 133 treated 
with rhythm-control). The 1-, 3- and 5-year survival rates were 92.4%, 70.6%, and 57.8% 
respectively in rate-controlled patients and 94.5%, 79.6%, and 63.5% respectively in 
rhythm-controlled patients (p>0.1). After baseline adjustments, no difference in mortality 
was seen.
Conclusions In patients with AF and isolated diastolic heart failure, rhythm-control 
seems to offer no survival advantage over rate-control. Randomized clinical trials are 
needed to verify these findings and examine the effect of each strategy on stroke risk, 
heart failure decompensation and quality of life.
2:45 p.m.
819-6	 Atrial	Fibrillation	Begets	Ventricular	Fibrillation	in	Post-
Myocardial	Infarction	Patients
Rajiv Sankaranarayanan, Michael James, Bogdan Nuta, Mandy Townsend, Stephanie 
Burtchaell, Russell Holloway, Paul Ewings, Taunton and Somerset Hospital, University of 
Bristol, Taunton, United Kingdom
Background: Atrial fibrillation (AF) remains an independent predictor of increased in-
hospital and long term mortality in post-myocardial infarction (MI) patients. We therefore 
investigated whether AF predisposes to ventricular tachycardia (VT) or ventricular 
fibrillation (VF) in post-MI patients thereby accounting for the increased mortality.
Methods: 500 consecutive patients (358 male, 142 female) with a diagnosis of acute 
MI were enrolled between March 2000 and March 2002. Follow-up was between 4 to 
6.6 years (mean 5.3 years). AF was identified in 124 patients out of which it was present 
prior to admission in 67(established AF) and developed subsequent to admission in 57 
patients (new onset AF). We included a wide range of variables that might influence or 
confound the results into the database.
Results: Mortality in patients in AF group when compared to non- AF group was 59% 
versus 27% (p<0.001). AF patients also demonstrated a significantly higher incidence 
of VF (13 % in AF group versus 6% in non-AF group,p=0.03) but not VT (20% versus 
17%,p=0.50).Amongst the co-morbid patient characteristics, univariate logistic analysis 
identified that VF has significant association with ejection fraction (0.04), infarct size 
(p=0.04), peak CPK level (p=0.01) and AF (p=0.03).However multivariate analysis 
showed that only AF was significantly and independently associated with VF. This 
association was with AF on admission or established AF (p<0.01) rather than with new 
onset AF (p=0.57).
Conclusions: AF in the setting of MI is independently associated with an increased risk 
of VF. This could be due to rapid stimulation of the vulnerable ventricle with short-long-
short sequences or due to alteration in the mechano-electrical feedback in the ventricle. 
Chronic AF may alter ventricular electrophysiology thereby acting as a substrate and 
the sudden occurrence of acute myocardial ischaemia acts a trigger for ventricular 
arrhythmias in the vulnerable period. The results of this study emphasize that patients 
with myocardial infarction who are in atrial fibrillation on admission are at high risk for 
developing ventricular fibrillation and should therefore be monitored, investigated and 
treated intensively.
3:00 p.m.
819-7	 Left	Atrial	Enlargement	Correlates	With	Inflammation	
and	Oxidative	Stress	in	Patients	at	High	Risk	for	Atrial	
Fibrillation
William H. Jang, Jose R. Cuellar, Irfan Shukrullah, Samuel C. Dudley, Jr., Heather L. 
Bloom, Emory University School of Medicine, Atlanta, GA, Atlanta VAMC, Decatur, GA
Background: Left Atrial (LA) enlargement strongly predisposes patients to atrial 
fibrillation (AF). The reason for this relationship is unclear, however. Recent studies have 
suggested oxidation of contractile or Ca2+ handling proteins may be involved. Therefore, 
we evaluated the relationship of oxidative stress and inflammatory markers and LA size 
in a cohort at high risk for AF.
Methods: Serum markers of oxidation and inflammation were measured in a cohort of 
patients with left ventricular dysfunction, a known risk factor for AF. LA size was obtained 
from echocardiography, with an anteroposterior diameter greater than 5.0 cm defined 
as enlarged. Markers include: derivatives of Reactive Oxidative Metabolites (dROMs), 
interleukin-1 beta (IL-1B), interleukin-6 (IL-6), C-reactive protein (CRP), tumor necrosis 
factor alpha (TNF-alpha), nitrotyrosine, reduced glutathione (EhGSH), and cystiene 
(EhCySH). Univariate and multivariate analysis were performed to examine the relationship 
between LA enlargement and these markers of oxidative stress after correcting for age, 
gender, body mass index, (BMI), hypertension, diabetes and use of statins, angiotensin-
converting enzyme inhibitors (ACE) or angiotensin receptor blockers (ARB).
Results:	Analysis of 171 patients, average age 67, EF 19.4%, 81% male[SCD1] , 36% 
diabetic, 59% hypertensive, 67% smokers, 56% on statins, 82% on ACE or ARB and 38% 
with BMI greater than 30. Univariate analysis showed that BMI, CRP, IL-6, and reduced 
glutathione were associated with LA enlargement (p= 0.04, 0.021, <0.001, and .004; 
r= .240, .213 .329 and .242). Multivariate analysis demonstrated that the inflammatory 
markers, CRP and IL-6, were strongly and independently associated with LA enlargement 
(p= 0.018 and <.001). Reduced glutathione, an oxidative stress marker, remained 
significant (p= 0.031), but BMI did not (p= 0.07).
Conclusions:	These data support the association between inflammatory and oxidative 
stress and LA enlargement in a group at high risk for development of AF. Therapies 
directed toward inflammation and oxidative stress may reverse LA enlargement and thus 
the reduce risk of AF and its incident stroke and cardiovascular morbidity/mortality.
3:15 p.m.
819-8	 Use	of	Warfarin	and	Performance	of	Stroke	Risk	
Stratification	Models	in	Atrial	Fibrillation
Leonardo Tamariz, Donald Parris, Julio Chirinos, Bernardo Lopez-Sanabria, Gordon 
Chen, Ana Palacio, University of Miami, Miami, FL
Background: Stroke is an important complication of atrial fibrillation (AF). Risk 
stratification models are used to predict stroke rates and guide therapy. We aimed to 
determine the use of warfarin in patients with AF by their risk of stroke and compare the 
different stroke risk stratification models.
Methods:	 We analyzed data from a retrospective cohort of a large health benefits 
company of subjects with AF. We compared the following stroke risk stratification models: 
CHADS2 (an acronym for congestive heart failure, hypertension, age > 65, diabetes, prior 
stroke), AFI (atrial fibrillation investigators), SPAF (stroke prevention atrial fibrillation) and 
Framingham scores. We determined the incidence of stroke over 12 months of follow-up 
by categories of risk on each risk stratification model using person-time analysis and the 
area under the receiver operating characteristic curve (ROC) of each risk stratification 
model.
Results: The cohort consisted of 18,197 subjects with AF with a mean age of 71±12.6 
years, 46% females and 29% heart failure. Only fifty percent of the cohort used warfarin 
despite increasing risk of stroke (table). The areas under the ROC curves were: CHADS2 
score 0.70; 95% CI 0.68-0.71, SPAF 0.66; 95% CI 0.65-0.67, for AFI 0.67; 95% CI 0.66-
0.68 and for the Framingham score 0.66; 95% CI 0.65-0.68.
Conclusions: There is a need to improve anticoagulation use in patients with AF. The 
CHADS2 score is a better predictor of stroke risk than other risk stratification models.
Risk of stroke and warfarin use by risk stratification models
Stroke risk 
stratification model
Categories of 
stroke risk
Annual risk of stroke per 1000 
person-years
% Use of 
warfarin
CHADS2
Low
Intermediate
High
0.12
0.29
0.98
51
49
50
AFI LowHigh
0.10
0.41
50
50
SPAF LowHigh
0.16
0.45
51
49
Framingham LowHigh
0.087
0.40
52
49
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Implantable	Defibrillators	and	
Resynchronization:	Practice	and	
Outcomes
Tuesday, March 27, 2007, 7:00 a.m.-8:30 a.m.
Room 228-229-230
7:00 a.m.
830-3 	 A	Gender	and	Racial	Gap	in	Implantable	Cardioverter	
Defibrillator	Use	Among	Hospitalized	Heart	Failure	
Patients:	Data	From	the	American	Heart	Association’s	
Get	With	The	Guidelines	Heart	Failure	(GWTG-HF)	
Program.
Adrian F. Hernandez, Gregg C. Fonarow, Li Liang, Sana Al-Khatib, Kenneth A. LaBresh, 
Clyde Yancy, Nancy M. Albert, Eric D. Peterson, Duke Clinical Research Institute, 
Durham, NC
Background: The ACC/AHA guidelines for HF patients now recommend ICD implantation in 
symptomatic HF patients with an EF < 30%, optimally managed and reasonable functional 
status. The influence of gender and race is unknown on ICD use in this population.
Methods: Data were collected by 133 hospitals participating in the GWTG-HF quality 
improvement program from January 2005 until April 2006. The frequency of ICD use 
at discharge was determined from potentially eligible HF patients with an EF <30%. 
Associated factors with ICD use were determined by a multivariable logistic regression 
model using generalized estimation equation method.
Results: Among 20,511 discharges, 4111 fulfilled eligibility criteria for ICD use. Mean 
age was 66.7, 33.2% female, ischemic etiology 56.3%, mean LVEF 20%. Race/ethnicity 
was 64.3% Caucasian, 24.7% African-American and 6.5% Hispanic. There were 1165 
(28.3%) patients with an ICD on discharge (482 new implants). The frequency of ICD 
use among females was 21.3% versus 31.9% for males (p< 0.0001) and for African-
Americans was 21.8% versus 31.6% for Caucasians (p<0.0001). Table below shows 
adjusted odds ratios for ICD use.
Conclusions: Less than a third of potentially eligible HF patients received an ICD and 
there are significant gender and race disparities in ICD use. Further initiatives are 
needed to understand and close the gap in ICD use overall and for these populations. 
Factors	Associated	with	ICD	use	at	Discharge	Among	Eligible	Patients	
Factor OR Lower	95%	CL Upper	95%	CL P-Value
Age (per 10 years) 0.81 0.76 0.87 <0.001
Female 0.62 0.52 0.74 <0.001
Caucasian 1.28 1.0 1.63 0.048
BMI (per 5) 0.94 0.88 1.01 0.071
Anemia 0.65 0.47 0.9 0.009
Depression 0.63 0.45 0.86 0.0042
Hyperlipidemia 1.44 1.21 1.7 <0.001
Hypertension 0.71 0.58 0.86 <0.001
Ischemic 1.66 1.40 1.96 <0.001
Smoking 0.59 0.47 0.74 <0.001
7:15 a.m.
830-4	 Programming	Ventricular	Tachycardia	Therapy	in	
Patients	With	a	Primary	Prevention	Implantable	
Cardioverter	Defibrillator	Indication:	Preliminary	
Results	From	the	PROVE	Trial
Mohammad Saeed, Sumati Ramadas, Curtis Neason, Mehdi Razavi, Abdi Rasekh, Ali 
Massumi, St. Luke’s Episcopal Hospital/ Texas Heart Institute, Houston, TX
Background: Recent studies have demonstrated that the use of implantable cardioverter-
defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) 
significantly reduces mortality in patients with ventricular dysfunction and mild-to-moderate 
heart failure. These studies, however, utilized predominantly shock-only ICDs without the 
programming of antitachycardia pacing (ATP). The PROVE trial is designed to determine if 
ATP therapy is clinically beneficial in patients receiving defibrillator for primary prevention 
of sudden cardiac death. Methods: This cohort consists of data from initial implants and 
subsequent follow-up in patients enrolled in PROVE, a prospective, non-randomized, 
multi-center study using market released ICDs and CRT-Ds. Each device is programmed 
with a monitor zone for cycle lengths 330-400ms, a ventricular tachycardia (VT) zone with 
ATP as first therapy from 270-330ms, and a ventricular fibrillation (VF) zone with high 
voltage shocks for cycle lengths less than 270ms. Patients are then followed at 3, 6, and 
12 months. Incidence of (VT) and the rate of successful termination by ATP were then 
analyzed. Results: There were 633 primary implants in PROVE (75% male, 67.3 ± 11.9 
years). Of the total implants, 35% were single chamber ICDs, 43% were dual chamber 
ICDs, and 22% were CRT-Ds. There have been 40 episodes of sustained VT detected 
in the VT zone among the cohort at a mean follow-up duration of 4.0 ± 1.6 months. 33 
(82.5%) episodes of VT were successfully terminated with ATP while 7 (17.5%) episodes 
of VT were detected but ATP was not successful. Of the 55 episodes of supraventricular 
tachycardia in the VT zone, 46 (84%) episodes were appropriately discriminated and 
therapy was subsequently withheld while 9 (16%) episodes resulted in inappropriate ATP. 
2 of the 11 shocks (18%) in the VF zone were inappropriate. Conclusions: Early follow-
up data from PROVE trial suggests that incidence of VT is significant among patients 
receiving ICDs or CRTs for primary prevention of sudden cardiac death. Programming 
empiric ATP therapy at time of implant in these patients can pace terminate majority of 
these VT episodes, potentially avoiding painful shocks.
7:30 a.m.
830-5	 ICD	Therapy	and	Outcomes	in	Survivors	of	Sudden	
Cardiac	Arrest	After	High-Risk	Myocardial	Infarction:	
The	VALsartan	In	Acute	myocardial	iNfarcTion	
(VALIANT)	Trial
Kent Stephenson, Jens J. Thune, Steven Zelenkofske, John J.V. McMurray, Robert M. 
Califf, Lars Kober, Jean-Lucien Rouleau, Eric J. Velazquez, Aldo P. Maggioni, Marc A. 
Pfeffer, Scott D. Solomon, Brigham and Women’s Hospital, Boston, MA
Background.	Survivors of sudden cardiac arrest (SCA) are at increased risk for future 
events. To assess the clinical course of patients successfully resuscitated after SCA, we 
reviewed data from VALIANT.
Methods.	VALIANT enrolled 14,703 patients median 5 days after MI complicated by LV 
dysfunction, HF, or both. Patients were considered a survivor of SCA if they lived at least 
1 day after being resuscitated and demonstrated cognitive function. Cox proportional 
hazards model was used to assess the risk of death among patients successfully 
resuscitated from SCA according to ICD status. Survival time defined as time from SCA.
Results.	Of 1057 patients with SCA and no previous ICD, 155 (15%) were resuscitated. 
Of these, 37 (24%) received an ICD within 6 weeks (median 11 days). Median time 
to SCA was 47 days (interquartile range 10-256) for patients receiving an ICD and 
43 days (9-189) for those who did not (P=0.59). Patients receiving an ICD were male 
(84%), had lower Killip class, higher BMI at baseline, and more often received primary 
PCI or thrombolysis. Of patients surviving SCA in the US, 24/44 (55%) received an ICD 
compared with 13/111 (12%) outside the US. Mortality during follow-up was 56% for 
patients not receiving an ICD; 26% for patients receiving an ICD (HR 0.31, 0.14-0.67), 
similar to matched patients without SCA.
Conclusion.	Survivors of SCA are at high risk of death during follow-up. Although not 
randomized and subject to bias, survivors of SCA receiving ICD had similar outcomes to 
matched patients without SCA. 
7:45 a.m.
830-6	 Impact	of	Race	and	Gender	on	Likelihood	of	Implant	of	
Cardiac	Defibrillators	and	Biventricular	Pacemakers	in	
Patients	With	Reduced	Left	Ventricular	Systolic	Function
Mikhael F. El-Chami, Jonathan J. Langberg, Heather Bush, Ibrahim R. Hanna, Emory 
University, Atlanta, GA, Cardiology P.C., Birmingham, AL
Background: Implantable cardiac defibrillators (ICD) and biventricular (BiV) pacemakers 
decrease mortality and heart failure symptoms in patients with reduced left ventricular 
(LV) ejection fraction (EF). We sought to investigate the impact of gender and race on 
implant of these devices in patients with LV systolic dysfunction.
Methods: Data were obtained from ADVANCENT(SM), a multicenter registry of patients 
with LVEF≤40%. 26,264 patients from 106 US centers were enrolled as of September 30, 
2004. The mean age was 66.4 years, 71.5% were males and 81.9% were white. 10,394 
subjects (39.6%) had devices implanted. Of these patients, 23% had pacemakers, 51% 
had single or dual chamber ICDs , 19% had BiV-ICDs, and 4% had BiV pacemakers.
Results: The overall rate of device implantation was higher in white patients compared 
with non-whites (41.1% vs. 32.5% p<0.0001). This finding was also true for the rates of 
implantation of all types of ICDs (28.6% vs. 23.9%, p<0.0001), and BiV devices (11.2% 
vs. 7.7%, p<0.0001). In multivariable regression analysis, after adjusting for age, gender, 
LVEF, NYHA class, coronary artery disease, QRS duration, comorbidities, education, 
and insurance type, black race remained a strong and independent negative predictor 
of device implantation (OR 0.86, 95%CI 0.791-0.927), or any ICD implantation (OR 0.88, 
95%CI 0.817-0.964). Female gender was also independently associated with decreased 
implantation rates for any device (OR 0.70, 95%CI 0.66-0.76), or any ICD (OR 0.59, 
95%CI 0.55-0.64).
When the patient’s race and gender were considered in aggregate, the rate of ICD 
was lowest in black women(18.5%), followed by white women (19.1%), black men 
(27.1%), and white men (32.1%)(p<.0001).
Conclusions: In this large cohort of patients with reduced LVEF, minorities and women 
were significantly less likely to receive device implants. These findings were most 
pronounced in black women, and could not be explained by disparities in demographic 
or clinical characteristics.
JACC  March 6, 2007  ABSTRACTS - Cardiac Arrhythmias    7A 
C
ardiac A
rrhythm
ias
8:00 a.m.
830-7	 Devices	in	Heart	Failure:	A	Systematic	Review	of	the	
Efficacy,	Effectiveness,	and	Safety	of	Implantable	
Cardioverter	Defibrillators	and	Cardiac	Resynchronization	
Therapy	in	Left	Ventricular	Dysfunction
Justin Ezekowitz, Finlay McAlister, Nicola Hooton, Donna Dryden, Ben Vandermeer, 
Brian Rowe, University of Alberta, Edmonton, AB, Canada
Background: Heart failure (HF) is associated with substantial morbidity and mortality 
despite best therapy. The objective of this systematic review was to determine the efficacy, 
effectiveness and safety of cardiac resynchronization therapy (CRT) and implantable 
cardioverter-defibrillators (ICD) in patients with HF.
Methods: An extensive electronic and bibliographic search (1980 to 2006) was carried out 
(including contact with investigators of trials and device manufacturers) for randomized 
clinical trials (RCT) for efficacy and controlled trials plus prospective cohort studies for 
effectiveness and safety in patients with HF. Meta-analytic techniques endorsed by the 
Cochrane Collaboration were used.
Results: Based on data pooled from all 15 RCT (n=527 deaths/4023 patients), CRT 
alone significantly reduced all-cause mortality, with a relative risk (RR) of 0.70 (95%CI 
0.60 to 0.81). However, sudden cardiac death (n=102 deaths/2776 patients) was almost 
identical between CRT and control (RR 1.01, 95%CI 0.69 to 1.48) and only HF death 
(n=149 deaths/2646 patients) was reduced (RR 0.59, 95%CI 0.43 to 0.81). In 4 of the 15 
CRT trials (n=90 deaths/1409 patients) that included ICD as background therapy in both 
arms of the trial, the RR 0.88 (95%CI 0.59 to 1.32) was non-significant.
Using data from 12 RCT (n=1778 deaths/8516 patients), ICD alone reduced all-
cause mortality, (RR 0.80, 95%CI 0.71 to 0.90), sudden cardiac death (RR 0.48, 
95%CI 0.38 to 0.60) without a change in non-cardiac death and with limited 
data, HF death. The benefit of ICD was similar for all-cause mortality from the 10 
observational studies RR 0.51 (95%CI 0.39, 0.67).
78 studies (10653 patients) were included in the safety review for CRT and 45 studies 
(21250 patients) for ICD. For CRT and ICD respectively, implant success was 93% 
and 99%, peri-implant deaths 0.4% and 1.1%, lead dislodgement 6.8% and 4.6% and 
mechanical malfunctions in 1.6% and 1.3%.
Conclusions: In HF patients with meeting RCT entry criteria, both ICD and CRT reduce 
all-cause mortality. However, only ICD reduces sudden cardiac death, and only CRT 
reduces HF death, leading for a difficult choice as the rate of complications from these 
devices is not insignificant.
8:15 a.m.
830-8	 Mortality	of	Heart	Failure	Patients	After	Cardiac	
Resynchronization	Therapy:	Choice	of	Device	and	
Identification	of	Predictors
Rong Bai, Kenneth C Civello, Luigi Di Biase, Chi Keong Ching, Dimpi Patel, Lucie 
Popova, Mohammed N. Khan, Subramanya Prasad, Tamer S. Fahmy, Claude S. Elayi, 
Oussama M. Wazni, Jennifer E. Cummings, Robert A. Schweikert, Thomas Dresing, 
Walid Saliba, Patrick Tchou, Mauricio Arruda, David Martin, Bruce Wilkoff, J. David 
Burkhardt, Andrea Natale, Cleveland Clinic Foundation, Cleveland, OH
Objectives: This study compares the long-term survival benefits of cardiac 
resynchronization therapy (CRT) with and without defibrillator capability in a cohort of 
heart failure patients. It also seeks to identify predictors of death in this population with 
different co-morbidities.
Backgrounds: CRT and implantable cardioverter-defibrillator (ICD) have both been 
shown to decrease mortality in patients with heart failure. Although there was a significant 
reduction in all cause mortality in the CRT population, a direct comparison of CRT-
Pacemaker and CRT-Defibrillator was not performed. Less data is available comparing 
the incidence of death in CRT patients with different co-morbidities.
Methods:	 542 consecutive patients undergoing either CRT-Defibrillator or CRT-
Pacemaker implantation between 1999 and 2005 were studied. All patients were followed-
up at 1, 3, 6, 9, 12 months following the procedure and every six months thereafter. 
A minimum of one year follow-up for all surviving patients was required. The primary 
endpoint of this study was all-cause mortality which was compared between patients with 
CRT-Pacemaker and CRT-Defibrillator; with and without diabetes mellitus, chronic renal 
failure, chronic obstructive pulmonary diseases or history of atrial fibrillation.
Results: Total mortality was significant lower among patients with CRT-Defibrillator as 
compared with those with CRT-Pacemaker (18.5% vs. 38.8%, P<0.0001). A Kaplan-Meier 
curve showed that the survival difference between the two groups became evident since 
the first year after implantation and continued through 80 months of follow-up (P=0.03). 
Patients with chronic renal failure, diabetes mellitus or history of atrial fibrillation are at 
high risk of death even after CRT-Defibrillator insertion.
Conclusion: CRT-Defibrillator has additional survival benefits over CRT-Pacemaker and 
should be recommended to most heart failure patients who meet the current indications 
for biventricular pacing. Chronic renal failure, diabetes mellitus and history of atrial 
fibrillation are strong independent predictors of death in CRT population. 
ACC.ORAL CONTRIBUTIONS
836 
Mechanisms	of	Ventricular	Arrhythmias
Tuesday, March 27, 2007, 9:00 a.m.-10:30 a.m.
Room 217-218-219
9:00 a.m.
836-3	 Evidence	for	Mechanically-Induced	Ion-Channel	
Dysfunction	as	a	Mechanism	in	Chest	Blow-Induced	
Ventricular	Fibrillation	(Commotio	Cordis)
Mark S. Link, Barry J. Maron, Christopher P. Song, Paresh Mane, N. A. Mark Estes, III, Tufts-
New England Medical Center, Boston, MA, Minneapolis Heart Institute, Minneapolis, MN
Background. Sudden cardiac death secondary to innocent chest wall blows in sports and 
other daily activities has been reported with increasing frequency. In an experimental model 
we have shown that ventricular fibrillation could be induced with a 30 mph baseball blow 
to the chest wall during the vulnerable period of repolarization, and that the initiation of 
ventricular fibrillation was related to the peak left ventricular pressures generated by the 
chest blow. Mechanical activation of ion channels is believed to be an underlying mechanism 
by which ventricular fibrillation occurs. Since ion channels are anchored to micro-tubules 
within the cell, if disruption of the micro-tubules alters the incidence of ventricular fibrillation 
it would provide further evidence that mechanical activation of ion channels occurs.
Methods. Ten animals (mean 12.4 + 1.5 kg) were randomized to receive 10 mg colchicine 
intravenously, a known microtubule disrupter, or a control solution. Investigators were 
blinded to which solution the animal received. Animals were given up to 6 impacts with 
a 30 mph baseball on the chest wall directly over the cardiac silhouette, timed to impact 
during the vulnerable period for ventricular fibrillation.
Results. Initiation of ventricular fibrillation was seen in 14 of the 29 (48%) impacts in the 
colchicine animals compared to only 3 of 28 (11%) in the control animals (p=0.002). The 
peak left ventricular pressure generated by the blow was not different (colchicine animals; 
404 + 61 mmHg, and controls; 386.7 + 114.6 mmHg (p = 0.45).
Conclusion. The initiation of ventricular fibrillation by chest blows was markedly increased by 
selective interference with microtubule function, providing further evidence that mechanical 
activation of ion channels underlies the mechanism of ventricular fibrillation in commotio cordis.
9:15 a.m.
836-4	 Isolated	Left	Ventricular	Noncompaction	Is	
Arrhythmogenic	in	the	Absence	of	Heart	Failure,	Left	
Ventricular	Dysfunction,	and	Myocardial	Fibrosis
William T. Katisiyannis, Robert G. Hauser, Marc T. Ellingson, Charles C. Gornick, 
Timothy G. Dirks, Matthew M. Thielman, John R. Lesser, Barry J. Maron, Minneapolis 
Heart Institute Foundation, Minneapolis, MN
Background: Left ventricular noncompaction (LVNC) is an inherited cardiomyopathy 
characterized by trabeculations and deep recesses within the endomyocardium. LVNC 
is increasingly recognized due to advanced cardiac magnetic resonance imaging (CMR). 
Clinical signs may include arrhythmias, heart failure, and thromboembolism. We report our 
experience with patients whose only manifestation of LVNC was a ventricular arrhythmia.
Methods:	LVNC was diagnosed if CMR showed a noncompacted endocardial layer which 
was twice as thick as the compacted segment at end-systole. Patients were excluded if 
they had heart failure, left ventricular dilation or ejection fraction < 55% by CMR and 
echocardiography, delayed hyperenhancement following gadolinium contrast-enhanced 
CMR (fibrosis), or clinically significant coexisting cardiac disease.
Results:	Since 2002 CMR identified 39 patients with LVNC at our center. Of these, 10 
patients met the criteria for this study. Average age was 31.8±15.7 (range: 11-59) years 
and 7 were male. Presenting symptoms were syncope (n=5), palpitations (n=1), and 
dyspnea (n=1); 3 patients were asymptomatic and were evaluated for a family history 
of LVNC (n=2) or murmur (n=1). All patients had sinus rhythm and the ECG was normal 
(n=5) or non-specific (n=5). Arrhythmias included polymorphic ventricular tachycardia 
(VT) (n=1), non-sustained VT (n=5) and ventricular ectopy (n=4). Echocardiographic 
findings included LVNC in 4 patients, 2 patients had apical hypertrophy, and 2 
patients were normal, including one with syncope and polymorphic VT. CMR delayed 
hyperenhancement after gadolinium was absent in each of these 10 patients. During 
average follow-up of 23.9±15.9 months, all patients were alive; 7 have implantable 
cardioverter-defibrillators (ICD), and one has received a shock for symptomatic VT.
Conclusions: LVNC appears to represent a pure arrhythmogenic substrate independent 
of left ventricular size or function, myocardial fibrosis by CMR, and heart failure. Thus 
patients with subtler forms of LVNC may be prone to ventricular arrhythmias and sudden 
death. Additional studies are needed to understand this emerging entity including 
indications for ICD implantation.
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836-5	 Mechanisms	of	Differential	Patterns	of	Survival	
Between	Andersen-Tawil	(LQT7)	and	Timothy	(LQT8)	
Syndromes
Han-Dong Chang, Sheng-Nan Wu, Ruey Jen Sung, National Cheng Kung University 
College of Medicine, Tainan, Taiwan,ROC
Background: Andersen-Tawil syndrome (ATS) is caused by genetic mutations leading 
to “loss of function” of Kir2.1 channel and Timothy syndrome (TS) to “gain of function” of 
Cav1.2 channel. Both ATS and TS clinically manifest QT prolongation and have a high 
prevalence of ventricular arrhythmias (64% and 71%, respectively). However, patients 
with ATS rarely experience sudden death and those with TS seldom live beyond 3 
years of age. We sought to determine electrophysiological mechanisms responsible for 
disparate clinical outcomes between ATS and TS.
Methods	 and	 Results: We adopted a modified dynamic Luo-Rudy simulation model 
to study action potential (AP) of cardiac ventricular myocyte at various cycle lengths 
with [K+]
o 
set at 4.5 mM. In simulated ATS, stepwise 10% reduction of Kir2.1 channel 
conductance progressively prolonged terminal phase of AP and depolarized resting 
membrane potential (RMP); early afterdepolarizations (EAD) and spontaneous AP 
appeared after the reduction reached > 80%. In simulated TS, stepwise 2X increase 
in Cav1.2 inactivation time constant (ITC) resulted in marked prolongation AP without 
affecting RMP; delayed afterdepolarizations (DAD) appeared when increase in ITC 
reached 6X. To correlate transmural dispersion of refractoriness (TDR) with T-peak to 
T-end (Tp-Te) interval of pseudo ECG, it was noted that TDR remained relatively stable 
despite progressive increase in Tp-Te during stepwise reduction of Kir2.1 channel 
conductance in ATS whereas TDR closely coincided with the increase in Tp-Te interval 
during incremental increase in ITC of Cav1.2 channel in TS. Besides, in TS, AP duration 
restitution curve was much steeper compared to that of ATS.
Conclusions: (1) Despite EAD and spontaneous AP, relatively stable TDR and flatter 
restitution curve of AP duration rmay account for less likelihood of triggering serious 
arrhythmias in ATS and (2) in contrast, DAD-mediated triggered activity in the presence 
of marked TDR and steeper restitution curve of AP duration may be a cause of torsades 
de pointes along with an ease of degeneration into ventricular fibrillation in TS. Thus, 
clinically TS connotes a poorer prognosis than ATS.
9:45 a.m.
836-6	 Possible	Increased	Risk	of	Cardiac	Arrhythmias	in	
Patients	With	Acquired	Short	QT	Interval
Ramin Assadi, Richard Chang, Amir Abdipour, Sudha M. Pai, Kenneth R. Jutzy, Loma 
Linda University Medical Center, Loma Linda, CA
Background: Short QT syndrome is a recently described genetic disease characterized 
by short QT interval, high risk of sudden death, atrial fibrillation, and short refractory 
periods; however, there are other known factors that shorten QT interval, such as 
increased heart rate, hyperthermia, hypercalcemia, hyperkalemia, acidosis, and 
administration of digitalis glycosides. There is little data available in current literature 
regarding the acquired etiologies and their possible associations with clinically significant 
arrhythmias.The purpose of this study was to evaluate the association of short QT interval 
(including acquired forms) with cardiac arrhythmias including atrial fibrillation/flutter and 
ventricular tachyarrhythmias.
Methods: Nineteen patients with short corrected QT intervals (<300ms) irrespective of 
the etiology were evaluated for cardiac arrhythmias on the same day the short QT interval 
was detected; other variables that could potentially affect the QT interval such as heart 
rate, hyperkalemia, hypercalcemia, acidosis, hyperthermia, use of digital glycosides, and 
renal insufficiency have been included in this matched case-control study. Each case 
had 2 controls matching in sex, age, and ethnicity. At least 85% of the cases and 80% of 
controls had some evidence of structural heart disease on their echocardiograms.
Results: Twelve cases (63%) showed atrial fibrillation and/or atrial flutter simultaneous 
with short QT interval, and 32% developed cardiac arrest due to ventricular 
tachyarrhythmias after short QT was detected. After adjusting for age, sex, ethnicity, heart 
rate, temperature, corrected serum calcium, serum potassium, acid-base status, digitalis 
use and creatinine, with multivariable logistic regression analysis, patients with short QT 
interval possess significantly increased risk of arrhythmia (p=0.017). The minimum risk of 
arrhythmia for cases that have short QT interval is 4.46 times compared to their matched 
controls with normal QT intervals.
Conclusions: Short QT interval including the acquired form may be an independent risk factor 
for cardiac arrhythmias such as atrial fibrillation, atrial flutter, and ventricular tachyarrhythmias.
10:00 a.m.
836-7	 Variable	Genetic	Backgrounds	Between	Congenital	and	
Acquired	Long	QT	Syndromes
Hideki Itoh, Takeru Makiyama, Seiko Ohno, Yuko Oka, Tomoko Sakaguchi, Iori Nagaoka, 
Takashi Ashihara, Makoto Ito, Masaharu Akao, Minoru Horie, Shiga University of 
Medical Science, Otsu, Japan
Backgrounds: Over half of congenital long QT syndrome (cLQTS) are associated with 
cardiac ion channels gene mutations, while genetic backgrounds for acquired long QT 
syndrome (aLQTS) are not clear.
Methods: We analyzed genetic backgrounds in 196 unrelated LQTS probands including 138 
cLQTS and 58 aLQTS probands. We also evaluated 107 family members for genotyped LQTS.
Results: In basal clinical characteristics, aLQTS were significantly older (cLQTS vs. 
aLQTS, 28 ± 19 vs. 58 ± 20 years, p < 0.0001) and female for aLQTS tended to be more 
than cLQTS (cLQTS vs. aLQTS, 65 vs. 79 %, p = 0.06). Symptomatic patients were equal 
between 2 groups (cLQTS vs. aLQTS, 60 vs. 60 %). In genetic analyses, we identified 
mutations associated with cardiac ion channels genes in 63 of 138 cLQTS and 16 of 
58 aLQTS, and could detect gene mutations for aLQTS less than cLQTS (cLQTS vs. 
aLQTS, 46 vs. 28 %, p < 0.05). Eleven of 16 mutations associated with aLQTS were novel 
or previously reported as mutations associated with aLQTS, while other 5 mutations have 
been reported as mutations for cLQTS. In LQT1 and LQT2 forms, mutations sites for 
aLQTS were different from cLQTS, that most of mutations for aLQTS were detected 
in non-pore regions (non-pore mutations for cLQTS vs. aLQTS, 45 % vs. 87 %, p < 
0.001). In analyses for family members, QT intervals of mutation carriers for cLQTS were 
prolonged but shorter than genotyped probands (probands vs. family members, 515 ± 68 
vs. 474 ± 55 ms, p < 0.01) and only 7 (19 %) of 37 genotyped family members for cLQTS 
had syncopal attacks. On the other hand, all mutation carieers for genotyped aLQTS had 
not experienced any cardiac events and the QTc intervals were normal (436 ± 49 ms).
Conclusions:	  Though genetic backgrounds for aLQTS are less than cLQTS, we 
note that aLQTS with gene mutations are common than expectedly. A part of genetic 
backgrounds could overlap between cLQTS and aLQTS, and genetic factors always 
could not dominate clinical phenotypes.
10:15 a.m.
836-8	 Effects	of	Adenosine	on	Canine	and	Human	Reentrant	
Ventricular	Tachycardia
Bindi K. Shah, Steven M. Markowitz, Sei Iwai, Kenneth M. Stein, David Dobesh, Dmitry 
Nemirovsky, Daniel Morin, Eran Zacks, Bruce B. Lerman, Cornell University Medical 
Center, New York, NY
Background: Adenosine has no direct electrophysiologic effects on ventricular myocardium. 
Rather, its actions are indirect and mediated through its antiadrenergic effects on cAMP, 
thus inhibiting Ica(L), Iti, and delayed afterdepolarizations. These actions account for its 
ability to terminate ventricular tachycardia (VT) due to cAMP mediated triggered activity 
(outflow tract VT). The purpose of this study was to determine whether adenosine’s effects 
on VT are mechanism specific by examining the effects of adenosine on reentrant VT in 
humans and a canine model using electroanatomic mapping to validate mechanism.
Methods: We examined the effects of adenosine on 15 patients with structural heart 
disease who were referred to our laboratory for ablation of VT due to a macroreentrant 
circuit. The mechanism of VT was characterized by three-dimensional electroanatomic 
mapping, entrainment, and results of successful radiofrequency ablation. VT induction 
was attempted with programmed stimulation in the baseline state and then during 
concurrent catecholamine infusion. In the canine model, 4 mongrel dogs underwent 
coronary ligation and induction of VT 4 days later with mapping of the circuit using an 
epicardial multielectrode array. Similarly, adenosine was administered during VT induced 
in the baseline state in 3 dogs and during catecholamine infusion in 1 dog.
Results: All 15 human subjects (ARVC 4/15, ischemic cardiomyopathy 9/15; nonischemic 
cardiomyopathy 2/15; 60+/-14 years; 15 male) had inducible VT and a reentrant 
circuit confirmed. 5/15 patients had catecholamine dependent VT. VT was adenosine-
insensitive in all patients (no change in cycle length or termination). In the canine model, 
an isochronal map of VT obtained with the multielectrode array demonstrated a clear 
reentrant circuit with a “figure of eight” reentry. All 4 VTs in this model were adenosine 
insensitive, including the catecholamine dependent VT.
Conclusions: Reentrant VT, whether catecholamine-dependent or independent, is adenosine-
insensitive. These data add further support for the hypothesis that adenosine’s effects on VT are 
mechanism specific, only terminating VT that is due to cAMP-mediated triggered activity.
ACC.ORAL CONTRIBUTIONS
846 
Novel	Technologies	and	Techniques	for	
Catheter	Ablation
Tuesday, March 27, 2007, 2:00 p.m.-3:30 p.m.
Room 217-218-219
2:00 p.m.
846-3	 Experimental	Studies	With	a	9-French	Forward-
Looking	Intracardiac	Imaging	and	Ablation	Catheter	
Developed	in	a	National	Institutes	of	Health	Supported	
Bioengineering	Research	Partnership	Grant	Program
David J. Sahn, Kalyanam Shivkumar, Aman Majahan, Muhammad Ashraf, Long Liu, 
Jonathan Cannata, Xunchang Chen, Raymond Chia, Aaron Dentinger, Matthew 
O’Donnell, K.Kirk Shung, Douglas N. Stephens, Kai Thomenius, Oregon Health & 
Science University, Portland, OR, University of California, Los Angeles, CA
Background: Intracardiac ultrasound imaging catheters to date have been side-looking 
because of the limited available space on the tip of a catheter for forward-looking arrays.
Methods: We have integrated a high frequency, high resolution, near field optimized 
28-element 13 MHz broad bandwidth forward-looking array on a 9 French EP-style 
highly steerable catheter. The scanning catheter also has a custom tip with an ablation 
electrode face and two ports, one for a thermocouple and one for an anchoring guidewire. 
This device was tested in 4 acute pig studies for image quality, anatomic identification, 
visualization of other catheter devices and a mechanism for stabilization when imaging 
ablation. Proximal and distal electrodes allowed 3D spatial registration of catheter location 
with NavX mapping.
Results: In all animals, microlinear forward-looking array catheters were positioned in the 
right atrium and ventricle, and in 3 pigs successfully imaged and localized ablation was 
verified on post-mortem photography on the right side of the septum. In the fourth animal, 
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imaging was performed in the right ventricular apex in two locations. The device has 
adequate shielding to avoid radiofrequency interference during ablation and was capable 
of resolving both bubbling of tissue and intensity changes during ablation out to 2 cm 
from the transducer face.
Conclusions: The performance of this device in terms of penetration and resolution 
exceeded specifications and as a forward looking device, it is very easy to use.
2:15 p.m.
846-4	 Location	on	Left	Atrial	3-D	Computer	Tomography	of	
Lesions	Delivered	Through	Balloon-Based	Ablation	
Systems
Robert A. Schweikert, Walid Saliba, Sakis Themistoclakis, Antonio Raviele, Aldo 
Bonso, Antonio Rossillo, J. David Burkhardt, Jennifer Cummings, Mandeep Bhargava, 
David Martin, Oussama Wazni, Mohamed Kanj, Kenneth Civello, Michael McWilliams, 
Mohammed Khan, Shane Bailey, Andrea Natale, Cleveland Clinic, Cleveland, OH
Background: Current balloon-based ablation systems for atrial fibrillation (AF) are 
designed to be deployed outside the pulmonary vein (PV) so that the antrum may be 
included in the lesion set. We assessed the location of electrical isolation of the PVs 
by two of such balloon-based ablation systems in patients undergoing ablation for 
paroxysmal AF.
Methods: In 11 patients with paroxysmal AF undergoing PV isolation either with the 
endoscopic laser balloon ablation system (EAS, CardioFocus) (9 patients) or with high 
intensity focused ultrasound (HIFU, Pro-Rhythm) (2 patients), we assessed the site of 
electrical isolation on registered 3-D CT reconstruction of the left atrium (LA). Patients 
were selected based upon the presence of paroxysmal AF, normal LA size and PV size 
no larger than 2 cm by pre-procedural cardiac CT. Balloon placement at the PV ostium 
was guided and verified by intracardiac echocardiography (ICE). After isolation was 
verified with circular mapping, the 3-D CT reconstruction of the LA for each patient was 
registered into the CARTO system (CARTO Merge, Biosense Webster). After registration 
was completed, the circular mapping catheter was placed to the most proximal site of 
electrical isolation. Location points around the circumference of the circular mapping 
catheter were then acquired and displayed on the registered LA 3-D reconstruction. The 
site of electrical isolation was assessed in a total of 44 PVs.
Results: Despite the fact that by ICE the balloon appeared to be deployed at the level 
of the PV antrum, in all PVs the level of electrical isolation appeared to be at the end of 
the tubular portion of the PV. In none of the PVs did the antrum appear to be included 
in the lesion set.
Conclusions: In our preliminary experience, despite positioning of the balloon-based 
ablation systems at a proximal location in the PV antrum, the electrical isolation appeared 
to be limited to the end of the tubular portion of the PV without extension into the antral 
region. Whether this has an effect upon the cure rate of these balloon-based ablation 
systems requires further follow up evaluation.
2:30 p.m.
846-5	 Intracardiac	Echo-Guided	Image	Integration:	Optimizing	
Strategies	for	Registration
Tamer S. Fahmy, Hanka Mlcochova, Oussama M. Wazni, Dimpi Patel, Luigi Di Biase, 
Robert Cihak, Mohamed Kanj, Rong Bai, Chi Keong Ching, kenneth C. Civello, 
Mohamed Khan, Claude C. Elayi, Mazen El-Ali, Dhanunjaya Lakkireddy, Lucie Popova, 
Salwa Beheiry, Jennifer E. Cummings, David Burkhardt, David O. Martin, Mandeeb 
Bhargava, Thomas Dresing, Mauricio Arruda, Robert A. Schweikert, Petr Peichl, Josef 
Kautzner, Richard Hongo, Steven Hao, Patrick Tchou, Walid Saliba, Andrea Natale, 
Cleveland Clinic, Cleveland, OH
Background:	 Image integration is being used in ablation procedures. However, the 
success of this initiative is dependent on the accuracy of the image integration process. 
This study aims to evaluate the in-vivo accuracy and reliability of the integrated image 
with the use of intracardiac echo (ICE).
Methods:	One hundred twenty four patients undergoing AF ablation were recruited for 
the study from three different centers. Cardiac CT was performed to all patients and a 3D 
image of the left atrium (LA) and pulmonary veins (PVs) was extracted for registration 
after segmentation using the CARTOMERGE software. Different landmark points (LM) 
selected for registration were compared. Surface registration was then done and its 
impact on integration and the selected LMs was evaluated.
Results:	The best LM registration was achieved when the posterior points on the PVs 
were selected (5.6+3.2 mm). LMs taken on the anterior wall, or left atrial appendage 
resulted in a larger registration error (9.1+2.5mm). The mean error for surface registration 
was 2.17+1.65mm. However, surface registration resulted in shifting of the initially 
registered LMs at the area of interest leading to a larger error that was confirmed by ICE 
(9.2+2.1mm) (Figure1).
Conclusion:	Posterior wall points at the PV-LA junction are the most accurate LMs for 
registration of 3D images of the LA.	The concurrent use of the present surface registration 
algorithm may result in shift of the LMs with loss of their initial correlation with the area 
of interest.
2:45 p.m.
846-6	 Comparison	of	Left	Atrial	Volume	Using	Gated	Cardiac	
Fluoroscopy	3-D	Image	Rendering	vs.	Cardiac	
Computed	Tomography
Amin Al-Ahmad, Dominique Sander-Porkristl, Lars Wigstrom, Paul J. Wang, Paul C. Zei, 
Henry H. Hsia, Jan Boese, Guenter Lauritsch, Teri Moore, Frandics Chan, Rebecca 
Fahrig, Stanford University, Stanford, CA
Background: 3-dimentional (3-D) imaging of the left atrial (LA) during ablation of atrial 
fibrillation may be useful. 3-D visualization of cardiac structures reconstructed from 
projections acquired on a C-arm flat-panel fluoroscopy system has been developed. We 
sought to compare LA volume between this system and cardiac CT (CTA) in an in-vivo 
animal model.
Methods: Standard gated CTA images (Siemens Sensation 16) were acquired in 6 adult 
swine. Within 2 hours the animals then underwent imaging using a Siemens AXIOM Artis 
dTA C-arm system (Siemens Medical Solutions, Forchheim, Germany) modified to allow 
acquisition of several bi-directional sweeps during synchronized acquisition of the ECG 
for retrospective gating. C-arm CT volumes were produced using enhanced software 
(DynaCT)(Figure). For each imaging modality, full cardiac volumes were reconstructed 
at 10 points through the cardiac cycle. The LA was identified and its boarders were 
traced for volume analysis. The LA volumes were averaged throughout the 10 cardiac 
phases and relative deviations of the C-arm CT measurements compared to the CTA 
measurements were calculated.
Results: The average deviation between CTA and C-arm CT was 11.1% during atrial end 
diastole, and 20.4% during atrial systole.
Conclusions: Visualization of LA anatomy during ablation procedures is possible and 
accurate. Access to 3-D cardiac reconstructions acquired during ablation procedures will 
be valuable for procedural planning, guidance and ongoing evaluation. 
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3:00 p.m.
846-7	 Using	Entropy	to	Characterize	Complex	Fractionated	
Atrial	Electrograms	During	Atrial	Fibrillation
Jason Ng, Alexsey Borodyanskiy, Roger Villuendas, Alan H. Kadish, Jeffrey J. 
Goldberger, Northwestern University, Chicago, IL
Background: Complex fractionated atrial electrograms (CFAE) have been targeted for 
ablation of atrial fibrillation (AF). Currently, there are multiple definitions for CFAE with no 
standard quantification method. The aim of this study was to test the ability of entropy to 
quantify the complexity and fractionation of atrial electrograms (EGM) during AF.
Methods: Bipolar atrial EGMs were obtained from 9 patients undergoing radiofrequency 
ablation who were in AF at the time of the procedure. Sequential recordings of at least 
15 second duration of AF episodes were made in multiple sites in each atrium. The 
morphology of EGMs was classified as either simple (S), moderately complex (M), and 
complex (C) by a consensus of 3 independent reviewers. Each episode was divided into 
two second windows for which Shannon’s entropy - a measure of signal’s randomness 
- was computed, averaged, and compared for each of the 3 classifications.
Results: Ninety one episodes were studied (40 S, 30 M, 21 C). The mean of Shannon’s 
entropy was significantly smaller for S EGMs versus M EGMs (0.17±0.05 vs 0.20±0.03, 
p<0.01) and also significantly smaller than the C EGMs (0.17±0.05 vs 0.21±0.03, p<0.02) 
while no significant difference was observed between the C and M signal. Entropy was also 
able to track dynamic changes in signal complexity with time resolution of two seconds.
Conclusions: Entropy is an effective method for quantifying EGM complexity and 
fractionation during AF. This measure may aid in the targeting of ablation sites for AF. 
3:15 p.m.
846-8	 Catheter	Ablation	of	Atrial	Fibrillation	and	Flutter	
Using	a	New	Robotic	Navigation	System:	Interim	
Follow-up	Results
Walid I. Saliba, Josef Kautzner, Vivek Reddy, Pierre Jais, Jennifer Cummings, Robert 
Schweikert, David Burkhardt, Johannes Brachmann, Andrea Natale, Cleveland Clinic 
Foundation, Cleveland, OH
Background: Catheter ablation is an established curative modality for various arrhythmias. 
A robotic steerable guide catheter (SGC: Hansen Medical) allows better catheter stability and 
greater degrees of freedom of catheter movement. This reports details the interim follow up 
results from the initial clinical experience using this remote navigation system to perform LA 
and RA mapping and radiofrequency ablation of atrial fibrillation (AF)/ atrial flutter (AFL).
Methods: A total of 39 patients with antiarrhythmic drug (AAD) refractory atrial arrhythmia 
(AF 30 / AFL 9) were studied: 28M/11F, mean age 57 yrs (28-78), mean LVEF 58% (42%-
69%). In all patients 3D reconstruction of the corresponding atrial chamber anatomy was 
performed with the CARTO electroanatomic mapping system or the EnSite NavX system 
using the SGC. In patients undergoing AF ablation, 2 transseptal punctures (TSP) were 
performed under ICE guidance with one of the TSP being performed using the Robotic 
Catheter Control System (CCS). Pulmonary vein antrum isolation (PVAI) was performed 
using a 3.5mm thermocool catheter manipulated using the SGC and was verified by 
circular mapping. Patients were followed clinically for recurrence of arrhythmia with an 
event transmitter and ambulatory holter monitoring. Clinical recurrence of AF/AFL was 
defined as AF/AFL episodes > 1 minute duration.
Results: PVAI was performed in 30 pts. including 14 with concomitant atrial flutter 
ablation. All PV’s including the SVC were successfully isolated. In 9 patients, atrial flutter 
was mapped and ablated with bidirectional block obtained. Two patients developed 
pericardial tamponade requiring pericardiocentesis with no other sequelae (Procedure 
aborted in one pt). At 90 days follow up, 26 pts and 5 pts were free from atrial arrhythmia 
off AAD and on AAD respectively. 2 patients developed recurrent atrial arrhythmia; 1 AF 
patient required another procedure for atrial flutter; 3patients were lost to follow up.
Conclusions: This preliminary human experience suggests that mapping and ablation of 
AFL and AF using this novel robotic catheter with remote control system is feasible with 
similar intermediate results to conventional approach.
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901-234	 Analysis	of	Action	Potentials	in	the	Canine	
Interventricular	Septum:	No	Evidence	of	M	Cells
Shiho Morita, Douglas P. Zipes, Hiroshi Morita, Jiashin Wu, Krannert Institute of 
Cardiology, Indiana University School of Medicine, Indianapolis, IN
Background: Transmural heterogeneity in the ventricular free wall, enhanced by M cells, 
plays an important role in arrhythmogenesis in the long QT syndrome (LQTS). However, 
it is unclear whether M cells are present in the canine interventricular septum (IVS). This 
study evaluated transmural heterogeneity in the IVS with and without drug-induced LQTS.
Methods:	 We isolated arterially perfused sections of IVS from 21 canine hearts and 
recorded 256 channels of action potentials (APs) on their cut-exposed transseptal surfaces 
using an optical mapping system. Tissues were paced from the left ventricular endocardium 
(LV endo) at cycle lengths (CLs) of 500, 1000, 2000, and 4000ms. We induced LQT2 and 
LQT3 with sotalol and anemone toxin II (ATX-II) in 6 and 9 preparations, respectively.
Results: We observed that all APs on the transseptal surfaces lacked a prominent phase-
1 notch and that APD lengthened progressively across the IVS from the right ventricular 
(RV) to LV endocardium without a mid-myocardial maximum under all conditions (Figure). 
Increasing CLs and concentrations of drug prolonged APD (LV endo APD=286±16, 441±72, 
and 1046±176ms for control, sotalol 100mol/L, and ATX- II 10nmol/L, CL=4000ms) and 
increased the transseptal dispersion of APDs (dispersion=37±13, 102±54, and 179±78ms 
for control, sotalol 100mol/L, and ATX- II 10nmol/L, CL=4000ms).
Conclusions: We found no evidence of M cells in the canine IVS. Bradycardia, sotalol, 
and ATX-II prolonged APDs and increased transseptal dispersion. 
9:00 a.m.
901-237	 Functional	Characterization	of	Epicardial	Beating	Heart	
Radiofrequency	Left	Atrial	Maze
Takeyoshi Ota, David Francischelli, Douglas Hettrick, David Schwartzman, Marco A. 
Zenati, University of Pittsburgh, Pittsburgh, PA
Background: The cut-and-sew Maze procedure is the gold standard for surgical 
treatment of atrial fibrillation but is associated to long-term impairment of left atrial (LA) 
transport function. We have developed a bipolar irrigated radiofrequency ablation device 
for epicardial beating heart LA ablation. We hypothesized that, as opposed to the cut-and-
sew Maze, the epicardial radiofrequency LA Maze would result in minimal acute changes 
in LA hemodynamics using a catheter-based pressure-volume analysis.
Methods: Six healthy large swine were studied. LA lesions were created around the left atrial 
appendage (LAA), left (LPVs) and right pulmonary veins (RPVs) on the beating heart. Connecting 
lesions were created from the LAA to the LPVs and from the LPVs to the mitral annulus through 
the RPVs. Using LA and LV conductance catheters, simultaneous LA and LV pressure-volume 
recordings were taken and 27 indices of LA and LV mechanical function were calculated at six 
time points. Functional indices that were assessed included: LA pressure, Av (V loop area), Aa 
(A loop area), Ep (linear slope of the passive filling phase), Vr (refill volume), Ees (end-systolic 
elastance slope), Eed (end-diastolic elastance slope), Vc (conduit volume). The encircling lesions 
were assessed with pacing of distal myocardium to confirm electrical isolation.
Results: Complete electrical isolations were achieved in all lesions. The electrical 
isolation of LAA did not exert any significant effect on LA and LV functions. The physical 
LAA isolation did not also have any affect except the slight increase in the LA Ep (p<0.05). 
There was no significant difference in all measured indices after all ablation. At autopsy, 
there was no damage to the surrounding structures such as the circumflex coronary 
artery. Transmural ablation was histologically proven in all lesions.
Conclusions: Epicardial radiofrequency beating heart LA Maze was safe and effective 
in producing transmural ablations. Electrical or physical LAA isolation and LA ablation did 
not significantly have an influence on acute LA or LV mechanical functions in a healthy 
porcine heart. Further studies are warranted in a chronic survival model.
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901-240	 Arrhythmic	Risk	Stratification	After	Myocardial	
Infarction	in	the	MADIT	II	Era:	Should	We	Consider	
Infarct	Localization?
Patrizio Pascale, Juerg Schlaepfer, Mauro Oddo, Marie-Denise Schaller, Pierre Vogt, 
Martin Fromer, University Hospital Lausanne, Lausanne, Switzerland
Background:	 The results of the MADIT II study have expanded the recommended 
use of prophylactic defibrillator in patients with remote myocardial infarction (MI) and 
left ventricular (LV) dysfunction. However, the challenge remains to accurately stratify 
patients to identify those most likely to benefit from the therapy. Many studies focused on 
the «quantitative» issue of MI characterization as expressed indirectly by LV function or 
alternatively by infarct size. To date, the question whether a specific location of prior MI is 
at higher risk of sustained ventricular arrhythmias has not been addressed.
Objectives:	To evaluate the localization of prior MI in patients with sustained ventricular 
tachycardia (VT) or ventricular fibrillation (VF) not triggered by an ischemic event.
Method:	Consecutive patients admitted for VT or VF related to ischemic heart disease 
over an 8-year period were included. Localization of prior MI was based on clinical 
records, left ventriculogram or echocardiogram.
Results:	265 patients were identified. 145 (55%) had acute MI, 56 (21%) had significant 
coronary artery stenosis requiring revascularization and 17 (6%) had a prior MI but did not 
undergo coronary angiography. Of the 47 patients (18%) without concomitant coronary 
artery stenosis, localization of prior MI was combined inferior and anterior in 7 patients. In 
the 40 patients with a single localization of MI, the proportion of inferior MI was significantly 
higher than anterior MI (80% vs. 20%; absolute difference, -60; 95% confidence interval (CI), 
-37.2 to -74.7; P=<0.0001), though median ejection fraction in inferior MI was significantly 
higher (0.38 (IQR 0.30-0.43) vs. 0.29 (IQR 0.22-0.33); P=0.027).
Conclusion: Our study shows that in patients with remote MI and no concomitant 
coronary artery stenosis as a possible trigger to ventricular arrhythmias, an inferior 
compared to an anterior localization of prior MI may be associated with a higher risk 
of suffering from VT or VF. This association was found despite a better LV function in 
patients with prior inferior MI. These results suggest that the localization of prior MI should 
also be considered in future studies on arrhythmic risk stratification.
9:00 a.m.
901-241	 Co-Registration	of	Doppler	Tissue	Velocity	Data	
with	MSCT	of	the	Coronary	Veins	to	Optimize	
Left	Ventricular	Lead	Placement	for	Cardiac	
Resynchronization	Therapy
Jeff M. Hsing, Giuseppe Saracino, Ronan Curtin, Neil Greenberg, Mario J. Garcia, 
Bruce L. Wilkoff, James D. Thomas, Richard A. Grimm, Cleveland Clinic Foundation, 
Cleveland, OH
Background:	Cardiac Resynchronization Therapy (CRT) is beneficial for moderate heart 
failure patients. However, up to one-third of patients are non-responders and sub-optimal 
Coronary Sinus (CS) lead placement is believed to be a key factor. Tissue Synchronization 
Imaging (TSI) derived from Tissue Doppler localizes electromechanical delay, and multi-
slice computed tomography (MSCT) can visualize the 3D coronary venous anatomy. We 
describe the feasibility of Co-registering TSI and MSCT data to guide optimal CS lead 
placement during CRT.
Method:	 Patients scheduled for CRT underwent TSI and cardiac MSCT prior to 
implantation. TSI time to peak velocity data was measured for each cardiac segment. 
Coronary veins were extracted from MSCT data using volume rendering. Custom 
developed software co-registered TSI images and coronary veins with a point-merge 
approach to minimize the error of the 3D-registration function.
Results: Co-registering TSI and MSCT data sets provided useful information in 5 out 
of 5 patients undergoing CRT. Once co-registered, the coronary vein closest to the 
most dyssynchronous segment as determined by the longest time to peak velocity was 
identified. The coronary vein location was then targeted for CRT CS lead implantation.
Conclusion: Co-registration of TSI images with MSCT of the coronary veins to identify the 
coronary vein closest to the most dyssynchronous segment is feasible. This information is 
being used to optimize CRT CS lead placement in hopes of improving CRT response.
9:00 a.m.
901-238	 Pulmonary	Vein	Occlusion:	Structural	and	Functional	
severity	Indices
luigi Di Biase, Tamer S. Fahmy, Oussama M. Wazni, Jennifer E. Cummings, Mohamed 
Kanj, Chi Keong Ching, Mohamed Khan, Claude S. Elayi, kenneth C. Civello, Mazen El-
Ali, Sergio Thal, Rong Bai, Dimpi Patel, Subramania K. Prasad, Lucie Popova, David O. 
Martin, David Burkhardt, Dhanunjaya Lakkireddy, Thomas Dresing, Mandeeb Bhargava, 
Robert A. Schweikert, Michelle Andrews-Williams, Walid Saliba, Lourdes Prieto, Patrick 
Tchou, Mauricio Arruda, Andrea Natale, Cleveland Clinic, Cleveland, OH
Background:	Pulmonary vein occlusion (PVO) is a rare complication that can develop 
following radiofrequency ablation (RFA) of AF. Data regarding the number of occluded 
veins and the clinical course of those patients is minimal. This study highlights the 
functional and clinical consequences of the various numbers of occluded veins.
Methods:	Data from 18 patients with complete occlusion of at least one pulmonary vein 
(PV) following RFA for AF using different ablation strategies were collected. PVO was 
diagnosed by CT scan and the percent stenoses of the ipsilateral veins were added 
together to evaluate the total drainage of each lung independently [Cumulative Stenosis 
Index (CSI)]. Quantitative lung perfusion was performed and the relative perfusion of 
each lung (% of total lung perfusion) was determined. Patients’ symptoms were divided 
into 4 grades according to their severity/number. Relations between the symptoms, CSI 
and perfusion were analyzed.
Results:	The patients’ symptoms correlated well with the underlying lung findings, and 
showed a positive correlation with the CSI (r = 0.843 p<0.05) and a negative one with the 
lung perfusion (r = -0.667, p<0.05). A lung perfusion <25% correlated well with a CSI > 
75% and indicated the occurrence of severe lung diseases.
Conclusion:	 Patients with single PVO are mostly asymptomatic. In patients with 
concurrent ipsilateral PVS/PVO, evaluation of the CSI and pulmonary perfusion may 
provide an insight into the severity of the condition and prompt early intervention. 
9:00 a.m.
901-239	 Early	Atrial	Remodeling	Can	Predict	Maintenance	
of	Sinus	Rhythm	at	6	Months	in	Patients	with	Atrial	
Fibrillation	Undergoing	Pulmonary	Vein	Antral	Isolation
Sukaina J. Jaffer, Susan E. Jasper, Margaret M. Park, Allen G. Borowski, Diana O. 
Dolney, Jared Klein, Kevin Shrestha, Brandon C. Varr, Andrea Natale, W. H. Wilson 
Tang, Allan L. Klein, CCF, CLEVELAND, OH
Background: Atrial fibrillation (AF) is associated with structural and neurohormonal 
changes with subsequent decrease in left atrial (LA) function. The purpose of this study 
was to determine if early changes in atrial remodeling by neurohormones and left atrial 
volume could predict maintenance of sinus rhythm in patients undergoing pulmonary vein 
antral isolation (PVAI).
Methods: One hundred and fifty-five patients with AF who underwent PVAI between 
2004 - 2006 were studied. Baseline demographics, brain natriuretic peptide (BNP) and 
2D echocardiograms were performed on all patients prior to PVAI and repeated at 3 
month follow up. Patients were then analyzed based on maintenance of sinus rhythm 
(n=82) versus recurrence of AFrequiring second PVAI (n=73) at 6 months. Recurrence 
was defined by Holter monitor recordings at 6 months.
Results: Patients who maintained sinus rhythm at 6 months had early remodeling at 3 
months with a parallel decrease in both BNP levels (% change from baseline, -24 + 65 vs 49 
+ 142; P<0.01) and maximum LA volumes (LAVmax) (% change from baseline, -19 + 13 vs 
-4 + 22; P<0.01) compared to those who had a late recurrence of AF. Multivariate analysis 
showed that the LAVmax at 3 month follow up had a higher positive predictive value for 
maintenance of sinus rhythm compared to BNP (80%; P=0.015 vs 72%; P=0.07).
Conclusions:	 In patients undergoing PVAI, parameters of early LA remodeling (BNP 
and LAVmax) at 3 months can identify those patients who are likely to maintain sinus 
rhythm at 6 months.
Predictors of Maintenance of Sinus Rhythm following PVAI
Baseline	
characteristics
Multivariate	
chi-square
Multivariate	
p-value	
Area	under	
the	Curve
Positive	
Predictive	
value
Negative	
Predictive	
value
BNP follow-up ( 
pg/ml ) 3.1 0.077 0.78 72% 74%
LAVmax follow 
up (cm3) 5.9 0.015 0.80 80% 81%
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901-242	 Implantable	Cardioverter	Defibrillator	Therapy	
Improves	the	Survival	of	Patients	with	Prior	Coronary	
Revascularization:	Data	from	the	Sudden	Cardiac	Death	
in	Heart	Failure	Trial
Sana M. Al-Khatib, Anne S. Hellkamp, Kerry L. Lee, Daniel B. Mark, Gust H. Bardy, 
The SCD-HeFT investigators, Duke Clinical Research Institute, Durham, NC, Seattle 
Institute for Cardiac Research, Seattle, WA
Background: We conducted this analysis to assess the effect of ICD therapy on mortality 
and sudden cardiac death (SCD) in patients with prior coronary revascularization enrolled 
in the SCD-HeFT, a randomized comparison of ICD therapy, amiodarone, and placebo 
in 2,521 patients with functional class II or III congestive heart failure for > 3 months and 
ejection fraction ≤ 35%.
Methods: We identified patients with ischemic heart disease not randomized to the 
amiodarone arm and divided them into 1) those with no prior revascularization (n=256), 
2) those with prior percutaneous coronary intervention (PCI) (n=268) and 3) those with 
prior coronary artery bypass grafting (CABG) (n=361). Cox proportional hazards models 
were used to examine the effect of revascularization on mortality and SCD. We examined 
interactions between ICD therapy, PCI and CABG.
Results: The median time from revascularization to enrollment in SCD-HeFT was 3.1 
years (IQR 1.0, 6.6). ICD therapy was evenly distributed among the 3 groups. There 
were no associations between revascularization and the risk of death and SCD (all p > 
0.1). There was no differential ICD benefit across revascularization groups (all therapy-
by-revascularization interaction p >0.2), although in the CABG group, there was a trend 
toward less benefit from ICD therapy.
Conclusions: In SCD-HeFT, there was a trend toward less benefit from ICD therapy 
in patients with prior CABG. PCI patients, however, were as likely to benefit from ICD 
therapy as the non-revascularized patients. 
Hazard ratios and 95% Confidence Intervals for death and SCD
CABG PCI No revascularization
Death
ICD versus placebo 0.89 (0.61, 1.31) 0.65 (0.41, 1.02) 0.68 (0.45, 1.02)
SCD
ICD versus placebo 0.54 (0.26, 1.14) 0.38 (0.15, 0.94) 0.44 (0.22, 0.91)
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902-234	 The	Expression	Of	Toll-like	Receptor2	In	Patients	With	
Non-valvular	Atrial	Fibrillation
Hitoshi Ichiki, Kagoshima university, Kagoshima, Japan, R&D Center, BioMedical 
Laboratories, Saitama, Japan
Background: Toll-like receptors (TLRs) are a family of proteins that trigger host innate 
immune responses to a wide variety of pathogens. Many studies have demonstrated 
that TLRs recognize pathogen-associated molecular patterns. It has been reported that 
infection and/or inflammation may play a pivotal role in atrial fibrillation (Af), suggested by 
increasing plasma level of C-reactive protein (CRP) and interleukin6 (IL6) in patients with 
Af. Therefore, we examined whether the expression of TLR2 is elevated in patients with 
Af and TLR2 is changed during the follow-up after defibrillation by catheter ablation.
Methods: The expression of TLR2 on circulating monocytes was analyzed in the 
patients with non-valvular Af (Af group; n=13, mean age: 58±11 y.o.) and the patients 
with sinus rhythm (control group; n=24, mean age: 53±16 y.o.) by a flow-cytometer. The 
patients manifested clinical signs of infection were excluded from this study. Doppler 
echocardiographic study and TLR2, CRP, IL6, and procollagen 3 peptide (PIIINP) 
measurements were performed just before catheter ablation and at one-month follow-up 
in Af group. Welch test was used for statistical analysis.
Results: The expression of TLR2 in Af group was significantly higher when compared with 
that in control group (86±20 vs. 71±16; P<0.05). No significant differences existed in white 
blood cell (WBC) (4693±804 vs. 4879±1604 count/mm3) and CRP (0.10±0.10 vs. 0.11±0.10 
mg/L) between the two groups. All data of IL6 (1.8±1.8 pg/ml) and PIIIP (0.7±0.1 U/ml) in 
Af group were in the normal range. During one-month follow-up after catheter ablation in Af 
group, left atrial volume (60±22 vs. 43±10 mm3, p<0.05) and left ventricular diastolic dimension 
(48±4 vs. 44±4 mm, p<0.05) were significantly diminished, whereas the expression of TLR2 
remained unchanged in higher level(87±16 at pre-ablation vs. 81±9 at one-month follow-up, 
p=NS). CRP (0.11±0.10 vs. 0.09±0.08 mg/L, p=NS) and WBC (4517±728 vs. 5933±1322 
count/mm3) were also unchanged during the follow-up.
Conclusions: Our results suggest that infection and/or inflammation may play an 
important role in the pathogenesis of Af in patients with non-valvular Af.
10:00 a.m.
902-237	 Ace-inhibitors	Did	Not	Prevent	Atrial	Fibrillation	In	The	
Pacemaker	Mode	Selection	Trial
Hector F. Lozano, Anne S. Hellkamp, K. L. Lee, Alicia Montanez, Greg Flaker, Gervasio 
A. Lamas, Mount Sinai Medical Center, Miami Beach, FL
BACKGROUND: Recent clinical evidence supports a beneficial effect of angiotensin-
converting enzyme inhibitors (ACE-I) to prevent atrial fibrillation (AF). We investigated 
whether use of ACE-I reduced the incidence or the recurrence rate of AF in patients 
enrolled in the pacemaker Mode Selection Trial (MOST).
METHODS: MOST was a 5-year, 2010-patient randomized trial of pacing in sinus node 
dysfunction. We analyzed the MOST database to compare the incidence of AF between 
ACE-I users and nonusers. The association of ACE-I use with AF was assessed using 
Cox proportional hazards models with ACE-I use as a time-dependent covariate and 
adjusted for other known AF predictors
RESULTS: We identified 939 (47%) patients who did not take ACE-I at any time and 
1070 (53%) patients who took ACE-I at some point during the trial. Overall, the risk of AF 
in the ACE-I treatment group did not differ from the risk observed in patients not taking 
these medications (hazard ratio [HR] = 1.00, 95% confidence interval [CI] = 0.83, 1.22, 
p=0.98). There were no subgroups in which ACE-I use had a significant association with 
reduced AF risk (TABLE 1)
CONCLUSIONS: ACE-I may not be effective for prevention of AF, in contrast to recent 
reports. Continuous electrocardiogram monitoring to identify AF may account for the 
discrepancy between these results and previous publications. Randomized clinical trials 
that define the role of ACE-I in treating AF are needed.
TABLE	1:	Relative	Risk	of	AF	for	patients	on	ACE-I	vs.	patients	not	on	ACE-I 
Subgroup N ACE-I	use	at	any	time HR	(CI) p
prior HF 404 75% (304) 0.77 (0.54, 1.11) 0.16
prior HTN 1248 65% (814) 0.83 (0.66, 1.05) 0.13
age 75 or older 984 54% (533) 0.94 (0.71, 1.24) 0.64
%VP > 40 1329 56% (740) 1.13 (0.90, 1.42) 0.29
VVI / %VP > 40 514 57% (295) 1.07 (0.76, 1.50) 0.71
prior AF/flutter 913 55% (508) 0.98 (0.79, 1.23) 0.88
10:00 a.m.
902-238	 The	Source	of	Cytokine	Release	in	Patients	with	Atrial	
Fibrillation
Ioan Liuba, Anders Englund, Henrik Almroth, Lena Jonasson, Håkan Walfridsson, 
Department of Cardiology, University Hospital Linköping, Linköping, Sweden, 
Department of Cardiology, University Hospital Örebro, Örebro, Sweden
Background:	Some studies have reported an association of atrial fibrillation (AF) with low-grade 
systemic inflammation. We sought to assess the source of inflammation in these patients.
Methods: The study group consisted of 29 patients referred for radiofrequency catheter 
ablation: 9 patients with permanent lone AF, 10 patients with paroxysmal lone AF and 10 
control patients with WPW syndrome and no evidence of AF (mean age 58 ± 13 vs 53±10 
vs 43±16 yrs). High sensitive C-reactive protein (CRP), interleukin 6 (IL-6) and interleukin 
8 (IL-8) were assessed in blood samples from a peripheral vein, right atrium, coronary 
sinus, as well as from the left and right upper pulmonary veins. All samples were collected 
before the ablation.
Results:	Compared to controls and patients with paroxysmal AF, patients with permanent 
AF had higher plasma levels of IL-6 at all sample sites (peripheral vein: median, 1.21 vs 
1.28 vs 2.24 pg/mL, p<0.05; right atrium: 0.90 vs 1.02 vs 2.19 pg/mL, p<0.05; coronary 
sinus: 0.91 vs 0.90 vs 1.99 pg/mL, p<0.05; left upper pulmonary vein: 0.99 vs 0.99 vs 1.96 
pg/mL, p<0.05; right upper pulmonary vein: 0.98 vs 1.15 vs 2.30 pg/mL, p<0.05; values 
are adjusted for age). No IL-6 concentration gradient was noted between the 5 sample 
sites. The levels of IL-8 were significantly higher in patients with permanent AF than in 
patients with paroxysmal AF and controls. This difference was however noted only in 
samples from the peripheral vein and right atrium but not in samples from the coronary 
sinus and pulmonary veins (peripheral vein: 2.58 vs 3.06 vs 5.05 pg/mL, p<0.05; right 
atrium: 2.30 vs 3.06 vs 4.11 pg/mL, p<0.05). No differences in the CRP levels were noted 
in the 3 groups of patients. In addition, there were no differences in the IL-6 and IL-8 
levels between patients with paroxysmal AF and controls.
Conclusions: The finding of elevated plasma levels of IL-6 and Il-8 in patients with 
permanent AF but not in those with paroxysmal AF suggests a link between a low-grade 
inflammation and arrhythmia burden. The normal CRP levels and the higher IL-8 levels in 
the peripheral blood and in the right atrium but not in the coronary sinus and pulmonary 
veins suggest a possible inflammatory source in the systemic circulation.
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902-239	 Atrial	Resynchronization	Therapy	in	Patients	Unsuitable	
for	Left	Atrial	Ablation	Procedures	for	the	Management	
of	Atrial	Fibrillation
Rajiv Sankaranarayanan, Russell Holloway, Michael James, Taunton and Somerset 
Hospital, Taunton, United Kingdom
Background: We conducted this study to determine whether patients who are unsuitable 
for left atrial(LA) ablation, would respond to treatment of their atrial fibrillation(AF) with 
atrial resynchronization by bi-atrial pacing.
Methods: We analyzed the outcome of bi-atrial pacing in our atrial resynchronization 
program according to whether the patients were deemed suitable or unsuitable for LA 
ablation and compared their outcome for an equal duration pre and post-pacemaker 
implant with regard to symptoms, anti-arrhythmic drug requirement, AF episodes and 
hospital admissions. 17 patients were considered unsuitable for ablation therapy due to co-
morbidities like heart failure (8/17), left atrial dilatation (10/17), valvular heart disease (7/17), 
left ventricular hypertrophy (7/17) and severe chronic lung disease (2/17). 14 patients were 
considered suitable for ablation as they demonstrated no contraindication. Mean follow-up 
was 32 ± 20 months (unsuitable group) and 36 ± 22 months(suitable group).
Results:	13/17 of the unsuitable group and 8/14 of the suitable group demonstrated a 
significant improvement in both symptoms and AF, the difference between the 2 groups 
was not significantly different (p=0.44). There was a significant improvement in mean 
AF episodes/month following bi-atrial pacing in both the groups (suitable group pre 
19.5 ± 9.2, post 8.3 ± 11.7, p=0.009; unsuitable group pre 23.2 ± 7.9, post 7.2 ± 9.6, 
p<0.001), no significant difference between the 2 groups (p=0.33). There was a reduction 
in mean number of AF admissions in both the groups (suitable group pre 2.2 ± 1.9, post 
0.9 ± 1, p=0.03; unsuitable group 3 ± 4.2, post 0.9 ± 1.4, p=0.045), difference between 
the 2 groups not significant (p=0.70). The mean number of anti-arrhythmic drugs was 
also reduced in both the groups (suitable group pre 3.5 ± 1.3, post 1.8 ± 0.9, p<0.001; 
unsuitable group pre 3.5 ± 1.7, post 1.5 ± 0.9, p<0.001), difference between the 2 groups 
not significant (p=0.56).
Conclusions: This study shows that atrial resynchronization therapy with bi-atrial pacing 
suppresses both symptoms and AF, thus providing an effective alternative for patients 
unsuitable for catheter ablation.
10:00 a.m.
902-240	 The	Role	of	Right	Ventricular	Function	in	Patients	With	
Dual	Chamber	Pacing	and	Different	Hemodynamic	
Configurations:	A	Long	Term	Study
Eugenio Moro, Carlo Marcon, Luigi Sciarra, Elena Marras, Manuela Bocchino, Pietro 
Delise, Department of Cardiology - Conegliano General Hospital, Conegliano, Italy
Long term sequalae of right ventricular apical pacing (RVAp) are not widely investigated 
in different subgroups of patients (pts).
Therefore we prospectively assessed the long term effects of RVAp in pts with different 
basal hemodynamic configurations.
Population. We studied 32 selected pts (20 M, 12 F, 69±6 years) and indication for 
DDD pacing. At enrollment post implantation pts were divided in 2 groups. Group 
I: left ventricular ejection fraction (LVEF) <55%, right ventricular ejection fraction 
(RVEF) >45%; Group II: LVEF <55%, RVEF <45%.
Methods. AV delay was optimized by echo. Echo/Doppler was performed at baseline and after 
12, 24, 36 months from implantation. At the end of each period we collected: LVEF, RVEF, left 
ventricular myocardial performance index (MPI), NYHA class and quality of life (QoL).
Results. Multivariate analysis identified only RVEF as predictor of adverse clinical 
evolution (p<0.001). Data are reported in Table I. 
GROUP I POST IMPLANT 12 MONTHS p 24 MONTHS p 36 MONTHS p
LVEF % 50±9 49±10 NS 48±5 NS 48±7 NS
MPI 0.41±0.06 0.42±0.3 NS 0.44±0.4 0.08 0.46±0.1 0.001
QoL 10±4 11±8 NS 12±4 NS 12±6 NS
NYHA 1.6±0.4 1.7±0.8 NS 1.8±0.5 NS 1.9±0.4 NS
RVEF % 49.±7 48±5 NS 48±8 NS 47±5 NS
GROUP II
LVEF % 47±6 46±7 NS 44±4 NS 44±5 0.05
MPI 0.42±0.04 0.43±0.1 NS 0.45±0.09 NS 0.46±0.1 0.01
QoL 16±6 17±4 NS 18±7 NS 18±5 NS
NYHA 1.5±0.7 1.8±0.3 NS 2.2±0.5 0.01 2.6±0.6 0.001
RVEF % 43±5 40±4 0.1 38±6 0.01 36±7 0.001
Conclusions. In pts with reduced left ventricular function MPI presented progressive 
worsening, without clinical implication. RVEF strongly predicts clinical course and has 
a central role in the selection of pacing modality. Our data suggest that among pts 
with reduced LVEF an alternative pacing modality is indicated when right ventricular 
dysfunction is present.
10:00 a.m.
902-241	 Comparison	Of	Coupled	And	Paired	Pacing	For	Rapid	
Rate-control	During	Atrial	Fibrillation
Attila Kardos, Berthold Stegeman, Csaba Foldesi, Attila Mihalcz, Levente Csakany, 
Tamas Szili-Torok, Hungarian Institute of Cardiology, Budapest, Hungary
Background: Rapid and irregular ventricular responses are features of atrial fibrillation 
(AF). Delivering a premature electric stimulation to the heart above the effective refractory 
period (ERP) of a ventricular activation by a sensed (coupled pacing; CP) or a paced 
(paired pacing; PP) ventricular stimulation can rapidly decrease and regularize the 
mechanical heart rate because of concealed veantriculoatrial conduction.Objective: The 
purpose of the present study was to compare the rate controlling effects of CP and PP 
during AF with high ventricular rates in patients scheduled for elective pulmonary vein 
isolation.Methods:	11 patients (9 males) with paroxysmal or persistent atrial fibrillation 
were included into this prospective single center study. During spontaneous AF standard 
quadripolar diagnostic catheter was advanced to the apex of the right ventricle. Following 
determination of the ERP of the ventricle CP and PP was applied in random order. The 
mechanical effect of pacing was detected via arterial pressure tracing. During CP the 
coupling interval of 20 ms above the ERP after the sensed ventricular activation from 
the surface electrogram was used to reach optimal haemodynamic effect.PP was started 
with a basic cycle length of 800 ms followed by an extra stimulus with a coupling interval 
of 20 ms after the ERP. The drive train was then shortened at 20 ms decrements. The 
mechanical pulse rate (MPR) range was recorded for 3 minutes. Proarrhythmic effects 
were characterised by the number of PVC’s.Results: The MPR during AF (104±21 beat/
min) was successfully controlled using CP in all of the patients (58±7 beat/min). Using CP 
the controlled rhythm remained irregular, (RR range: 896±56 - 1452±101 ms). PP was 
applicable continuously in 9 pts (73%), resulted in regular MPR range (62±6 - 80±8 beats/
min).No ventricular extra beats were observed during CP, PP caused premature beats 
and couplets in 27% (3 out of 11) of the patients ( 35±12 PVC’s, 2±1 nsVT’s per patient), 
causing failure of continuous MPR controll.Conclusions:	1. Both CP and PP can reduce 
the MPR during AF. 2. CP is more applicable, but PP has the advantage to achieve a 
predefined target heart rate. 3. CP has proarrhythmic effect, as compared to PP.	
10:00 a.m.
902-242	 Influence	of	Lead	Location	on	Clinical	Outcomes	with	
Cardiac	Resynchronization:	Experience	from	the	
DECREASE-HF	Study
Imran K. Niazi, John Hummel, Lisa McCallum, Julie Wang, Mindi Newman, Patrick 
Yong, DECREASE-HF Study Investigators, St Luke’s Medical Center, Milwaukee, WI, 
Boston Scientific, Saint Paul, MN
Background: While studies of cardiac resynchronization therapy (CRT) have shown the 
importance of coronary venous lead location on acute hemodynamic performance, the 
effect of lead location on long-term clinical outcomes from large randomized clinical trials 
has not been reported with a uniform method for identifying lead location.
Methods: The DECREASE-HF study randomized pts to biventricular CRT, LV CRT 
and biventricular CRT with V-V timing. Study arms were retrospectively pooled and 
stratified into two groups based on lead location as determined by an experienced single 
observer review of radiograms: anterior (ANT) vs. posterior or lateral (POLAT). Indicators 
of functional capacity (table below) were measured as 6 month change (mean ± SD). 
Hazard ratios for all-cause mortality, combined all-cause mortality and heart failure 
hospitalization, and ventricular tachyarrhythmias (VT/VF) were adjusted for significant 
baseline covariates.
Results: Lead location data were available for 167 pts (126 POLAT, 41 ANT). Pts were 
67% male, 66% ischemic, mean age 67 years, LVEF 23%, and QRS 166 ms. No significant 
differences in demographics were found between POLAT and ANT at baseline. Functional 
status outcomes and clinically important events were stratified by lead location.
Conclusions: Although indicators of functional capacity showed no differences, the risk 
of clinically important events was significantly less with POLAT when compared to ANT. 
Prospective studies are needed to confirm these results.
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903-234	 Restitution	Properties	Immediately	Preceding	
Conduction	Block	During	Ventricular	Fibrillation
Jian Huang, Kang-An Cheng, Derek J. Dosdall, Jack M. Rogers, Raymond E. Ideker, 
Univeristy of Alabama at Birmingham, Birmingham, AL
Background: The diastolic interval (DI) restitution hypothesis for ventricular fibrillation 
(VF) states that the slope of the DI versus action potential duration (APD) restitution curve 
exceeds 1 at VF activation rates, creating dynamic heterogeneities that cause conduction 
block and wavebreak that maintains VF. To test this hypothesis, we determined if any 
portion of the DI restitution curve during VF is >1 immediately preceding conduction block 
in the tissue containing the advancing activation front immediately adjacent to the tissue 
in which the activation front blocked.
Methods: A mapping plaque with 504 unipolar electrodes 2 mm apart in a 24x21 array 
was held on the left ventricular surface in 6 open chest pigs. The electrode at the center 
of the plaque was replaced by a 3 mm diameter hole. A conventional microelectrode 
(tip resistance, 10 to 30 M , filled with 3 mol/L KCl) was mounted on a 30-µm Ag-AgCl 
spiral wire to allow the microelectrode to follow cardiac motion. The microelectrode was 
used to record the transmembrane APD through the hole at the center of the plaque. 
Electrically-induced VF episodes (4-6 in each pig) were mapped with both microelectrode 
and mapping array simultaneously for 20 s. We estimated (1) the time of conduction block 
at the 4 electrodes surrounding the microelectrode. and (2) the restitution curve from the 
APDs and DIs recorded by the microelectrode for the 15 VF cycles immediately before 
each conduction block episode. Block was considered to have occurred if the conduction 
time between two neighboring electrodes was > 50 ms.
Results: There were 31±18 instances of conduction block at the 4 electrodes surrounding 
the microelectrode during each 20s VF episode. Block occurred on average every 
675±240 ms at one or more of the 4 electrodes. The maximum slopes of the DI restitution 
curves immediately before conduction block were < 1 (0.2±0.5).
Conclusions: The DI restitution curve during VF was not greater than 1 immediately 
preceding conduction block. Therefore, DI restitution slope by itself does not predict 
conduction block during VF.
11:00 a.m.
903-237	 Anatomic	Evaluation	of	the	Right	Atrial	Cavo-tricuspid	
Isthmus	by	MDCT
Farhood Saremi, Oganes Ashikyan, Khushboo Kaushal, Subramaniam Krishnan, 
Swaminatha Gurudevan, Jagat Narula, Jaspreet Brar, University of California, Irvine, CA
Background: Right atrial cavo-tricuspid isthmus is the target for catheter ablation of 
isthmus-dependent atrial flutter. Autopsies and angiographic findings have shown a highly 
variable isthmus anatomy that can make ablation difficult. Therefore, rational adaptation of 
the ablation approach to the anatomic variants of this region may contribute to successful 
treatment. No systematic investigations have been made about the dimensions of the 
right atrial isthmus with MDCT. The purpose of this study was to test the hypothesis that 
cardiac MDCT could provide enough information regarding the structure of the isthmus.
Methods: Using a 64 MDCT, we retrospectively studied the isthmic area in 107 
consecutive patients underwent coronary CT angiography. Utilizing standard gated CT 
technique (isotropic resolution, 0.5 mm), out of 107 exams 100 with good image quality 
were analyzed (middiastolic image sets). The cavo-tricuspid isthmus was assessed along 
three parallel levels described in the literature as paraseptal isthmus, central isthmus, and 
inferolateral isthmus. At paraseptal level, the distance of AVN artery to coronary sinus 
wall was measured.
Results: CT studies showed a wide variation in the width of the isthmus; paraseptal 
isthmus (9 to 26 mm; 18 ± 4), central isthmus (7 to 33 mm; 21±6), and inferolateral 
isthmus (9 to 44 mm; 25±7). The isthmus was concave in 87% with a mean depth of 
6.3±2 mm (3 to 15 mm). A sub- Eustachian recess was revealed in 45%, with a mean 
depth of 9±3 mm (range 4 to 15 mm). A Eustachian valve was visualized in 34% and a 
Thebesian valve in 50%. Eustachian ridge was seen in 66% with a mean thickness of 4 ± 
2 mm (range 1-9 mm). Coronary sinus ostium was 11±2 mm.	At the paraseptal level the 
AVN artery was close to the coronary sinus (1 to 6 mm; 2 ± 1).
Conclusions: Cardiac MDCT provides the necessary information regarding the size and 
anatomic variants of cavo-tricuspid isthmus. Our findings correlate well with the reported 
anatomic data. With widely used cardiac CT, our results may improve understanding of 
this critical area to facilitate ablation procedures.
11:00 a.m.
903-238	 Atrial	Fibrillation	Inducibility	in	Patients	With	No	Prior	
Atrial	Fibrillation.
Warangkna Boonyapisit, Siddharth Mukerji, Carol Chen-Scarabelli, Rita McLemore, 
Frank Pelosi, Hakan Oral, Frank Bogun, Aman Chugh, Eric Good, Ranjan Thakur, Fred 
Morady, Krit Jongnarangsin, University of Michigan, Ann Arbor, MI
Background: Atrial fibrillation (AF) inducibility after catheter ablation has been shown to be 
associated with higher recurrences of AF and AF noninducibility was associated with a better 
clinical outcome. However, the prevalence of AF inducibility in patients with no prior history of 
AF and the relationship between AF inducibility and left ventricular function are unknown.
Methods: We studied 34 patients (mean age 67±12) with no prior history of AF who 
underwent device implantation (12 pacemakers, 20 implantable cardioverter defibrillator, 
and 2 biventricular implantable cardioverter defibrillator). Electrophysiologic study was 
performed during the implantation. AF inducibility protocol consisted of left atrial pacing 
via the coronary sinus for 10 seconds at 300 ms, 250 ms and 200 ms. Pacing was 
attempted 3 times on each cycle length. If AF was still noninducible, the above pacing 
protocol was then repeated in the right atrium.
Results: AF lasting more than 60 seconds was induced in 16 patients (47%). Twelve of 
18 patients (67%) with a left ventricular ejection fraction (LVEF) of ≤ 35% (mean LVEF 
23±8%) versus 4 of 16 patients (25%) with a LVEF of >35% (mean LVEF 57±9%) had 
inducible AF (p=0.02). The mean left atrial diameter in patients with LVEF of ≤ 35% and 
LVEF of >35% were 46±8 mm and 39±5 mm, respectively (p=0.009).
Conclusions: AF inducibility was common in patients with no prior history of AF. The 
prevalence of AF inducibility was significantly higher in patients with a LVEF of ≤ 35%.
11:00 a.m.
903-239	 Prevalence	of	Long	QT	Syndrome	and	Identification	
of	Genetic	Alterations	in	a	Population	of	Japanese	
Children
Kenshi Hayashi, Katsuharu Uchiyama, Hidekazu Ino, Noboru Fujino, Tetsuo Konno, 
Eiichi Masuta, Toshinari Tsubokawa, Hiromasa Katoh, Yuichiro Sakamoto, Keisuke 
Nakashima, Yoshitake Hiramaru, Haruhiro Higashida, Masakazu Yamagishi, Kanazawa 
University, Kanazawa, Japan, Kanazawa Medical Association, Kanazawa, Japan
Background: Congenital long QT syndrome (LQTS) is caused by mutations in the genes 
encoding cardiac ion channels. It is extremely important to make an early diagnosis, 
because LQTS causes sudden deaths in children and young adults. However, in Japan 
as well as other countries, both the prevalence of LQTS and the frequencies of cardiac ion 
channel gene mutations on a population basis are not clear. Therefore, we prospectively 
determined the prevalence of LQTS and the frequencies of LQTS mutation carriers in 
Japanese children.
Methods:Electrocardiograms (ECGs) were recorded from 7,961 junior high school and 
elementary school students in Kanazawa city. QT intervals were measured automatically 
and were corrected by Bazett’s formula. LQTS score was determined by Schwartz’s 
criteria, and cardiac ion channel genes were analyzed in the subjects who had LQTS 
score ≥1.5. In vitro characterization of identified mutants was subsequently performed by 
heterologous expression experiments in CHO cells or Xenopus laevis oocytes.
Results:Forty-five of 4,044 males showed QTc >450 msec1/2, and 25 of 3,917 females 
showed QTc >460 msec1/2. We assigned 3 subjects to a	high probability of LQTS group 
(LQTS score ≥ 4), and 31 subjects to an	intermediate probability of LQTS group (1.5 ≤ 
LQTS score < 4). From gene analysis in 19 subjects, one KCNQ1 gene polymorphism 
(P448R), three HERG gene mutations (M124T, 545-551delCGGGCGG, 2310-2311 ins 
TCCC + 2311-2334 del), and one KCNE1 gene polymorphism (G38S) were detected. 
Eletrophysiological studies showed that the M124T HERG did generate current, and that 
it was reduced by 55% compared with that of the wild-type HERG (2223±161 versus 
993±113 nA, tail currents at -60 mV after a 3-second pulse to +40 mV, p<0.05).
Conclusions: In Japanese children, the frequencies of high and intermediate probabilities 
of LQTS were 0.038% and 0.389%, respectively. Under these condition, disease - causing 
mutations which were observed at a rate of 15.8 % in these subjects (LQTS score ≥ 
1.5, informed consent (+)) could impair the current carried by the defective ion channel, 
contributing to prolong cardiac repolarization associated arrhythmogenesis.
11:00 a.m.
903-240	 Contraction	Front	Mapping:	A	Novel	Tool	In	Evaluating	
Acute	Response	To	Cardiac	Resynchronization	
Therapy
Ignatius Gerardo E. Zarraga, Mehreen A. Qureshi, Meneleo M. Dimaano, Tianrong Xie, 
Hien V. Nguyen, Masood Ahmad, University of Texas Medical Branch, Galveston, TX
Background:	 Real-time three-dimensional echocardiography (RT3D) assesses 
resynchrony in biventricular-paced patients by a segmental analysis of time to minimum 
systolic volumes. Using the 3D dataset (TomTec Research Arena), contraction front 
mapping (CFM) measures spatial and temporal activation of left ventricular (LV) contraction 
every 25 milliseconds and displays a bulls eye plot of the contraction wave front.
Methods:	 We studied 12 patients (mean age 66 + 14 years; 92% male) who had 
biventricular pacemakers implanted for heart failure. With the pacemaker turned off and on, 
the LV ejection fraction (LVEF) was measured by RT3D, and the LV dyssynchrony index 
(DI) was assessed using RT3D and tissue Doppler imaging (TDI), all within 1 hour.
Results: Biventricular pacing resulted in a significant increase in the mean LVEF from 
25.5 + 7.3% to 31.1 + 5.8% (p <0.0005). When the pacemaker was switched from off to 
on, the percent change in DI (% ΔDI), as measured by volume-based RT3D, correlated 
significantly with the % ΔDI measured by TDI (r = 0.74, p = 0.006) and with the % ΔDI 
measured by CFM (r = 0.64, p = 0.03). In addition, the concordance for directional 
changes in DI obtained by volume-based RT3D, CFM, and TDI was 100%.
Conclusions: CFM offers a promising new approach in the measurement of LV 
dyssynchrony from 3D echocardiographic images. CFM measurements are quantitative 
and provide an easily appreciable visual and dynamic map of LV dyssynchrony. 
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903-241	 Prediction	of	Cardiac	Decompensation	with	
Intrathoracic	Impedance	Monitoring
Claudia Ypenburg, Jeroen J. Bax, Ernst E. van der Wall, Lieselot van Erven, Leiden 
University Medical Center, Leiden, The Netherlands
Background: Intrathoracic impedance measurement (OptiVol) has been introduced in 
the new generation cardiac resynchronization therapy devices, and may permit early 
identification of pulmonary fluid accumulation secondary to left-sided heart failure. When 
the fluid index rises above 60 Ohm.day an audible alarm (OptiVol alert) can be triggered. 
In the present study, we evaluated the clinical value of this OptiVol alert and its prediction 
for cardiac decompensation.
Methods: One hundred-fifteen consecutive patients (New York Heart Association class 
3.0±0.5 and LV ejection fraction 25±5%) were included. The default alert setting was 60 
Ohm.day. When presenting with OptiVol alert, current hemodynamic status was evaluated 
by history, drug use, physical examination, laboratory tests and chest x-ray.
Results: During follow-up (9±5 months), 30 patients experienced 45 OptiVol alerts. 
However, only in 15 cases (33%) clinical signs and symptoms of heart failure were 
present (P<0.05). ROC curve analysis showed that increasing the threshold for OptiVol 
alert provided a substantial increase in specificity for detection of heart failure, with 
the optimal cut-off value identified at 120 Ohm.day, yielding a sensitivity of 60% with a 
specificity of 71%.
Conclusions: Intrathoracic impedance measurement may be a useful tool for monitoring 
pulmonary fluid status. With the proposed threshold for OptiVol alert of 120 Ohm.day a 
reasonable balance between sensitivity and specificity is obtained, although this cut-off 
value needs further testing in prospective, larger studies.
11:00 a.m.
903-242	 Complication	Rate	Following	Device	Implantation	in	
Patients	with	Impaired	Renal	Function
Emad F. Aziz, Dan Musat, Delia Cotiga, Sripal Bangalore, Joseph Mathew, David 
Djebali, Jorge Silva, Ashraf Fawzy, Eyal Herzog, Aysha Arshad, Jonathan Steinberg, St. 
Luke’s-Roosevelt Hospital Center, New York City, NY
Background:	We sought to study the complication rates following implantation of permanent 
pacemakers (PPM) and defibrillators (ICD) in patients with impaired renal function.
Methods:	683 consecutive patients who had PPM or ICD placed was retrospectively 
studied. Patient’s Creatinine Clearance was calculated using the Modification of Diet 
in Renal Disease equation for estimation of glomerular filtration rate. Chronic Kidney 
Disease (CKD) was classified as per the National Kidney foundation classification as 
Stage I (CrCl≥90), Stage II (60-89), Stage III (30-59), Stage IV (15-29) and Stage V 
(≤15). The primary endpoint was cumulative in-hospital incidence of major complications, 
defined as hematoma, infection, hemothorax, and lead or device failure.
Results:	221 (33%) had PPM, 319 (48%) had ICDs, 106 (16%) had BiVi-ICD, and 19 
(3%) had lead revisions. Primary endpoint seen in 51 (7.5%) patients. Predictors of 
primary endpoint were lower CrCl (p<0.0001), diabetes (p=0.02), CAD (p=0.003) and 
hypertension (p=0.047). CKD (OR 1.032; 95% CI= 1.019 to 1.046, P < 0.00001) was the 
strongest predictor for the primary endpoint followed by DM (OR 3.01; 95% CI= 1.16 to 
7.87, P=0.02). The relationship of CKD and outcome was driven by higher infection rate 
(X2 = 15.02, P < 0.0001) and hematoma development (X2 = 8.85, P = 0.003).
Conclusions:	Renal insufficiency markedly increases the risk of procedure complications 
in patients undergoing PPM and ICD implantation. 
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904-234	 Characterization	of	Ion	Channels	in	Human	Adipose	
Tissue-Derived	Stem	Cells
Xiaowen Bai, Junyi Ma, Yaohua Song, Susanne Freyberg, Yasheng Yan, Zhizhong Pan, 
Jody Vykoukal, Daynene Vykoukal, Eckhard U. Alt, Department of Molecular Pathology, 
University of Texas M.D. Anderson Cancer Center, Houston, TX
Background: Human adipose tissue-derived stem cells (hADSCs) are preferable source 
for myocardial regeneration due to their strong proliferative capability, multipotency, 
abundance and accessibility. One concern for cell-based therapy is that stem cells may 
exhibit electrical properties that could negatively interfere with the normal conductance of 
the heart. The present study was designed to investigate the electrical properties of ionic 
channels in undifferentiated hADSCs.
Methods: hADSCs (passage2-3) were cultured in alpha-MEM plus 20% FBS. Functional 
ion channels in cultured undifferentiated hADSCs were analyzed by whole-cell patch- 
clamp recordings. mRNA expression levels were examined by RT-PCR.
Results: In this study, four types of ion channel currents were found to be present in a 
total of 145 hADSCs: delayed rectifier K+ current (IKDR), Ca2+-activated K+ current (IKCa), 
transient outward K+ current (Ito) and tetrodotoxin-sensitive transient inward Na+ current 
(INa.TTX). Most of the hADSCs (106 of 145) showed a slowly activating outward current 
that was likely IKDR and inhibited by 15 mM tetraethyl ammonium (TEA). IKDR coexisted 
with IKCa. The transient outward current Ito was detected in 27 cells. A small population of 
cells (11 of 145) showed INa.TTX. The inward current generally coexisted with the outward 
current. In addition, RT-PCR results showed molecular evidence for the expression of 
functional ion channels at mRNA levels, including Kv1.1, Kv2.1, Kv1.5, Kv7.3, Kv11.1 and 
Heag1 (possible responsible for IKDR); MaxiK, KCNN3 and KCNN4 for IKCa; Kv1.4, Kv4.1, 
Kv4.2 and Kv4.3 for Ito and hNE-Na for INa.TTX. Expression of mRNA for voltage-dependent 
calcium channel subunits α 1C and α 1H was also positive, but no voltage-dependent 
calcium current was detected in any hADSCs examined. 
Conclusions:	Our systematic characterization of ion channels in ADSCs is an important step in 
assessing safety issues for future clinical stem cell based therapy for myocardial infarction.
Noon
904-237	 The	Efficacy	of	Ablation	Techniques	for	the	Treatment	of	
Atrial	Fibrillation:	Is	Pulmonary	Vein	Isolation	Adequate	
as	Lone	Ablation	Therapy?
Vaughn A. Starnes, Mark J. Cunningham, Becky M. Lopez, Candace Bart, Keck School 
of Medicine of the University of Southern California, Los Angeles, CA
Background:	The surgical treatment for atrial fibrillation (AF) has evolved to include 
choices of modified maze (right and left atrial ablation with standard ablation lines) and 
pulmonary vein isolation. The purpose of this study was to examine the results of 131 
patients who had either modified maze procedure (MMP) or bipolar ablation alone for 
pulmonary vein isolation (PVI).
Methods:	A	Retrospective review was performed of all patients who underwent MMP 
(N=46) or PVI alone (N=85). Follow-up was available on 100% of the patients.
Results:	 In the MMP group there were 11 (24%) CABG procedures and 25 other 
procedures including mitral valve repair (MVRpr), aortic valve replacement (AVR), 
tricuspid valve repair (TVRpr) and mitral valve (MV) ring insertion.	In the PVI group there 
were 24 (29%) CABG	procedures and 48 concomitant procedures including MVRpr, AVR, 
TVRpr, and MV ring insertion. There were 6 permanent pacemakers inserted in the MMP 
group and 1 in the PVI group. The mean follow-up was 32±25 for the MMP group and 
33±25 for the PVI group. Freedom from AF at the latest follow-up visit is 80% (37/46) in 
the MMP group and 75% (64/85) in the PVI group.
Conclusion:	The data suggests that PVI is as effective as MMP for AF in concomitant 
cardiac surgical procedures. The advantage of PVI over MMP is the simplicity of the 
approach and the decreased likelihood of a pacemaker requirement. 
MMP (N=46) PVI (N=85)
Age (Years) 66±13 66±13
Gender (Male %) 63% (N=29) 85% (N=50)
Persistent AF (%) 83% (N=38) 80% (N=68)
AF Duration (Months) 46±63 33±52
LA Diameter (CM) 5.0±11 5.1±12
EF (%) 51±11 54±12
Freedom from AF at the Last Follow-up Visit 80% (37/46) 75% (64/85)
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904-238	 Depression,	Anxiety,	and	Quality	Of	Life	In	Patients	
With	Atrial	Fibrillation
Graham Thrall, Gregory YH Lip, Douglas Carroll, Deirdre Lane, The University of 
Birmingham, Birmingham, United Kingdom
Objective:	To examine the prevalence and persistence of depression and anxiety in 
patients with atrial fibrillation (AF), and their effect on future quality of life (QoL).
Methods: The Beck Depression Inventory (BDI) and State-Trait Anxiety Inventory (STAI) 
were completed by 101 patients with AF (62 males; mean (SD) age 66.3 (11.0) years), 
compared to 97 hypertensive patients in sinus rhythm (64 males; mean (SD) age 68.0 
(7.2) years; as ‘disease controls’) at baseline and at six-months. QoL was ascertained at 
six-months using the Dartmouth Care Cooperative Information Project (COOP) charts.
Results: At baseline among AF patients, symptoms of depression, and state and 
trait anxiety prevailed in 38%, 28%, and 38%, respectively. The analogous figures 
for hypertensive patients were 30%, 23%, and 22%. AF patients displayed higher 
levels of trait anxiety (p<0.05), with no significant differences in baseline depression, 
or state anxiety between AF patients and ‘disease controls’. Symptoms of depression 
and anxiety (state and trait) persisted at six-months in 36.8% and 33.3%, respectively. 
Multiple regression analysis revealed that baseline depression score provided the best 
independent prediction of QoL at six-months (R2 =.20).
Conclusions: Approximately one-third of AF patients experience elevated levels of 
depression and anxiety, which persist at six-months. Symptoms of depression were the 
strongest independent predictor of future QoL in these patients.
Independent baseline predictors of six month quality of life in atrial 
fibrillation patients
Model Contribution to R2 B Beta 95% CI for B F P
BDI Score .20 .41 .46 .22 - .60 18.9 <.001
BDI score
Gender .29
.38
-3.88
.43
-.31
.20 - .56
-6.42 - -1.34 15.22 <.001
BDI Score
Gender
Employed
.34
.41
-3.40
3.22
.27
-.27
.24
.24 - .59
-5.90 - -92
.55 - 5.90
12.79 <.001
Noon
904-239	 Impact	Object	Shape	and	Resultant	Left	Ventricular	
Pressure	Critically	Important	in	the	Generation	
of	Ventricular	Fibrillation	from	Chest	Wall	Impact	
(Commotio	Cordis)
Mark S. Link, Barry J. Maron, Arthur R. Garan, Christopher P. Song, N. A. Mark Estes, 
III, Tufts-New England Medical Center, Boston, MA, Minneapolis Heart Institute, 
Minneapolis, MN
Background: Sudden death due to low-energy blunt trauma to the precordium (commotio 
cordis) has been described with different sporting objects. However, the relative risk of 
sudden death in relation to the shape of the object (i.e., baseball, golfball) is not known 
and is the subject of the current study.
Methods: In a juvenile swine model (mean weight 15 ± 1.1 kg), impacts were given with 
two different spherical shapes (72 cm equivalent to a baseball diameter, and 42 cm 
equivalent to a golfball), and a flat object. Objects were similar in weight (150 grams) 
and impact velocity was 30 mph in all impacts. The order of impacts was randomized and 
gated to the vulnerable portion of the cardiac cycle.
Results: Sixteen swine underwent 140 impacts. The likelihood of ventricular fibrillation 
was significantly increased by the smaller diameter objects (p= 0.009). The smallest 
diameter object was associated with the highest risk of ventricular fibrillation (9 of 47 
impacts: 19%), while the intermediate diameter object showed an intermediate risk (5 of 
47: 10%). There were no episodes of ventricular fibrillation with the flat object (0 of 46). 
Smaller diameter was also associated with a higher increase in left ventricular pressure 
with chest impact (42 cm: 470 ± 135 mmHg; 72 cm: 384 ± 111 mmHg; flat: 295 ± 105 
mmHg) and a higher likelihood of ST segment elevations (42 cm: 58%; 72 cm: 38%; and 
flat: 0%), and bundle branch block (42 cm: 18%; 72 cm: 7%; flat 0%).
Conclusions: The shape of the impact projectile markedly influences the risk of ventricular 
fibrillation with chest wall impact. This effect is likely mediated via a greater increase in left 
ventricular pressure. Spreading the impact force over a larger area will decrease the risk 
of sudden death and has implications for the design of protective equipment.
Noon
904-240	 Adverse	Clinical	Events	Associated	with	Normal	
Pacemaker	Pulse	Generator	End-of-Service	Life	
Behavior
Robert G. Hauser, Andrew E. Epstein, Stephen C. Vlay, David S. Cannom, David 
L. Hayes, Linda M. Kallinen, Adrian K. Almquist, Susan L. Song, G. Frank O. Tyers, 
Marleen Irwin, Minneapolis Heart Institute Foundation, Minneapolis, MN
Background: Pacemaker pulse generators (PG) are designed to change pacing mode 
and/or pacing rate when the battery voltage falls to a level indicating impending battery 
depletion. Such changes in pacing mode or rate are termed elective replacement 
indicators (ERI) and they decrease current drain and slow battery depletion until the PG is 
replaced. Unfortunately the ERI may cause significant symptoms in susceptible patients. 
The aim of this study was to determine the incidence of major adverse clinical events 
(MACE) associated with the ERI in otherwise normally functioning PG.
Methods: From 1998 to 2006, 9 centers prospectively entered PG data using a web-
based format. Normal battery depletion was the appearance of the ERI in patients who 
had regular pacemaker follow-up. PG were excluded if they or their leads were not 
functioning normally, or if they were not adequately followed. MACE were death, angina, 
heart failure, syncope or near syncope, and tachyarrhythmias.
Results: During the study, 2,652 PG were removed from service 7.3±3.1 years after 
implant. Of these, 2,317 (87%) were replaced for normal battery depletion and the 
remainder (13%) were removed for other reasons, including abnormal severe or 
accelerated battery depletion (5%), advisories (4%), and electronic (2%) or connector 
(1%) defects. Overall, MACE were experienced by 62 patients. Of these, 21 (34%) 
were associated with normal battery depletion and the ERI. Symptoms at ERI included 
syncope or near syncope (n=13), heart failure (n=5), tachyarrhythmia (n=2) and angina 
(n=1). MACE at ERI involved 13 models from 3 manufacturers; 17 of the 21 PG were 
DDDR devices that reverted to VVI mode and disabled rate response at ERI. Another 
133 patients experienced minor symptoms at ERI. MACE due to PG causes other 
than ERI were death (n=1), syncope or near syncope (n=33), heart failure (n= 5), and 
tachyarrhythmia (n=2 ).
Conclusions:	Although the overall incidence of MACE due to PG is very low, pacing mode 
and rate changes at ERI account for a third of PG major adverse events and many minor 
symptoms. These observations suggest that unphysiologic ERIs should be avoided in future 
PG designs, and they support the development of improved monitoring technologies.	
Noon
904-241	 A	15-Year	Study	on	Pacemaker	Related	Infections:	
A	Claim	for	Using	Post-Operative	Antibiotics
Anushka Jayasuriya, Marleen Irwin, Sajad Gulamhusein, Bonnie Carbol, Kim Kyllo, 
Mano Senaratne, Grey Nuns Hospital, Edmonton, AB, Canada
Background: Although the reported incidence of pacemaker related infection (INF) is low, 
it necessitates the removal of the pacing system for cure. The present study elucidates 
factors associated with INF over a 15 yr period.
Methods: A retrospective chart review was conducted on all patients(pts) undergoing 
pacemaker surgery from 1991-2006. Implant and clinical follow-up data were collected 
prospectively and entered into the SPSS data management system.
Results: There were 2667 procedures (lost to follow-up = 36, 1.3%) with INF identified in 
44 (1.7%) pts. Time from last procedure: <3m = 15 (34.1%); 3m-1yr = 13 (29.5%); >1yr 
= 16 (36.4%). On univariate analysis, the following were associated with an increased 
risk of INF: non-use of post-operative oral antibiotics (POST, 3.0% vs. 0.4%, p<0.001), 
out-pt procedures (OP, 2.4% vs. 1.0%, p = 0.003), repeat procedures(RP, 2.7% vs.1.2%, 
p = 0.004), non-use of peri-operative antibiotics (PERI, 3.7% vs. 1.5%, p = 0.047). The 
following were not significant: length of procedure; surgical suite ( procedure room vs. 
the operating room); diabetes; bacitracin use; age; gender. On multivariate analysis the 
following were significant (coefficients denote relative importance of each): POST (0.915), 
RP (0.571), OP (0.344). During the 15 yr period the incidence of INF fell from 5.8% 
(no PERI) to 2.4% (PERI), to 0.8% (PERI with POST). With POST, the infection rates 
were significantly reduced: New implants (0/900 = 0.0% vs. 22/964 = 2.3%, p<0.001); 
RP (6/499 = 1.2% vs. 16/304 = 5.3%, p = 0.001); OP (6/804 = 0.7% vs. 25/498 = 5.0%, 
p<0.001). The infection rate of the RP group fell to 1.0% (1/105) vs. 3.2% (21/658, p = 
0.170), when prior pacemaker related procedures had POST administered.
Conclusions: The present study confirms a higher risk of INF associated with RP and 
OP. POST appears to be the most important factor minimising INF. The decrease in the 
INF for RP (albeit p = 0.170) where the prior procedures had POST, suggests the higher 
rate of INF for RP may be related to recrudescence of bacterial colonization at the time of 
the original procedures as opposed to new INF. The present study makes a strong case 
for the use of an extended course of POST to minimize pacemaker related infections.
Noon
904-242	 Steadiness	of	Left	Ventricular	Ejection	Fraction	
after	Revascularization	in	Patients	post	Myocardial	
Infarction:	Impact	on	Primary	Prevention	with	
Implantable	Cardioverter	/	Defibrillators	(ICD)
Rona K. Reibis, Karl Wegscheider, Victoria Basinkevic, Andreas Suciu, Heinz A. Voeller, 
Klinik am See Ruedersdorf/Berlin, Ruedersdorf/Berlin, Germany, Institute of Statistics 
and Biometrics, Hamburg, Germany
Background: Reduced left ventricular ejection fraction (LVEF) is the most powerful 
predictor of sudden cardiac death (SCD) in patients (pts.) after myocardial infarction (MI). 
It is unknown, how complete revascularization of pts. with LVEF of 30-40% reverses left 
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ventricular remodelling and consecutively influences the indication for ICD.
Methods: Within the prospective multi-centre German PreSCD-II-registry 2046 
consecutive pts. at least 1 month after MI were included between 12/03 - 05/05. Of 
these, 277 pts. (65.5 ± 10.6 y, 83% male) with an initial LVEF of ≤ 40% after complete 
revascularization by PCI (74.3%) or CABG (24.7%) were re-investigated by biplane 
echocardiography after a mean follow-up of 441 ± 220 days to assess LV performance 
due to stunning or hibernating. According to their initial LVEF pts. were stratified in 2 
groups: group 1 with LVEF ≤ 30% (n=76; 61 male; 66.1 ± 11 y) and group 2 with LVEF of 
30-40% (n=201; 170 male; 65.4 ± 10 y).
Results: 19 pts. died during the follow-up (10 for cardiac reasons, out of them 5 for SCD, 
overall mortality 10.5% in group 1, 5.5% in group 2). 6 pts. were lost to follow-up (5.7%). 
The remaining 242 pts. at first look seemed to reveal a significant increase of LVEF of 
6.2% ± 9% (35.3 ± 6.1% vs. 41.4 ± 10.7%, p < 0.001), but with considerable individual 
variation (SD=9.0%). However, these results turned out to be predominantly due to pre-
selection of patients by reduced LVEF and to regression towards the mean caused by 
measurement error. After a statistical bias correction the true LVEF improvement was 
estimated to be not more than 2%, but remained statistically significant.
Conclusion: Even after complete revascularization the recovery of impaired LVEF in pts 
post MI turned out to be rather moderate, on average. However, due to the observed 
considerable instability of LVEF determinations, LV function should be assessed rather 
regularly within the first year after MI before treatment decisions with longterm effects like 
preventive ICD implantation are made.
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905-234	 Phenotypic	Expression	of	the	Congenital	Long	QT	
Syndrome	in	Caucasian	and	Japanese	Patients	With	
Matched	KCNQ1	Genotypes
Judy F. Liu, Ilan Goldenberg, Arthur J. Moss, Coeli M.B. Lopes, Wataru Shimizu, Arthur 
A.M. Wilde, Scott McNitt, University of Rochester Medical Center, Heart Research 
Follow-up Program, Rochester, NY
Background: Ethnic differences may affect the phenotypic expression of genetic 
disorders. We compared the clinical course of Caucasian and Japanese long QT type-1 
(LQT1) patients that were matched for mutations in the KCNQ1 gene.
Methods: The study population comprised 64 Caucasian and 38 Japanese patients 
enrolled in the International LQTS Registry. The two ethnic groups were matched for six 
individual KCNQ1 mutations that were categorized into dominant negative and loss of 
function types. The primary end point was the occurrence of a first LQTS-related cardiac 
event from birth through age 40 years.
Results: Japanese patients had a significantly higher cumulative rate of cardiac events than 
Caucasian patients (Figure). The frequency of the high-risk dominant negative mutation-
type was 63% and 37% in Japanese and Caucasian patients, respectively (p<0.001). After 
multivariate adjustment for gender, QTc, and therapy with β-blockers, Japanese ethnicity 
was associated with a 4.4-fold increase in the risk of cardiac events (p<0.001). However, 
when the mutation type was added into the multivariate model, the risk associated with 
Japanese ethnicity was no longer significant (HR=1.89; p=0.15), whereas the dominant 
negative mutation type was the greatest predictor of risk (HR=4.66; p=0.001).
Conclusions: Our data provide evidence that ethnic differences in the clinical expression 
of LQTS can be attributed to differences in the frequencies of the mutation-type carried 
by the individual populations. 
1:00 p.m.
905-237	 Delineation	of	Reentrant	Circuit	in	Atypical	
Atrioventricular	Nodal	Reentrant	Tachycardia	with	
Eccentric	Coronary	Sinus	Activation
Kiyoshi Otomo, Keita Handa, Tadafumi Nanbu, Yasutoshi Nagata, Kikuya Uno, Yoshito 
Iesaka, Tsuchiura Kyodo Hospiital, Tsuchiura, Japan
Background Atypical AV nodal reentrant tachycardia (AVNRT) with eccentric coronary 
sinus (CS) activation (ECSA) has been reported. However, the electrophysiological 
property and successful ablation site have not been fully characterized. The purposes of 
this study were to evaluate the electrophysiological property and successful ablation site 
and to delineate the reentrant circuit (RC) in atypical AVNRT with ECSA.
Methods	 Electrophysiological data were reviewed in consecutive 330 patients 
(pts) with AVNRT.
Results Eighteen pts (5%) presented ECSA during 23 atypical AVNRTs (slow-slow: 12, 
fast-slow: 11) with the earliest retrograde atrial activation registered at the roof of the CS 
11±5 mm distal to the ostium, while the remaining 312 pts (95%) presented concentric CS 
activation. The pts with ECSA were significantly younger than those with concentric CS 
activation (38±18 versus 51±18 years; P<0.01). Presence of the upper and lower common 
pathways was suggested in 3 (17%) and 18 pts (100%), respectively, and the former was 
manifested by ventriculo-atrial dissociation (n=2) or variable H-A interval with stable H-H 
interval during tachycardia (n=1). The local atrial electrogram at the earliest retrograde 
atrial activation site during tachycardia (AV ratio: 1.6±1.2) presented the characteristic 
features of the “dull and sharp” components, suggesting an initial depolarization of the 
left atrial myocardium and subsequent conduction to the CS musculature. Ablation to 
the earliest retrograde atrial activation site inside the CS terminated tachycardia and 
eliminated tachycardia inducibility with complete elimination (n=12; 67%) or modification 
of the leftward slow pathway (SP) conduction (n=6; 33%) without any complications. In 
2 pts (11%), the anterograde as well as retrograde SP conduction was eliminated after 
ablation inside the CS.
Conclusion Ablation to the atrial insertion of the leftward SP rendered the tachycardia non-
inducible, suggesting the leftward SP constituted the retrograde limb of the RC in atypical 
AVNRT with ECSA. Both the anterograde and retrograde limbs were shifted to the left side 
in 11%, while the RC was considered sub-atrial in 17% of atypical AVNRT with ECSA.
1:00 p.m.
905-238	 Monitoring	of	Esophageal	Temperature	During	
Pulmonary	Vein	Isolation:	New	Computational	
Method	for	Assessment	of	Proximity	of	Ablation	
Site	to	Esophagus
Dan Musat, Sripal Bangalore, Aysha Arshad, Emad Aziz, Delia Cotiga, Tina Sichrovsky, 
Jonathan S. Steinberg, St Luke’s Roosevelt Hospital, Columbia University College of 
Physicians and Surgeons, New York, NY
Background: Atrio-esophageal fistula (AEF) is a potentially catastrophic complication of 
left atrial (LA) ablation. Real time assessment of esophageal (E) position and temperature 
(T°) response to pulmonary vein isolation (PVI) has not been extensively explored nor 
has a practical assessment of minimal physical separation between ablation site and E.
Methods: In 47 consecutive pts who underwent PVI of 104 PVs, a thermal probe (TP) 
was used to monitor T° fluctuations in the E during application of radiofrequency (RF) 
energy. The tip of the TP was positioned at the level of the targeted PV and repositioned 
as needed. RF was discontinued for T° rise of more than 0.5°C. The proximity of individual 
PVs to the E was measured from the TP tip to the closest posterior part of the Lasso 
catheter from review of biplane projections (LAO 60° and RAO 30°). These raw distances 
were entered into the Pithagorean formula and the actual distance was derived. Finally, 
the preablation CT was compared to the real-time assessment.
Results: Patients were 60+ 10 yrs, 60% male and 68% lone AF. The TP in the E was 
relatively closer to the left sided PVs (L-common: 19.4± 13 mm, LUPV: 20.7± 11 mm, 
LLPV: 20.3± 13 mm) than the right-sided ones (RUPV: 38.4± 18 mm, RLPV: 37.3± 17 
mm). RF was stopped due to T° increase in 76/1303 (5.8%) deliveries. T° rise was more 
likely during ablation of left-sided PVs vs right-sided PVs (52 % versus 12%, p< 0.00001). 
There was low likelihood of increase in T° when RF was delivered ≥ 29 mm from the E: 
PPA= 66 %, NPA= 97 %. Correlations made with the CT scan showed that distances on 
X-Ray images were only moderately correlated for all the PVs (r = 0.51, p< 0.0001).
Conclusion:	A TP placed in the E provides real time T° monitoring and anatomic localization. 
T° rise is more likely during ablation of left PVs and for practical use, all RF deliveries within 
29 mm of esophagus are at greatest risk. Real time TP monitoring is a better assessment 
technique for esophageal position during AF ablation than pre-CT angio.
1:00 p.m.
905-239	 Ventricular	Arrhythmia	“Bursts”	in	the	Setting	of	Acute	
Anterior	Infarct	Artery	Recanalization:	A	Re-Definition	
of	“Reperfusion	Arrhythmias”
Mohamed Majidi, Andrzej S. Kosinski, Sana M. Al-Khatib, Miguel Lemmert, Ricardo G. 
Baeza, Suzanne W. Crater, Hein W. Wellens, Anton P. Gorgels, Mitchell W. Krucoff, 
Duke Clinical Research Institute, Durham, NC
Background:	 Reperfusion arrhythmias are of unique interest as they may reflect 
myocellular response to epicardial recanalization in STEMI pts, however not all 
arrhythmias during STEMI relate to reperfusion. Using continuous ST segment recovery 
and angiographic criteria to identify reperfusion, we sought to specifically characterize 
ventricular BURST arrhythmias resulting from epicardial recanalization.
Methods: A total of 181 pts with anterior STEMI and final TIMI 3 flow after primary PCI 
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had continuous 24-hr digital 12-lead ECG and Holter recording started prior to PCI. All 
ventricular beats (VPC) were validated from Holter in a blinded fashion. VPC rates for 
every 5 minute period were correlated with independent core lab analysis of TIMI flow and 
ST segment recovery. We defined Reperfusion “BURST” as shown in the figure.
RESULTS: Holter recordings showed that any VPC occurred in 181/181 (100%) of pts 
while reperfusion BURST occurred in 118/181 pts (65%). Median duration of BURST was 
60 min (IQR: 5-140). Median total number of VPCs in BURST was 1013 (IQR: 264-3438).
Conclusions: All anterior MI pts have arrhythmias, however only a fraction have 
BURST arrhythmia associated with reperfusion making specific definition of reperfusion 
arrhythmia challenging in the clinical setting. Using simultaneous continuous ECG and 
Holter monitoring, reperfusion arrhythmias may be better identified, leading to a clearer 
understanding of their pathophysiologic and prognostic significance.
1:00 p.m.
905-240	 Time	Course	And	Extent	Of	LV	Resynchronization	
Following	CRT;	Effects	On	Clinical	And	
Echocardiographic	Benefit.
Gabe B. Bleeker, Eduard R. Holman, Eric Boersma, Ernst E. van der Wall, Martin J. 
Schalij, Jeroen J. Bax, Leiden University Medical Center, Leiden, The Netherlands
Background: Recent studies have demonstrated that a positive response to cardiac 
resynchronization therapy (CRT) is related to the presence of pre-implantation 
left ventricular (LV) dyssynchrony. However, the time course and the extent of LV 
resynchronization following CRT implantation and their relationship to response are 
currently unknown.
Methods: One hundred consecutive patients scheduled for the implantation of a CRT device 
were prospectively included (Inclusion criteria: NYHA class III-IV heart failure, LV ejection 
fraction ≤35% and a QRS duration >120 ms).	All patients needed to have substantial pre-
implantation LV dyssynchrony (≥65 ms) on color-coded tissue Doppler imaging (TDI).
Results: Immediately post-implantation LV dyssynchrony was reduced from 114±36 
ms to 40±33 ms (P<0.001) which persisted at 6 months follow-up (35±31 ms (P<0.001 
versus baseline and P=NS versus immediate post-implantation). At 6 months follow-up 
85 patients (85%) were classified as responders to CRT (defined as >10% reduction in LV 
end-systolic volume). Baseline characteristics were comparable between responders and 
non-responders. Immediately post-implantation the responders to CRT demonstrated a 
significant reduction in LV dyssynchrony from 115±37 ms to 32±23 ms (P<0.001). The 
non-responders, however failed to show a significant reduction in LV dyssynchrony (from 
106±29 ms to 79±44 ms, P=NS). If the extent of LV resynchronization was <25% the 
response rate to CRT was only 10%, whereas in the patients with LV resynchronization 
≥25% response rate was excellent (93%).
Conclusion: LV resynchronization following CRT is an acute phenomenon, the extent of 
which is predictive for echocardiographic response to CRT at 6 months follow-up. 
1:00 p.m.
905-241	 Reverse-Polarity	Pacing:	The	Hemodynamic	Benefit	
of	Anodal	Versus	Cathodal	Currents	in	Cardiac	
Resynchronization	Therapy
Michael S. Lloyd, S. Patrick Whalen, Jonathan Langberg, Emory University, Atlanta, GA
Background: Cardiac pacing can be achieved with currents of either anodal or cathodal 
polarity. In contrast to conventional cathodal pacing, anodal pacing initially hyperpolarizes 
tissue and improves myocardial contractility in animal models. This may be especially 
valuable in pacing therapy for heart failure. We compared the hemodynamic effects of anodal 
pacing currents to cathodal currents in the context of cardiac resynchronization therapy.
Methods: In 13 patients undergoing device implantation, we compared the mean left ventricular 
outflow velocity-time integral (LV-VTI) in three different pacing configurations for both anodal 
and cathodal polarities (39 comparisons). The indifferent electrode in all configurations was 
either at the pocket (unipolar) or right ventricular defibrillation coil (virtual unipolar) to ensure 
that the only stimulating currents were at the lead tips. Intraoperative continuous-wave Doppler 
measurements were taken at a fixed interrogation angle while polarities were reversed during 
unipolar left ventricular, unipolar biventricular, and shared-coil biventricular pacing. Comparisons 
used identical pacing rates, AV intervals, and pacing outputs.
Results: Data was suitable for analysis in 37 of the 39 polarity comparisons. Patients 
had a mean ejection fraction of 0.18 ± 0.08 and a mean QRS duration of 140 ± 34 ms. 
All capture thresholds were under 4.5 volts at a pulse width of 0.4 ms. Anodal polarity 
significantly increased average LV-VTI in 36 of the 37 comparisons. The mean LV-VTI for 
each comparison was 2.8 ± 2.6 cm or 14.8% higher with anodal polarity (p < 0.001). The 
combined mean LV-VTI for all anodal configurations was likewise higher (24.4 ± 11.7 cm) 
compared to cathodal configurations (21.7 ± 10.9 cm; p < 0.001).
Conclusion: Left ventricular and biventricular pacing with currents of anodal polarity 
significantly improve a measure of left ventricular function compared to traditional 
cathodal polarity. Our findings show that a simple reversal of pacing circuit polarity may 
further improve cardiac function in patients with cardiac resynchronization devices.
1:00 p.m.
905-242	 Is	Outpatient	Implantation	of	Biventricular	Devices	Safe?
Janet K. Han, Zenaida Feliciano, VA Greater Los Angeles Healthcare System, Los 
Angeles, CA, David Geffen School of Medicine at UCLA, Los Angeles, CA
Background: Implantation of cardiac resynchronization devices, both with (CRT-D) 
and without (CRT) defibrillator is increasing as more studies show the benefits of CRT 
in heart failure patients. Complication rates for CRT and CRT-D in COMPANION and 
CARE-HF were 8-10% and 10% respectively. Routine care includes overnight admission 
to observe for early postoperative complications. We routinely perform new CRT and 
CRT-D implantations on an outpatient (OP) basis with discharge 2-3 hours afterwards 
and follow-up within 14 days. This study evaluates the safety of same day discharge after 
OP CRT and CRT-D implantation.
Methods: Retrospective data analysis was performed at a single tertiary care teaching 
institution from a computerized database over the previous 4.5 years.
Results: 80 patients underwent OP implantation; 76 were CRT-D, 4 were CRT, 71 were 
successful (89%). Mean age was 68 years, mean EF was 22%, 71.3% had ischemic 
cardiomyopathy, and 93.8% were NYHA III. Total complication rate was 7%. These 
were: 1 atrial lead dislodgement (1.4%), 2 hypoventilations post-sedation (2.8%), 1 
pocket infection (1.4%) and 1 oversedation (1.4%). There were no hematomas, cardiac 
perforations, coronary sinus dissections, pneumothoraces, or deaths. 68 of 71 (95.6%) 
were discharged the same day.
Conclusions: Routine outpatient implantation of CRT is a safe alternative. Further 
studies are needed to assess the cost effectiveness and overall impact of outpatient 
device implantation. 
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906-234	 Association	Between	KCNE1	Potassium	Channel	
Polymorphism	Mink38g	and	Lone	Atrial	Fibrillation
Hugo Verdejo, Maria Paz Ocaranza, Rolando Gonzalez, Pontificia Universidad Catolica 
de Chile, Santiago, Chile
Introduction: Pathogenesis of lone atrial fibrillation (AF) is still poorly understood. 
Recently, a single-nucleotide polymorphism at position 112 in the KCNE1 gene, resulting 
in a glycine/serine substitution at position 38 in the minK peptide (minK38G) was 
associated with AF in Asiatic in-hospital subjects. New investigations have confirmed 
the physiological relevance of the polymorphism in atrial repolarization. However, the 
prevalence of minK38G in healthy individuals and its association with lone AF has not 
been assessed.
Objective: To determine the prevalence of minK38G in healthy individuals and its 
association with AF
Population and methods: Twenty-seven Hispanic subjects under 60 years with certified 
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antecedent of AF, without any other comorbidities and with normal echocardiogram were 
included. Twenty-eight age-matched healthy individuals with normal echocardiogram 
were included as controls. Human minK cDNA was obtained by PCR using leukocyte 
DNA as template. The minK38S and minK 38G alleles were determined by digestion 
of minK cDNA with MspA1 and agarose gel electrophoresis. Results: Mean age was 
48.3±9.4 in the AF group and 43.6±12 in the control group, p=0.08. Sixty-four percent 
of the subjects were female. Echocardiographic measurements were within normal 
values in both groups; however, atrial diameter was higher in the AF group (40.6±5.8 
vs. 34.8±3.7 mm, p=0.04). MinK38G allele had a high prevalence in the studied group, 
although lower than previously published for Asiatic population (45% vs. 67%). The 
occurrence of minK38G allele was more common in the AF group (53.7 vs. 37%, p=0.02) 
and the prevalence of minK38G homozygotes in the AF and control group was 5.5% 
vs. 0%, respectively (p=0.02). MinK38G homozigotes showed a markedly increased risk 
for AF (OR 5.35, IC95% 1.13-25.25, p= 0.03) Conclusions: There is a high prevalence 
of minK38G polymorphism in Hispanic population, although lower than the previously 
described for Asiatic cohorts. MinK38G homozigotes are at increased risk for AF even 
in absence of other comorbidities, suggesting a role in the development of a vulnerable 
substrate for AF in structurally normal hearts.
2:00 p.m.
906-237	 Improved	Regional	Left	Atrial	Motion	After	Pulmonary	
Vein	Isolation
David Nori, Gilbert Raff, David Haines, William Beaumont Hospital, Royal Oak, MI
Background: Pulmonary vein ablation (PV) is associated with decreased left atrial 
(LA) volumes. Whether this represents positive remodeling versus scaring and tissue 
contraction has not been determined. No data regarding its effect on regional LA wall 
motion has been reported. We sought to evaluate the global and regional wall motion as 
assessed by cardiac MRI (CMR) in patients with persistent atrial fibrillation (AFIB) before 
and 3 months after PV ablation.
Methods: 20 cardiac MR scans were analyzed. AFIB patients were examined by CMR 
pre-PV ablation. Images were acquired by TrueFISP using HLA, VLA and SA axis 
planes to measure LA volumes throughout the cardiac cycle. Time volumes curves were 
obtained. Chordal and radial segmental wall motion was obtained using Seimens graphic 
tools. CMR protocol was repeated in 3 months with 7 of 10 patients maintaining sinus 
rhythm.
Results: Baseline mean LA volumes in AFIB at maximal/minimal phases were 86.6 ± 21 
/ 66.2 ± 22 cc. After ablation, atrial volumes decreased: 79.6 ± 29 / 52.6 ± 25 cc.(p=0.17, 
0.02) Total LA emptying fraction (p=0.03) and cyclical volume change index (p=0.13) 
increased. Regional motion is displayed below. Ablation was associated with increased 
inferior (p<0.01), anterior (p=0.02), septal (p=0.02) radial shortening with the remaining 
segments showing a trend towards increasing regional motion.
Conclusions: Ablation is associated decreased atrial volumes throughout the cardiac 
cycle and increased regional wall motion in multiple segments. 
2:00 p.m.
906-238	 Technical	Considerations	for	Dominant	Frequency	
Analysis	of	Atrial	Fibrillation	Electrograms
Jason Ng, Alan H. Kadish, Jeffrey J. Goldberger, Northwestern University, Chicago, IL
Background: Dominant frequency (DF) analysis of atrial electrograms has been used to 
characterize atrial fibrillation (AF). The aim of this study was to explore technical issues 
that may affect the estimation of local activation rate during AF using DF analysis.
Methods: Epicardial atrial electrograms recorded during AF from 10 dogs were used to 
evaluate the effects of unipolar vs. bipolar recordings, bipolar electrode spacing, post-
recording processing, far field ventricular depolarizations, ventricular template subtraction, 
and signal duration on DF analysis. DFs were compared with activation rates obtained by 
manual marking and the reproducibility of the DFs was evaluated by calculating intraclass 
correlation coefficients (ICC).
Results: See table. Bipolar electrograms were found to preferable to unipolar 
electrograms. Pre-processing was a necessary step for bipolar signals but also aided 
analysis of unipolar recordings. Far field ventricular depolarizations (FFVDs) significantly 
affected DFs. Ventricular template subtraction helped DF analysis both in signals with 
minimal and significant ventricular components. A recording duration above two seconds 
was required for reliable DF measurements.
Conclusions: Various factors affect DF analysis. Proper interpretation of DF analysis 
requires careful evaluation of the AF signals and robust processing techniques.
Absolute difference between the DFs and mean activation rates. ICCs of 
the DF in parentheses.
Type Unprocessed Processed Subtraction
Unipolar (minimal FFVDs) 1.3±1.9 Hz (0.62) 0.3±0.7 Hz (0.45)
0.3±0.8 Hz 
(0.44)
Unipolar (significant FFVDs) 3.0±2.6 Hz (0.47) 2.4±2.5 Hz (0.23)
1.2±1.4 Hz 
(0.16)
Bipolar (2.5mm, minimal FFVDs) 9.7±1.6 Hz (0.01) 0.3±0.7 Hz (0.45) 0.2±0.3 Hz (0.9)
Bipolar (2.5mm, significant 
FFVDs)
10.1±1.4 Hz 
(-0.17)
0.3±0.7 Hz 
(0.45)
0.5±0.9 Hz 
(0.60)
Bipolar
(5mm, minimal FFVDs) 9.5±1.4 Hz (-0.01)
0.3±0.7 Hz 
(0.46)
0.3±0.4 Hz 
(0.93)
Bipolar
(5mm, significant FFVDs)
10.2±1.6 Hz 
(-0.22)
2.1±2.6 Hz 
(0.19)
0.5±0.7 Hz 
(0.65)
2:00 p.m.
906-239	 Should	Intravenous	Amiodarone	be	Utilized	for	
Haemodynamically-Tolerated	Sustained	Monomorphic	
Ventricular	Tachycardia?
David R. Tomlinson, Paul Cherian, Timothy R. Betts, Yaver Bashir, The John Radcliffe, 
Oxford, United Kingdom
Background: Current Resuscitation Council (UK) guidelines recommend intravenous 
(IV) amiodarone 300mg, for the pharmacological termination of haemodynamically-
tolerated, sustained monomorphic ventricular tachycardia (SMMVT). In contrast, the 
ACC/AHA/ESC 2006 guideline recommends bolus dose IV amiodarone only for patients 
with drug-refractory, or haemodynamically unstable VT.
Methods: Retrospective analysis of 40 consecutive patients with SMMVT who received 
bolus IV amiodarone 300mg. Study end-points were: VT termination within 20 and 60 
minutes, and incidence of hypotension requiring emergency DC cardioversion. The data 
were compared with a retrospective case series of IV amiodarone 150mg (Marill et al 
2006 - who used a 20-minute end-point) and historical controls from two randomised trials 
of IV lidocaine vs. sotalol or procainamide in the identical clinical setting (Ho et al 1994 
and Gorgels et al 1996 - who used a 15-minute study end-point).
Results: Baseline characteristics are given in the table. Median VT duration was 65 mins 
(range 15 - 6,000), 34 were male and with VT cycle length 360(74) ms (*indicates 60-
minute end-point).
Conclusions: Bolus dose IV amiodarone was less effective than procainamide and 
sotalol for acute termination haemodynamically-tolerated, SMMVT. Until randomised 
control trial data is available, IV amiodarone should not be recommended for the 
termination of haemodynamically-tolerated SMMVT in the emergency setting.
2:00 p.m.
906-240	 Varying	the	Left	Ventricular	Pacing	Vector	
Affects	Myocardial	Performance	During	Cardiac	
Resynchronization	Therapy
Daniel P. Morin, Rakesh Mishra, Tracey Shannon, Suneet Mittal, Steven M. Markowitz, 
Sei Iwai, Bindi K. Shah, Bruce B. Lerman, Kenneth M. Stein, Cornell University Medical 
Center, New York, NY
Background: In some cardiac resynchronization systems, the left ventricular (LV) pacing 
configuration can be reprogrammed to use various lead components (LV tip, LV ring, right 
ventricular defibrillation coil) as its poles. We hypothesized that changing the LV pacing 
configuration can affect LV performance as measured by the myocardial performance 
index (MPI, or “Tei index”), a validated echo-derived measure of combined LV systolic and 
diastolic function, with a lower MPI indicating better overall myocardial performance.
Methods: We studied 15 patients (age 64±13 y, 11 male, 9 with coronary artery disease) 
with EF≤35% (mean, 24±9), NYHA Class III-IV heart failure symptoms despite optimal 
medical therapy, and QRS ≥120 ms. Each patient had a biventricular ICD with a bipolar 
LV lead capable of varying its pacing configuration. Each device was programmed in 
random order to use each of the four possible pacing configurations (Dipole 1: LV lead tip 
to lead ring, 2: Ring to tip, 3: Tip to defibrillation coil, 4: Ring to coil). A physician blinded to 
dipole assignment measured the MPI while each pacing configuration was in effect. Each 
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measurement was made 3 times and these were averaged. The MPI during the default 
configuration (Dipole 1) was compared with each other configuration for the group as a 
whole and for each patient.
Results: The default pacing configuration resulted in the lowest MPI for only 4 of the 15 
patients (Dipole 2: 4 patients; D3: 4 patients; D4: 3 patients). Among this study population, 
the echo-guided identification and selection of the optimal configuration resulted in a 
statistically significant (t test, p=0.003) mean reduction in MPI of 0.12±0.13 (range, 0.00 
to 0.50) compared with the default configuration. However, for the entire group, no single 
configuration was consistently superior to the others (mean MPIs 0.84±0.38, 0.84±0.47, 
0.81±0.42, and 0.83±0.48, respectively; repeated measures ANOVA, p=0.87).
Conclusions:	 In individuals undergoing cardiac resynchronization therapy, the 
configuration of the LV pacing vector can affect myocardial performance. This suggests 
that echo-guided selection of LV pacing configuration may be useful in optimizing cardiac 
resynchronization.
2:00 p.m.
906-241	 Inter-observer	Variability	in	Identifying	the	Location	of	
Coronary	Venous	Leads
Imran K. Niazi, John Hummel, Lisa McCallum, Julie Wang, Mindi Newman, Patrick 
Yong, St Luke’s Medical Center, Milwaukee, WI, Boston Scientific, Saint Paul, MN
Background: Hemodynamic studies of cardiac resynchronization therapy (CRT) have 
demonstrated that coronary venous lead (CVL) location is an important determinant of 
benefit. However, whether implanting physicians consistently identify the location of the 
CVL is largely unknown.
Methods: Patients (pts) participating in the DECREASE HF study had their lead position 
assessed at the time of implant by the implanting physician as Anterior (Ant), Lateral 
(Lat), or Posterior (Pos). Radiograms from the anterior-posterior and lateral views were 
obtained from pts enrolled in the DECREASE-HF study of CRT and reviewed by an 
external physician experienced with the implant of CRT systems. The external physician 
was blinded to the original description of lead location. Inter-observer variability in the 
interpretation of CVL location was evaluated with the kappa statistic, which classifies 
agreement as “slight”, “poor”, “fair”, “moderate”, “substantial”, or “almost perfect”.
Results:	Radiograms were available for 163 pts. Mutual agreement was observed in 
123/163 (75%) pts. The inter-observer matrix and kappa statistic are shown below:
The kappa value of 0.25 corresponds to only fair agreement between the implanting 
physician and an external reviewer.
Conclusions: Considerable variation exists between observers in interpreting the 
location of CVLs. Given the importance of lead location, this finding suggests that 
standard definitions and techniques for identifying CVL position need to be established.
2:00 p.m.
906-242	 Thoracic	Electric	Impedance	and	Its	Changes	After	
Multiple	Shocks	for	External	Cardioversion	of	Atrial	
Fibrillation.	A	Role	for	Acute	Inflammatory	Response?
Stefano Fumagalli, Francesca Caldi, Francesca Tarantini, Claudia Di Serio, Margherita 
Padeletti, Lorenzo Boncinelli, Luigi Padeletti, Giulio Masotti, Serge Barold, Niccolò 
Marchionni, Intensive Care Unit, Geriatric Cardiology, Dep. of Critical Care Medicine 
and Surgery, University, Florence, Italy, Division of Cardiology, University of South 
Florida College of Medicine and Tampa General Hospital, Tampa, FL
Background: Thoracic impedance (TI), according to current Resuscitation Guidelines, is 
one of the major determinants of success of external cardioversion (ECV) or defibrillation. 
In fact, the current intensity crossing heart chambers is inversely associated with TI. 
Moreover, old experimental data seem to suggest that TI decreases after multiple shocks, 
allowing an easier flow of current through the thorax. With this study we wanted to 
evaluate normal baseline values of TI and its changes in patients (pts) undergoing ECV.
Methods: All the 193 pts (age: 73±9 years; men: 66%, BMI: 26.3±3.7 Kg/m2) who 
consecutively underwent ECV of atrial fibrillation or flutter between January 2004 and 
September 2006 were enrolled in the study. Biphasic shocks (Multipulse Biowave, Schiller/
ESAOTE) were delivered trough adhesive pads placed in antero-posterior position. Initial 
energy was set at 1 Joule/Kg, with progressive increases at 130 and 180 Joule in case of 
failure of previous attempts of ECV. In a subgroup of patients, plasma concentrations of 
Interleukin-6 (IL-6) and Tumor Necrosis Factor (TNF) - alpha were evaluated at baseline 
and after 5 hours from ECV.
Results: Mean TI was 57±12 Ohm; the variable had a normal distribution (p=0.624). 
Delivered shocks were 2.4±1.4, with 131 pts (67.9%) needing more than 1 shock. Final 
values of energy and of current intensity were 135±49 Joule and of 50±15 Ampere, 
respectively. TI significantly decreased after multiple shocks (57±12 vs 54±11 Ohm, -
5.7±3.3%, p<0.001), with the absolute reduction directly associated (R=0.640) with 
baseline TI (p<0.001) and the total amount of delivered energy (p<0.001). IL-6 (0.16±0.03 
vs 1.00±1.70 pg/mL, p=0.016) and TNF-alpha (1.39±0.71 vs 2.48±4.13 pg/mL, p=0.015) 
significantly increased with ECV.
Conclusions: TI, one of the determinants of success of ECV, significantly decreases 
after multiple shocks. At the same time, IL-6 and TNF-alpha increase their concentrations, 
possibly linking the changes in physical properties of thorax to acute inflammation.
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907-234	 Heterogeneous	Innervation	of	the	Left	Atrium	and	
Pulmonary	Veins
Roger Villuendas, Rishi Arora, Jack Cain, Laura Harvey, Rodney Greene, Jeffrey J. 
Goldberger, Alan H. Kadish, Northwestern University, Chicago, IL
Background: Heterogeneous distribution of the autonomic nervous system might contribute 
to create a substrate for atrial fibrillation in the left atrium and pulmonary veins (PV).
Methods: Frozen sections from the left atrial appendage (LAA), posterior left atrium 
(PLA), and PV of 4 dogs were immunostained with dopamine beta-hydroxylase to identify 
sympathetic (S) nerves (blue) and acetylcholinesterase to identify parasympathetic 
(P) nerves (brown). Nerve distribution and density (counted elements/10x field) were 
assessed by light microscopy.
Results: Nerve bundles containing ganglion cells (figure) were found only in the PV and 
PLA; none in the LAA (p<0.01). The PLA was the most richly innervated with bundles 
containing both P and S fibers (PV=0.1±0.1, PLA=0.3±0.3, LAA=0.01±0.03; p<0.01). 
Although P fibers predominated in all bundles, the S/P ratio of fibers within the bundles 
was not different among the sites (PV=0.21, PLA=0.15, LAA=0.19; p=NS). The density of 
individual P fibers outside the bundles was similar (PV=42±23, PLA=43±35, LAA=35±22; 
p=NS). The density of individual S fibers was higher in the LAA (PV=3±2, PLA=3±2, 
LAA=6±2; p<0.005).
Conclusion: Autonomic innervation in the left atrium is heterogeneous, with the PLA 
having the highest density of nerve bundles. The density of individual S fibers is higher in 
the LAA. Greater total nerve content as well as a lower S/P ratio of individual fibers outside 
the bundles may account for the unique electrophysiological characteristics of the PLA. 
3:00 p.m.
907-237	 Intraoperative	Radiofrequency	Ablation	With	an	
Irrigated	Unipolar	Probe	in	Patients	Undergoing	Fontan	
Conversion:	a	Safe	and	Effective	Approach	for	the	
Treatment	of	Atrial	Tachyarrhythmias
Jose M. Moltedo, Mariano Ithuralde, Alejandro Ithuralde, Carlos Seara, Maria 
Balestrini, Mauricio Abello, Javier Celada, Pablo Garcia de Lucis, Carlos Nojek, 
FLENI, Buenos Aires, Argentina
Background: Atrial tachyarrhythmias (AT) are a frequent long term complication of 
palliated congenital heart disease and are often refractory to medical treatment.	The 
aim of this study is to report the experience with intraoperative radiofrequency ablation 
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(IORFA) in patients with univentricular hearts and AT undergoing Fontan conversion.
Methods:	Retrospective observational study with data collected on all patients undergoing 
Fontan conversion between October 2003 and July 2006.
Results:	Seven patients were referred for Fontan conversion and IORFA was performed as an 
adjunct. Six were male; median age at the time of surgery was 21 years (range 18-33).	One had 
double inlet left ventricle, one D-transposition of the great arteries (TGA), one a hypoplastic right 
ventricle, two tricuspid atresia and two L-TGA (one with right sided AV valve atresia). All had a 
history of sustained and symptomatic atrial tachyarrhythmias requiring chronic antiarrhythmic 
therapy, including amiodarone in 5. Lesions were performed using a Cardioblate unipolar 
irrigated probe (Medtronic) for 60 seconds at 35 Watts during cardiopulmonary bypass. Lesions 
were placed between the atrial septal defect (ASD) and the atriotomy, the ASD and superior 
vena cava remnant, the coronary sinus and inferior vena cava (IVC) and the tricuspid valve and 
IVC, when appropriate. Average number of lesions was 3.5. Epicardial pacing catheters were 
placed and a permanent pacemaker was implanted. Post-op rhythm was sinus bradycardia 
with junctional escape rhythm requiring atrial pacing in all pts. One patient died on post-op day 
2 after a hemorrhagic complication. No complications were observed due to IORFA. Patients 
were followed for a median of 12.5 months (range 4-35) with periodic evaluations with ECG, 
Holter and pacemaker interrogation. They all remain asymptomatic; 2 developed isolated 3 
beats runs of atrial tachycardia detected during Holter monitoring.
Conclusions:	IORFA is a safe and effective therapy for atrial tachyarrythmias in patients with 
univentricular hearts and should be considered at the time of Fontan conversion. Further follow 
up is required to assess long term results.
3:00 p.m.
907-238	 Endothelial	Function,	Inflammatory	Process	And	
Oxidative	Stress	In	Chronic	Artial	Fibrillation:	The	
Impact	Of	Left	Atrium	Distention
Kosas Zisimos, Dimitris Tousoulis, Charalambos Antoniades, Gerasimos Siasos, Elli 
Stefanadi, Ioannis Ntarladimas, Kostantinos Toutouzas, Vavuranakis Emmanuel, 
Kyriakoula Marinou, Evaggelia Gerodimou, Georgia Triantafyllou, Despina Kardara, 
Christodoulos Stefanadis, Athens University, A Cardiology Department, Athens, Greece
Background: Previous studies have demonstrated that atrial fibrillation (AF) is associated 
with increased oxidative stress status and endothelial dysfunction. However, the 
underlying mechanisms and/or factors involvied in this process are unclear. We attempt 
to identify factors which modulate oxidative status, inflammatory process and endothelial 
function in patients with chronic atrial fibrillation.
Methods: The study population consisted of 66 patients with atrial fibrillation (aged 
73.2±1.2 years old) and 63 matched healthy controls. The oxidative stress status 
was determined by evaluating oxidized LDL (ox-LDL) levels and total lipid peroxides 
(PEROX), while the endothelial function was assessed by determining flow mediated 
dilation (FMD) in the brachial artery. C-reactive protein (CRP) measurement and cardiac 
echocardiography were performed in all the patients with conventional techniques.
Results: Patients with atrial fibrillation had significantly higher levels of ox-LDL and 
CRP (62.75±4.0 IU/L and 11.63±1.96 mg/dL) and lower FMD (0.44±0.014%) compared 
to healthy individuals (52.3±3.4 IU/L p<0.05 2.1±0.11mg/dL p<0.001 and 4.2±0.011% 
p<0.0001 respectively). Furthermore, the size of LA among AF patients, was significantly 
correlated with the levels of ox-LDL (r=0.358, p=0.005). The size of AF was the strongest 
and independent predictor of ox-LDL levels (beta(SE):1.575(0.434), p=0.001).
Conclusions: Atrial fibrillation is associated with significantly elevated CRP levels and 
increased oxidative stress status, leading to a respective impairment of endothelial 
function. Furthermore, we provide evidence that the extent of left atrium distention reflects 
the overall, systemic oxidative status among patients with atrial fibrillation.
3:00 p.m.
907-239	 QRS	Duration	Predicts	Sudden	Cardiac	Death	in	
Hypertensive	Patients:	the	Losartan	Intervention	for	
Endpoint	Reduction	in	Hypertension	(LIFE)	Study
Daniel P. Morin, Lasse Oikarinen, Matti Viitasalo, Lauri Toivonen, Markku S. Nieminen, Sverre E. 
Kjeldsen, Björn Dahlöf, Richard B. Devereux, Peter M. Okin, Cornell Medical Center, New York, NY
Background:Prolonged QRS duration (QRSd) has been associated with left ventricular 
dysfunction and dyssynchrony and with an increased risk of cardiovascular morbidity and 
mortality. However, whether QRSd is an independent predictor of sudden cardiac death 
(SCD) in the setting of aggressive antihypertensive therapy is unknown.
Methods:We examined the relationship between baseline QRSd and SCD in 9193 
hypertensive patients who were treated in a blinded manner with atenolol- or losartan-
based regimens. Baseline QRSd was measured to the nearest ms. SCD was defined as 
death due to coronary heart disease occurring within 24 hours of symptom onset.
Results:During a mean follow-up of 4.8±0.9 years, SCD occurred in 178 patients (1.9%). 
Compared with patients in whom SCD did not occur, patients who had SCD had longer 
baseline QRSd (111±24 vs 101±18 ms, p<0.001), were more likely male, of black race, 
and older, and more likely to have a history of CAD, MI, CHF, stroke or TIA, diabetes, 
atrial fibrillation, or ventricular arrhythmia, had higher baseline serum creatinine, serum 
uric acid, urine albumin/creatinine ratio and Cornell voltage-duration product, as well 
as lower HDL and ECG Sokolow-Lyon voltage. Baseline systolic and diastolic BP, total 
cholesterol, BMI, and prevalence of peripheral vascular disease were similar between 
the groups. In univariate Cox analysis, every 10 ms increase in QRSd was associated 
with a 26% increased risk of SCD (HR 1.26; 95% CI 1.18-1.33, p<0.001). In multivariate 
Cox analysis adjusting for the impact of treatment assignment and baseline differences 
between patients with and without SCD, QRSd remained a significant predictor of SCD, 
with a 17% increased risk of SCD for every 10 ms increase in QRSd (HR 1.17; CI 1.11-
1.24, p<0.001). QRSd remained a significant predictor of SCD even after controlling for 
the presence or absence of left bundle branch block (HR 1.11; CI 1.00-1.22, p=0.035).
Conclusions:In the setting of aggressive blood pressure lowering, a prolonged QRS 
duration identifies hypertensive patients at risk for sudden cardiac death. This relationship 
persists even after controlling for the presence or absence of left bundle branch block.
3:00 p.m.
907-240	 Acute	Effects	Of	Dual	Vs.	Single	Site	Right	Ventricular	
Pacing	In	Heart	Failure	Patients
Chris L. Kaufman, Stephen C. Vlay, Alan J. Bank, Smadar Kort, Dan R. Kaiser, Richard 
Russell, Stony Brook University Medical Center, Stony Brook, NY, St. Paul Heart Clinic, 
St. Paul, MN
Background: Conventional pacing at the right ventricular apex in patients with normal 
systolic function has been associated with increased risk of developing heart failure. 
Recent studies have shown improved heart function when pacing the right ventricular 
outflow tract (RVOT) as compared to the right ventricular apex (RVA). We studied the 
effect of simultaneous RVOT + RVA (Bi-RV) vs. single site RVA or RVOT pacing in CRT 
indicated heart failure patients who failed an LV lead placement. Methods: The acute 
effects of Bi-RV, RVOT, and RVA pacing were each randomly assigned in 19 heart failure 
patients (Age = 72.3 ± 2.0; 15 male, 4 female; NYHA = 1.3±0.1). Echocardiographic 
studies included but where not limited to the following parameters: the magnitude of 
systolic longitudinal displacement at the time of aortic valve closure (SCS), the time to 
peak displacement (T2Pk), peak systolic velocity, and the standard deviation of the times 
to peak systolic velocities (Ts-SD) were measured at 8 segments using tissue Doppler 
imaging (TDI) from apical two and four chamber views. Repeated-measures ANOVA 
was used to delineate differences between pacing conditions. Results are reported as 
mean ± SEM. Results: Global SCS was greatest during RVOT pacing (GSCS= 3.9±0.4 
mm) as compared to Bi-RV and RVA pacing (GSCS=3.1±0.3 and 2.5±0.3 mm, p<0.05) 
with Bi-RV also significantly greater than RVA (p<0.05). Peak systolic velocity was 
greatest during RVOT pacing(2.42±0.19 cm/s) as compared to Bi-RV and RVA pacing 
(2.18±0.18 and 2.07±0.22 cm/s, p<0.05), with no difference observed between Bi-RV 
and RVA. Althought not statistically significant, Ts-SD values were consistent with less 
dyssynchrony with RVOT pacing (38.3±3.8 ms) as compared to Bi-RV (41.4±3.6 ms) and 
RVA pacing (47.0±3.8 ms)(p = 0.10). Conclusion: Acute RVOT pacing in heart failure 
patients resulted in superior systolic contraction when compared to RVA or Bi-RV pacing 
and may be associated with reduced dysynchrony. Further studies are needed to clarify 
the magnitude of chronic improvement in systolic function and dyssynchrony with RVOT 
pacing in this population.
3:00 p.m.
907-241	 Achieving	Sufficient	Defibrillation	Safety	Margins	with	
Fixed	Duration	Waveforms	and	the	Use	of	Multiple	Time	
Constants
David Keane, N. Aweh, Bryan Hynes, Richard G. Sheahan, Tim V. Cripps, Yaver 
Bashir, Amir Zaidi, Gerard J. Fahy, Martin Lowe, Paul Doherty, Mark Kroll, St. Vincent’s 
University Hospital, Dublin, Ireland
Background: There are several options to achieve a sufficient safety margin in the patient 
with a high defibrillation threshold (DFT) with varying and typically modest success. 
Programming fixed (millisecond) durations of both phases of a biphasic waveform in an 
implantable cardioverter defibrillator (ICD) has demonstrated utility but so far only with the 
use of a single setting algorithm based on a 3.5 ms cardiac membrane time constant.
Methods: We established an informal multi-site registry of ICD implanting facilities. Each facility 
agreed to attempt the use of fixed duration waveforms whenever there was an inadequate 
safety margin with tilt-based waveforms. A 3.5-ms based fixed duration shock was tried first. If 
that failed to achieve a 10 J safety margin then a 2-ms based shock was used.
Results: Sixteen patients (15M, 1F) were entered into the registry (age 58.2 ± 17.9) with 
ejection fractions of .30 ± .11. Superior vena coil coils were used in 6 patients according 
to physician preference. The tilt-based DFTs were 35.4 ± 3.2 J delivered energy and 35.8 
± 3.3 J stored. The 3.5 ms-based shocks were evaluated on 14 patients and the DFT fell 
to 23.4 ± 6.3 J delivered (p<.0001) and 26.2 ± 6.9 stored energy (p < .0001). The 2-ms 
based fixed duration shocks were then evaluated on 6 patients and the delivered energy 
DFT was 22.2 ± 5.8 J (p = .001 vs. tilt-based shocks) while the stored energy DFT was 
27.9 ± 6.4 J (p = .01 vs. tilt-based shocks). Using the better of the two fixed duration 
waveforms, the mean safety margin was improved from -1.2 ± 1.9 J to 9.5 ± 5.9 J (p < 
.00001). Three patients still required lead repositioning after the use of the fixed duration 
waveforms. No additional leads were implanted.
Conclusion: The use of a selection of directly programmed duration biphasic shocks had 
a striking impact on the DFT for these difficult patients. Adequate safety margins were 
obtained with minimal lead manipulation and no other approaches were required.
3:00 p.m.
907-242	 A	New	Technique	for	Detecting	Stress-Induced	Ischemia	
Using	Analysis	of	the	ECG	Depolarization	Phase
Nili Zafrir, Moran Gadot, Shimon Abboud, Boris Strasberg, Rabin Medical Center, 
Petah Tikva, Israel
ECG based detection of exercise-induced myocardial ischemia is based on identifying 
ST changes, representing the repolarization phase. However, ischemia also induces 
depolarization changes, which can be studied using analysis of high frequency mid-QRS 
potentials (HFQRS). Our aim was to test the performance of this technique in patients 
undergoing exercise SPECT myocardial perfusion imaging (MPI).
Methods: Exercise MPI was performed in 95 consecutive patients (age: 62±11 yo, 72 
men) and used as the gold standard for the diagnosis of ischemia. High resolution ECG 
was digitized throughout the test and was later subjected to offline computer analysis 
(HyperQ™ System, BSP, Israel). HFQRS signals were extracted (Fig A) and time-intensity 
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curves calculated (Fig B). The relative intensity change in HFQRS during exercise was 
used as an index of ischemia.
Results: HFQRS analysis was possible in 85 patients of whom 33 exhibited ischemia 
by MPI. Ischemia was characterized by reduction in HFQRS intensity (Figs A, B). The 
HFQRS index of ischemia was found more sensitive than the conventional ST analysis 
(76% vs 59%, p<0.01) and with better specificity (85% vs 57%, p<0.01), higher positive 
predictive and negative values (76% vs 49% [p<0.01] and 85% vs 70% [p<0.05], 
respectively) and higher accuracy (81% vs 58%, p<0.001).
Conclusions: HFQRS analysis presents a significant improvement to current exercise 
ECG in detecting ischemia and may thus aid in enhancing the non-invasive diagnosis 
of ischemic heart disease. 
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908-234	 Presence	of	CRP	in	Left	Atrium	is	Associated	With	
Atrial	Fibrillation	Irrespective	of	Serum	CRP
Stavros E. Mounantonakis, Rashmi Ram, Marc A. Gillinov, Mina K. Chung, David R. Van 
Wagoner, Cleveland Clinic, Cleveland, OH
Backround: Evidence of a systemic inflammatory response with increased serum levels 
of C-reactive protein CRP has been well documented in atrial fibrillation (AF). CRP may 
have direct arrhythmogenic properties through calcium and phosphorylcholine binding 
and opsonin function for complement activation. However, direct localization of CRP to 
atria in patients with AF has not been reported.
Methods: CRP was evaluated in left atrial (LA) tissue specimens from 51 patients 
undergoing cardiac surgery. We examined 3 groups: 17 patients in AF at the time of 
surgery (AFAF), 17 patients with paroxysmal AF but in sinus rhythm (AFSR) at time of 
surgery, and 17 patients with no history of AF (SR). Groups were matched for CAD, 
mitral disease, LA size, left ventricular ejection fraction, and serum CRP. Specimens were 
paraffin embedded, formalin fixed, sectioned, and immunostained for tissue CRP. CRP 
staining was quantified by computerized image analysis and expressed as fractional area 
%. Non parametric tests were used for comparisons.
Results: CRP staining was evident in blood vessels, interstitial fibrosis and in atrial 
myocytes. CRP was significant more abundant in patients who were in AF at the time of 
the surgery compared to the other groups (3.9±2.9% in AFAF, 0.86±0.48% in AFSR and 
0.89±0.48% in SR group, P 0.026) LA CRP staining was not different in patients with a 
history of AF in SR at surgery compared to patients with no history of AF.
Conclusion: This is the first study to document the presence of CRP in human LA tissue 
and to correlate its presence with AF, irrespective of serum CRP levels. CRP may have 
a direct role in the promotion and perpetuation of AF. That patients with paroxysmal AF 
but in SR at time of surgery did not differ from patients with no history of AF suggests 
a dynamic and possibly reversible interplay between systemic inflammation and atrial 
rhythm, and supports the concept that treatments with anti-inflammatory effects may be 
beneficial for AF patients.
4:00 p.m.
908-237	 Observations	Regarding	Atrial	Fibrillation/Flutter	in	
Black	Patients	with	Heart	Failure
Judith E. Mitchell, Meriam F. Caboral, John Feng, Locquessa Okpala, Luther T. Clark, 
State University of New York Downstate Medical Center, Brooklyn, NY
Background: In heart failure (HF) the presence of atrial fibrillation or flutter (AF), found 
in up to 35% of patients (pts) with this condition, is linked to worsened prognosis. Blacks 
with HF have higher morbidity and mortality. We sought to determine the prevalence of AF 
and factors associated with its occurrence among black pts admitted with HF.
Methods: From 5/2003 to 8/2006 1,786 patients were admitted with decompensated 
HF. Demographics, vital signs, clinical symptoms, LV function, co-morbid conditions and 
medications were captured. Statistical significance level: p<0.05. Results: Population: 
N=1786 (42% Male, 58% Female), 91% black, 20% with AF, 72% >60 yrs (mean 68 + 
14), 56% systolic HF (EF<40%), 63% nonischemic etiology and alarmingly, 56% diabetics 
(DM). No significant association was seen between the presence of AF and the following: 
anemia (hgb<12 noted in almost 56%), h/o HTN (recorded in over 85%) or COPD/asthma 
(found in 15%). Twenty-six percent of the pts had creatinine (CR) >2mg/dl and 12% were 
on dialysis. No significant association between renal insufficiency and AF was observed. Of 
the documented medications, ACEI or ARB and digoxin were found to be significantly more 
common on admission (p=0.008 and p<0.001, respectively) in pts with AF. Complaints 
of dizziness or light-headedness were voiced with similar frequency irrespective of the 
presence of the atrial arrhythmia. But, palpitations were highly associated with AF, p=0.002. 
Multiple regression analysis included the following variables: hgb, CR, DM, alcohol use, 
gender, LV function and HF etiology. Only age > 60yrs, male gender and nonischemic 
etiology of HF were found to be predictors of AF in this predominantly black cohort.
Conclusions: We found a lower prevalence of AF in our pts compared with published 
data for AF prevalence in the general HF population. This despite the higher occurrence 
of known traditional risk factors for AF development such as HTN and DM, 85% and 
56% respectively. Amoung our cohort, predictors of AF included older age, male sex and 
nonischemic HF etiology. Whether these observed findings are based on differences in 
genetics or yet unrecognized/unmeasured clinical factors deserve further investigation.
4:00 p.m.
908-238	 The	Use	of	a	Standard	Radiofrequency	Energy	Delivery	
System	to	Facilitate	Transseptal	Puncture
Michael J. McWilliams, Patrick Tchou, The Cleveland Clinic, Cleveland, OH
Background: Transseptal puncture (TSP) is a standard means of catheter access to the left 
atrium via the venous system, but with a risk of cardiac perforation. Stretching and/or increased 
force to traverse the septum is required with elastic, aneurismal, or thick interatrial tissue. We 
report the facilitation of TSP by applying brief pulses of radiofrequency (RF) energy from a 
standard electrosurgical cautery generator (ESCG) through the needle tip.
Methods: Patients were selected based on having a standard indication for TSP. Under 
fluoroscopic and intracardiac echo (ICE) guidance, the TSP system including dilator, sheath 
and needle were positioned to tent the interatrial septum at the appropriate puncture site. The 
transseptal needle was advanced near the tip of the dilator but not exposed beyond the dilator. 
A standard ESCG was used to apply brief pulses (1-2 seconds) of RF energy to the proximal 
transseptal needle with the dilator functioning as an insulator. During the application, the needle 
tip was advanced exposing the tip beyond the dilator.
Results: Forty-two TSPs were performed without complications. Incremental outputs of power 
were tested initially and 15 watts was found to work well for the TSP. The TSPs were performed 
faster with no additional tenting of the septum by the advancing needle. Advancement of the 
dilalator and sheath across the septum was the same as standard TSP. The TSP needles and 
dilators showed no evidence of thrombus formation when withdrawn and flushed.
Conclusion: Use of a standard RF/ESCG can facilitate TSP. This approach may be especially 
helpful in cases involving an elastic, aneurysmal, or thick interatrial septum. Use of low energy 
to traverse the septum is dependent on having the transseptal needle advanced out of the 
dilator after initiation of RF delivery. Exposing the needle beyond the dilator tip prior to initiating 
RF delivery required higher outputs due to decreased current density at the exposed needle tip. 
This technique provides a safe alternative to utilizing dedicated RF transseptal equipment.
4:00 p.m.
908-239	 Initiation	Patterns	of	Ventricular	Tachycardia	
Determined	from	Analysis	of	Intracardiac	Electrograms	
in	the	MADIT	II	Database
Arvindh N. Kanagasundram, James Daubert, Wojciech Zareba, Henry Hsia, Amin Al 
Ahmad, Paul Wang, Arthur Moss, Paul Zei, Stanford University Hospital, Palo Alto, CA, 
University of Rochester Medical Center, Rochester, NY
Background: There are distinct mechanisms of initiation and maintenance of ventricular 
tachycardia (VT). This study examines the initiation patterns of VT stored on intracardiac 
electrograms from the MADIT-II trial database.
Methods: VT episodes (AV dissociation, ventricular > atrial rate) with a minimum of 5 recorded 
beats prior to VT and 10 total beats of VT (non-sustained VT defined as less than 30 beats, 
spontaneously terminated) were included. VT onset was categorized into one of 3 groups: 1) 
sudden, if not preceded by paced beats or VPCs, 2) extrasystolic, with preceding VPCs, or 3) 
pace-initiated, if preceded by paced beats. Prematurity index (PI), R-wave morphology, cycle 
length, and presence of short-long-short (pause-dependent) sequence for each episode were 
studied.
Results: 299 episodes in 78 patients met inclusion criteria. The most frequent initiation pattern 
was extrasystolic (172 episodes, 58%) followed by sudden onset (127 episodes, 42%) with no 
pace-initiated episodes. Among extrasystolic episodes, 74% were preceded by single PVCs, 
5% by paired PVCs and 21% by multiple PVCs (of which 81% were pause-dependent). The 
shortest PI of 0.63 was associated with episodes having a pause-dependent initiation pattern. 
Characteristics of polymorphic and monomorphic VT are summarized below: 
Type Number (%)
Sinus Cycle 
Length (s)
VT Cycle 
Length (s)
Extrasystolic onset 
% (PI)
Sudden Onset 
% (PI)
SLS % 
(PI)
NSVT 
%
Monomorphic 
VT
257 
(86%) 0.74 0.33 54% (0.74) 46% (0.70)
7% 
(0.65) 40%
Polmorphic 
VT 42 (14%) 0.86 0.25 76% (0.60) 24% (0.53)
19% 
(0.59) 50%
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Conclusions: Most VT episodes in the MADIT-II database are initiated by PVCs, most 
often single PVCs. Episodes of PMVT were rarer, associated with longer sinus cycle 
lengths and lower prematurity index.
4:00 p.m.
908-240	 The	Impact	of	Renal	Insufficiency	on	Long-
term	Outcomes	in	Patients	Undergoing	Cardiac	
Resynchronization	Therapy.
Kenji Ando, Takashi Yamada, Masahiko Goya, Takeshi Arita, Yoshimitsu Soga, Shinichi 
Shirai, Koyu Sakai, Masashi Iwabuchi, Hiroyoshi Yokoi, Hideyuki Nosaka, Masakiyo 
Nobuyoshi, Department of Cadiology,Kokura memorial hospital, Kitakyushu, Japan
Background: The impact of renal insufficiency (RI) on long-term outcomes in patients (pts) 
undergoing CRT is not well established.
Methods: We investigated 47 pts received CRT (age 68+/-10years, NYHA class 3.2+/-0.4, LVEF 
24+/-6%, LVEDD 64.9+/-6.0mm, pre QRS duration 174+/-28ms)and divided into two groups, 
33 pts without RI (non-RI pts) and 14 pts with RI (RI pts). RI was defined as serum creatinine 
level>1.5mg/dl. Long-term clinical data were obtained.
Results: Baseline clinical and echocardiographic characteristics were similar between two groups 
without ischemic cardiomyopathy (71% in RI pts vs.39% in non-RI pts, p=0.045), beta blocker use 
(36% in RI pts vs.70% in non-RI pts, p=0.03), post QRS duration (168ms in RI pts vs.150ms in non-RI 
pts, p=0.02) and serum creatinine levels (3.19mg/dl in RI pts vs.1.08mg/dl in non-RI pts, p<0.0001).
After mean follow-up of 407+/-249days, event free survival rates from heart failure hospitalization 
(HFH) were significantly lower in RI pts compared to non-RI pts (60% vs.82% at 1 year, Log-rank 
p=0.027) and event free survival rates from combined death and HFH were also significantly 
lower in RI-pts (56% vs.79% at 1 year, Log-rank p=0.0056).
After adjusted ischemic cardiomyopathy, beta blocker use and post QRS duration, RI pts was 
still associated with worse clinical outcomes (HFH: HR 5.2, 95%CI 1.1-25.0, p=0.041, death and 
HFH: HR 6.0, 95%CI 1.4 -25.6, p=0.015).
Conclusion: RI pts had worse clinical outcomes even if received CRT compared to non-RI pts. 
4:00 p.m.
908-241	 Inadvertent	Cardioversion	During	Routine	Defibrillation	
Testing	In	Patients	With	Atrial	Fibrillation	Undergoing	
defibrillator	implantation
Madhavi Kadiyala, Sobhan Kodali, Darren Traub, Barry L. Alpert, Frederick L. Porkolab, 
Puvalai M. VijayKumar, Alan H. Gradman, Leonard I. Ganz, The Western Pennsylvania 
Hospital, Pittsburgh, PA
Background: Atrial fibrillation (AF) is present in up to 17 % of patients (pts) undergoing 
implantable cardioverter defibrillator (ICD) implantation. The effects of defibrillation 
threshold (DFT) testing in pts with AF during ICD implantation is not well described. 
We sought to determine if DFT testing was associated with cardioversion (CV) to sinus 
rhythm (SR) in these pts and to identify factors that may predict CV.
Methods:We performed a retrospective chart analysis on 142 pts with AF who had ICD 
implantation between January ‘04 and July ‘06. We analyzed the data for any correlation 
between CV to SR and baseline characteristics of the pts, AF duration, left atrial size and 
the number of shocks during the procedure. Anticoagulation was typically held for several 
days prior to the procedure.
Results:	The 142 pts with AF constituted 20% of the pts undergoing ICD implantation 
during this time period. Paroxysmal and chronic AF was present in 42 and 100 pts of whom 
37 and 76 underwent DFT testing respectively. DFT testing was deferred in 29 pts either 
due to the presence of left atrial appendage thrombus on transesophageal echocardiogram 
or other clinical reasons. DFT testing was associated with CV to SR in 27.6% (21) of chronic 
AF pts and in 63%(12) of 19 paroxysmal AF pts, who were in AF at the time of testing. Mean 
INR at the time of implant was 1.26+0.23. Mean left atrial size was 4.96+0.85. Average 
number of shocks was 2.42+2.2. There was no significant correlation between CV to SR 
and left atrial size, number of shocks, left ventricular ejection fraction or duration of AF.
Conclusions: In patients with AF undergoing ICD implantation, DFT testing resulted in 
inadvertent CV to SR in 27.6% and 63% of pts with chronic and paroxysmal AF respectively. 
Generally elective CV is performed only when pts are therapeutically anticoagulated. DFT 
testing during ICD implantation, when pts are not anticoagulated may increase the risk 
of thromboembolic complications. A transesophageal echocardiogram to screen for left 
atrial appendage thrombus should be strongly considered in pts with AF undergoing ICD 
implantation and DFT testing.
4:00 p.m.
908-242	 Heart	Rate	Variability	is	Significantly	Increased	by	
Ivabradine	Compared	With	Amlodipine	in	Patients	With	
Chronic	Stable	Angina:	A	Prospective	Randomized	
Double-blind	Controlled	Study
John Camm, Jean-Yves Le Heuzey, Sverker Jern, Irina Savelieva, St George’s 
University of London, London, United Kingdom, Hopital Europeen Georges Pompidou, 
Paris, France
Background: Reduced heart rate variability (HRV) is a marker of impaired autonomic 
nervous system activity and is associated with increased all-cause and cardiovascular 
death. Ivabradine is a novel selective and specific inhibitor of the If current in the sinus node. 
In a multicenter, prospective, randomized, double-blind study, ivabradine had a similar 
antianginal effect as amlodipine in 1195 pts with chronic coronary artery disease (CAD).
Methods: Whether ivabradine improved HRV compared with amlodipine was studied in 
a subset of 319 pts who underwent ambulatory monitoring at baseline and after 3 months 
of therapy with ivabradine 7.5 mg bd (n=104) or 10 mg bd (n=106), or amlodipine 10 mg 
od (n=109). ANCOVA with Dunnett-Hsu’s method for multiple comparisons was used to 
test differences between groups.
Results: Baseline heart rates and HRV were similar in 3 groups. Ivabradine significantly 
reduced mean 24-hour, daytime and nocturnal heart rate. Reduction in heart rate was 
associated with a significant improvement in the majority of time- and frequency-domain 
parameters compared with amlodipine (Table).
Conclusions:	Therapy with a specific heart rate-lowering agent ivabradine is associated 
with a significant improvement in HRV, mainly its parasympathetic component, in pts 
with stable CAD as opposed to amlodipine. Whether this translates into a reduction in 
cardiovascular mortality and morbidity is currently under investigation in large long-term 
outcome trials of ivabradine.
Time-domain and frequency-domain HRV parameters and mean 
differences after 3 months of treatment
HRV 
parameter
Ivabradine 7.5 
mg bd
Ivabradine 10 
mg bd
Amlodipine 10 
mg od
IVA 7.5 vs 
AMLO
IVA 10 vs 
AMLO
SDNN, ms
Diff.
p
137.5±39.4
17.7±32.9
<0.0001
137±36.3
21.6±50.3
<0.0001
140.6±39.5
-1.2±28.4
0.74
p=0.0006 p<0.0001
RMSSD, ms
Diff.
p
33±18.7
5.2±14.4
0.1
35.1±19.8
11.4±51.9
0.0003
33.3±14.1
-1.9±12.9
0.54
p=0.17 p=0.001
pNN50, %
Diff.
p
7±6.8
3.1±7
0.0002
7.2±8.3
4.5±11.5
<0.0001
7.1±6.7
-0.6±6.1
0.47
p=0.0009 p<0.0001
LF power, 
ms2
Diff.
p
708.7±478.5
90.5±414
0.04
756±590.9
48.9±572.5
0.27
756.1±500.7
-131±374.2
0.003
p=0.0004 p=0.002
HF power, 
ms2
Diff.
p
298.8±369.9
56.5±284.4
0.23
368.2±514.4
131.5±799.3
0.007
277.4±210.3
-40.7±179.5
0.39
p=0.07 p<0.0001
Norm. HF 
power, U
Diff.
p
28.69±10.85
3.22±7.17
0.013
29.62±12.54
4.88±13.72
<0.0001
27.37±10.01
1.45±8.81
0.13
p=0.13 p=0.0015
LF/HF
Diff.
p
2.92±1.4
-0.44±0.86
<0.0001
2.95±1.54
-0.6±1.27
<0.0001
3.07±1.29
-0.13±0.99
0.21
p=0.009 p=0.0001
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909-234	 Ranolazine	Normalizes	Action	Potential	Duration	of	
Hypertrophied	Ventricular	Cardiomyocytes
Silvia Suffredini, Simona Brogioni, Elisabetta Cerbai, Luiz Belardinelli, Alessandro Mugelli, 
CIMMBA, University of Florence, Florence, Italy, CV Therapeutics, Palo Alto, CA
Background: Ranolazine is a novel anti-ischemic piperazine derivative recently approved 
as an add-on therapy for the symptomatic treatment of patients with stable angina. Recent 
studies suggest that ranolazine reduces calcium overload in the ischemic myocyte by 
inhibiting the late sodium current. Therefore, we investigated the electrophysiological 
effect of ranolazine on ventricular cardiomyocytes (VCMs) isolated from the hypertrophied 
heart of aged spontaneously hypertensive rats (SHR). In this model, alterations in 
cellular electrophysiological properties related to disturbances in calcium homeostasis 
have been extensively documented. Methods: Left VCMs isolated from the heart of 15-
month old SHR and normotensive Wistar Kyoto rats (WKY), were used for recording 
action potentials (APs) using the perforated-patch configuration. APs were elicited at 
0.2, 0.5 and 1 Hz and AP duration (APD) was measured at -50 mV (APD50) and 90% 
of repolarization (APD90). The electrophysiological effect of 3 and 10 µM ranolazine 
(RAN) and 1µM tetrodotoxin (TTX, a selective sodium channel blocker) were determined. 
Results: In SHR cells, APD was significantly increased with respect to WKY cells (221±21 
ms vs. 158±20 ms; p<0.05, n=9). RAN caused a concentration-dependent decrease of 
APD in SHR cells. At 0.2 Hz, APD50 was 170±21 ms in the absence, and 133±17 ms and 
106±18 ms in the presence of 3 µM and 10 µM RAN, respectively (p<0.05, n=13). APD90 
was 211±22 ms in the absence, and 182±17 ms and 157±18 ms in the presence of 3µM 
RAN and 10 µM RAN, respectively (p<0.005, n=13). The effect was qualitatively similar in 
myocytes stimulated at higher driving rates (0.5 or 1 Hz). In WKY cells, the effect of RAN 
was less pronounced. As a result, after exposure to 10 µM RAN, APD became similar in 
SHR (164±18 ms) and WKY VCMs (163±9 ms) (0.2 Hz; n=9; non significant). The effect 
of RAN on SHR cells was mimicked by 1µM TTX. Conclusions: Ranolazine shortens APD 
in SHR ventricular myocytes to a greater extent than in WKY VCMs. Thus, increased Na 
entry through non-inactivating Na channels may contribute to delayed repolarization in 
hypertrophied myocytes, an alteration which is attenuated by ranolazine.
9:00 a.m.
909-237	 Effect	of	Statin	Dose	on	Incidence	of	Atrial	Fibrillation:	
Data	from	the	PROVE	IT-TIMI	22	and	A	to	Z	Trials
Dalton S. McLean, Shmuel Ravid, Michael Blazing, Bernard Gersh, Amy Shui, Cannon 
P. Christopher, Thrombolysis in Myocardial Infarction (TIMI) Study Group, Brigham and 
Women’s Hospital, Boston, MA
Background: Inflammation has been suggested as a factor in the initiation and 
maintenance of atrial fibrillation (AF). Several observational studies have suggested 
that statins, presumably through their anti-inflammatory properties, decrease the risk of 
AF. Methods: We analyzed two randomized trials, PROVE IT - TIMI 22 and Phase Z of 
the A to Z trial, which compared lower-intensity versus higher-intensity statin therapy to 
evaluate whether higher-intensity statin therapy lowered risk of AF onset during the 2 
years of follow-up. We hypothesized that higher-intensity statin therapy would decrease 
AF risk when compared to lower-intensity statin therapy. Patients experiencing AF onset 
during follow-up were identified from the adverse event reports. Results: Neither study 
showed a decreased AF risk with higher-dose statin, and in A to Z, there was actually a 
trend toward increased AF risk with the higher statin dose. In PROVE IT - TIMI 22, 2.7% 
vs. 3.3% in the high- vs. standard-dose statin therapy respectively experienced the onset 
of AF over 2 years (OR 0.86, 95% CI 0.61-1.23; P = 0.41). In A to Z, rates were 1.6% vs. 
0.99% respectively (OR 1.58, 95% CI 0.92-2.70; P = 0.096). In both trials, CRP tended 
to be higher among patients experiencing onset of AF (Table). Conclusion: Although we 
cannot definitively exclude an effect, this study of 8,659 patients did not show a reduced 
AF incidence among patients taking higher dose statin therapy after acute coronary 
syndromes when compared with standard dose statin treatment. 
Relationship of C-reactive Protein (CRP) to the Presence of Atrial 
Fibrillation
PROVE	IT	-	TIMI	
22
Median CRP, AF present 
(mg/dL)
Median CRP, no AF 
(mg/dL) P-value
Baseline CRP 12.3 12.1 0.90
1 Month CRP 2.47 1.92 0.35
4 Month CRP 1.83 1.68 0.30
Z	Phase	of	A	to	Z
Baseline CRP 29.6 20.2 0.16
1 Month CRP 3.34 2.43 0.022
4 Month CRP 2.36 1.96 0.33
9:00 a.m.
909-239	 Regional	Scar	Encircling	Catheter	Ablation	To	Treat	
Ventricular	Tachycardia	In	Patients	With	Remote	
Myocardial	Infarction
Thomas Deneke, Bernd Lemke, Bernd Calcum, Thomas Lawo, Turgut Brodherr, Laif I. 
Bösche, Andreas Mügge, University Heart Center Bochum, BG Clinic Bergmannsheil, 
Bochum, Germany
Background:Catheter ablation of Ventricular Tachycardia (VT) in remote myocardial 
infarction (MI) is hampered by hemodynamic and electrical instability. Is regional catheter 
ablation effective when only using information from sinusrhythm mapping?
Methods:In patients (PTS) presenting for catheter ablation of ischemic VT left ventricular 
substrate mapping (CARTO, Biosense Webster) (detecting scar areas, damaged and 
normal myocardium by local bipolar voltage criteria) after documenting the clinical VT 
(either during admission ECG or programmed ventricular stimulation protocols). By 
pace-mapping the exit-region of the VT within the scar border zone was approximated 
and catheter ablation was performed along the local scar border (limited to areas with 
damaged myocardium). No mapping was performed during ongoing VT. If a VT (clinical 
or different morphology) was inducible after ablation approximation and regional scar 
encircling was repeated. Follow-up constituted of ECG-, ICD-holter interrogation and 
holter-ECG recording every 3 months.
Results: 66 PTS were included (mean ejection fraction 33±12%). 85% of the patients 
already had ICDs implanted with a mean of 25.9±22 episodes within 3 months prior to 
admission. A mean of 2.7±1.5 VTs were inducible per PT. Targeting all inducible VTs a 
mean of 1.7±0.7 regional scar encircling ablation lines were performed (mean ablation 
duration 882±448seconds). The clinical VT was rendered non-inducible in 64 out of the 
66 PTS (97%). During a mean follow-up of 12±10months 15% of all PTS (10/66) had 
documented episodes of sustained episodes of VT (different from clinical VT). Overall 
85% of all PTS were free from any sustained ventricular arrhythmia during the follow-up 
period. 3 access site complications (5%) occurred. During follow-up 4 PTS (6%) died 7 
days up to 15 months after the procedure.
Conclusions:Regional scar encircling ablation using mapping information only from 
sinusrhythm-mapping is effective in treating VT in remote MI eliminating any sustained 
ventricular arrhythmia in 85%. Linear ablation along the scar border within the exit region of 
clinically occurring VTs effectively long-term eliminates the arrhythmia in 97% of patients.
9:00 a.m.
909-240	 Not	Relative	Delay,	Absolute	Delay	in	Left	Ventricular	
Free	Wall	Contraction	is	Necessary	for	Response	to	
Cardiac	Resynchronization	Therapy
Hideaki Kanzaki, Satoshi Nakatani, Kazuhiro Satomi, Takashi Noda, Hideo Okamura, 
Kazuhiro Suyama, Takashi Kurita, Wataru Shimizu, Naohiko Aihara, Shiro Kamakura, 
Kazuo Niwaya, Masafumi Kitakaze, National Cardiovascular Center, Osaka, Japan
Background: Cardiac resynchronization therapy (CRT) can improve left ventricular (LV) 
performance in patients with dyssynchrony. Recent data suggest that CRT could be effective in 
a part of patients with RBBB or narrow QRS. However, this is inconsistent with the conventional 
rationale of dyssynchrony in LBBB. Our objective was to assess hypothesis that, not relative delay, 
absolute delay in LV free wall contraction may have an important impact on response to CRT.
Methods:	Forty-one patients with NYHA III-IV heart failure (LVEF 21 ± 9%, QRS 177 ± 
46 ms, 108-240 ms) were studied: 34 underwent CRT, and 7 ended by the test pacing 
because of no significant improvement in cardiac function. At baseline and 6 months after 
CRT, echocardiographic studies including color tissue Doppler imaging (TDI) from the 
apical views were performed with GE Vivid 7. Time-to-peak longitudinal velocity during 
ejection time (Ts) was measured at 12 segments of the left ventricle to assess the septal-
to-free wall relative delay of Ts and the absolute free wall delay (mean Ts from basal 
lateral and posterior wall) with TDI. The time-to-peak radial strain was calculated with 
speckles pattern tracking of myocardium in the LV short-axis view (EchoPAC BTO4, GE 
VingMed) to assess the delay in septal-posterior strain. Receiver-operating-characteristic 
(ROC) analysis was performed to compare with these parameters (Stata SE8.2, Stata).
Results: Nineteen (56% of the CRT patients) who showed significant LV reverse 
remodeling (>15% reduction in LV end-systolic volume) and/or improvement by one or 
more NYHA functional class after 6 months of CRT were defined as responders. The 
septal-to-free wall delay of >60 ms predicted the responders with a sensitivity of 37% 
and a specificity of 86%, the absolute free wall delay of >250 ms with 84% and 86%, 
respectively, and the delay in septal-posterior strain of >130 ms with 69% and 74%, 
respectively. Area under the ROC curve value was 0.622, 0.910 and 0.711, respectively.
Conclusion:	The necessary condition for response to CRT is the absolute delay in LV 
free wall contraction rather than the relative delay between the septal and free wall one.
9:00 a.m.
909-241	 Use	of	Implantable	Cardioverter-Defibrillators	in	
Patients	With	Left	Ventricular	Assist	Devices
Michael Kuhne, Michaela Sakumara, Stephen Reich, Hakan Oral, Frank Bogun, Aman 
Chugh, Krit Jongnarangsin, Eric Good, Francis Pagani, Frank Pelosi, Jr., Fred Morady, 
Cardiovascular Medicine, University of Michigan, Ann Arbor, MI, Cardiac Surgery, 
University of Michigan, Ann Arbor, MI
Background: More patients with a previously implanted cardioverter-defibrillator (ICD) are 
receiving left ventricular assist devices (LVADs) for the treatment of advanced heart failure. Little 
is known about the outcome of patients who have both ICDs and LVADs and about interactions 
when both devices are in use at the same time.
Methods: All patients who received an LVAD were included into the study if they had a previously 
implanted ICD or received an ICD after LVAD placement. Patients were excluded if the ICD was 
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permanently turned off at LVAD implant. Outcome variables including interactions between the 
two devices were determined.
Results: The population studied consisted of 77 patients with simultaneous ICD and LVAD therapy. 
Median follow-up was 42 months and the median time with both devices was four months. Patients 
were 52+/-12 years old, 68 (88%) were male. 56 (73%) had class IV heart failure, left ventricular 
ejection fraction was 13.3+/-5.3%. 48 (62%) had nonischemic cardiomyopathy. LVADs with 
pulsatile and continuous flow pumps were used in 56 (73%) and 21 patients (27%), respectively. 
10/56 patients (18%) with pulsatile flow and 4/21 (19%) with continuous flow LVADs received a 
total of 44 and 19 shocks in these two groups, respectively (p=ns). 44/63 shocks (70%) were 
appropriate. 50 patients (65%) were rehospitalized for a total of 164 hospitalizations. 51 patients 
(66%) received a heart transplant. In all nine patients (12%) who died during simultaneous use of 
ICD and LVAD as a bridge to transplant or destination therapy, circulation could be maintained, 
and the LVAD was turned off due to concomitant medical reasons ovther than pump failure, 
ventricular fibrillation or a device-related problem. Presumed interactions between LVAD and ICD 
occurred in two patients (2.6%), both with continuous flow pumps. In one case, telemetry failure 
resulted in an ICD generator change, in the second, noise sensing on the atrial channel of the ICD 
remained without clinical consequences. No shocks occurred due to device-related interaction.
Conclusion:Relevant interactions are rare when LVADs and ICDs are in use simultaneously. 
The presented data indicate that the use of both devices at the same time is safe.
9:00 a.m.
909-242	 Is	Wider	Worse?	Increasing	QRS	Duration	Predicts	
Cardiac	Mortality	in	Patients	with	Complete	and	
Persistent	Right	Bundle	Branch	Block
Christiana Adesanya, Kabir Yousuf, Carter Co, Gaur Shobhana, Sameer Ahmed, 
Anthony Pothoulakis, Masarrath Moinuddin, Agaram Suryaprasad, Satyendra Gupta, 
Veteran Affairs Medical Center, Dayton, OH, Wright State University, Boonshoft School 
of Medicine, Dayton, OH
Introduction: The association of right bundle branch block (RBBB) with mortality is less well 
established compared to left bundle branch block. However, the degree of QRS duration in 
RBBB may be more predictive of poor outcome.
Hypothesis: We examined the hypothesis that progressive increase in QRS duration may 
be associated with mortality.
Methods: Using the MUSE CVR Information System (GE Medical System) we identified 
a total of 52,852 patients with electrocardiograms and any patients with the diagnosis of 
complete and persistent RBBB (QRS >120 ms) between January 2000 and January 2004 
(some had EKGs confirming RBBB since 1987). The QRS durations were categorized 
into 4 groups: 120-129, 130-139, 140-149 and ≥150 ms.We examined the Computerized 
Patient Record System for patients’ demographic data and comorbid conditions. Primary 
endpoint was all-cause mortality and secondary endpoint was cardiac mortality. The 
effects of QRS duration, adjusted for age and comorbid conditions, on death rates were 
analyzed using the Cox proportional hazards regression model (p<0.05).
Results: A total of 997 (1.9%) patients were identified with RBBB (mean age 68.9 ± 10 
years) and were followed for 1-226 months (median 45). There were 420 (42.2%) patients 
with RBBB without clinically evident structural heart disease. Amongst the 997 patients, 
all-cause mortality was 344 (34.5%). There were 59 (5.9%) cardiac deaths, 191 (19.2%) 
non-cardiac and 94 (9.4%) unknown causes. Cardiac deaths in each QRS group were 
2 (1.9%), 6 (3.1%), 13 (5.0%) and 38 (11.2%) respectively. Patients with cardiac deaths 
had mean left ventricular ejection fraction of 38 ± 15%. The effect of QRS duration on all-
cause mortality was not statistically significant (p = 0.425). However, in patients with cardiac 
deaths, increasing QRS duration was significantly associated with morality (p = 0.0068). 
For every 10 ms increase in QRS duration, the risk of cardiac death rose by 26.6%.
Conclusion: Increasing QRS duration independently predicted cardiac mortality in patients with 
complete and persistent RBBB, but has no statistically significant effect on all-cause mortality. 
The length of QRS duration has added prognostic information to the presence of RBBB.
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910-234	 Ventricular	Rate	control	in	the	Goat	Model	of	Atrial	
Fibrillation:	Synergistic	effects	of	Metoprolol	and	
Adenosine	Receptor	Agonist
Sunniva de Haan, Sander Verheule, Marion Kuiper, Arne van Hunnik, Arvinder Dhalla, 
Luiz Belardinelli, Maurits Allessie, Ulrich Schotten, Maastricht University, Maastricht, 
The Netherlands, CV Therapeutics Inc., Palo Alto, CA
Background: Rate control is important in the management of atrial fibrillation (AF). Selective 
(A1) adenosine receptor agonists might reduce ventricular rate during AF by activation of 
G-protein coupled inward rectifier currents and by antagonizing β-adrenergic effects due to 
activation of inhibitory G proteins. We tested 2 hypotheses: 1. CVT-510 (full A1 agonist) and 
CVT-3619 (partial A1 agonist) reduce ventricular rate in the goat model of AF and 2. CVT-
510 and the β-receptor antagonist Metoprolol act synergistically on ventricular rate.
Methods	 &	 Results: In 12 goats, instrumented with atrial and ventricular epicardial 
electrodes, AF was induced by repetitive burst pacing. Bolus injections of CVT-510 and 
CVT-3619 dose-dependently prolonged the ventricular cycle length during AF (RRAF) 
within 5 min after administration (n=8, see fig). Continuous infusion of CVT-510 prolonged 
RRAF both in the presence and absence of Metoprolol (3µg/kg/min). However, the effect 
was significantly more pronounced in the presence of Metoprolol (n=6, p<0.05, ANOVA). 
CVT-510 increased QT-time from 198 ± 25 to 231 ± 31 without and from 224 ± 25 to 270 ± 
11 ms with Metoprolol. This increase was within the expected rate-related changes. 
Conclusions: A1 receptor agonists CVT-510 and CVT-3619 dose-dependently reduced 
ventricular rate during AF. The action of CVT-510 and Metoprolol on ventricular rate was 
synergistic. A1 receptor agonists may serve as new therapeutic agents for rate control in 
AF and should further be evaluated.
10:00 a.m.
910-237	 Progression	of	Atrial	Fibrillation	in	Patients	With	a	
First-Detected	Episode.	A	Long-term	Prospective	
Follow-Up	Study
Carlo Pappone, Andrea Radinovic, Francesco Manguso, Gabriele Vicedomini, Patrizio 
Mazzone, Alfio Stuto, Simone Gulletta, Maria E. Gelera, Andreina Santagostino, Laura 
LiVolsi, Gabriele Paglino, Simone Sala, Giuseppe Augello, Vincenzo Santinelli, San 
Raffaele Hospital-University, Milan, Italy
Background: This is the first study which reports the progression of atrial fibrillation 
(AF)according to current guidelines classification.
Methods: 106 untreated patients with a first symptomatic episode of AF (mean age, 
57.5 years, males 64.2%) were enrolled. Fifty-two patients had associated diseases 
and 54 lone AF.Patients who progressed to recurrent and persistent AF were treated 
pharmacologically according to the current guidelines. The endpoint was progression to 
permanent AF during a 4-year follow-up.
Results: Of the 106 patients, 50 (47%) experienced recurrent paroxysmal AF. Among 
patients with recurrent AF, 21(42%) further progressed to persistent AF and by the end of 
4 years 13 of the 21 patients with persistent AF (62%) finally progressed to permanent AF 
(median follow-up, 43 months). AF progression was completely asymptomatic in 16/50 
patients (13%). No adverse events developed in the 56 patients who had no recurrences. 
Transient ischemic attacks occurred in 6 patients with recurrent AF. Stroke (4 patients), 
pulmonary edema (3 patients).and/or death (one patient) developed in 8 patients who 
progressed to persistent AF.
Conclusions: Only a half of the patients with a first-detected episode of AF may 
develop recurrent episodes of paroxysmal AF during a 4-year follow-up. However, many 
patients with recurrent episodes will experience persistence and permanence of AF by 
4 years. Progression to persistent or permanent AF is associated with development of 
major complications.
10:00 a.m.
910-238	 The	Relationship	Between	the	Coronary	Artery	Anatomy	
and	the	Subeustachian	Isthmus,	Coronary	Sinus	Os-
Middle	Cardiac	Vein	and	Floor	of	Coronary	Sinus
Can Hasdemir, Oguz Yavuzgil, Cem Ulucan, Meral Kayikcioglu, Hakan Kultursay, 
Cuneyt Turkoglu, Levent H. Can, Serdar Payzin, Ege University School of Medicine, 
Department of Cardiology, Izmir, Turkey
Background:Coronary artery (CA) occlusions following catheter ablation (CAb) along 
the mitral-tricuspid valve annulus have been previously reported. Despite its significance, 
there is limited data regarding the distribution of CAs and their relation with the 
subeustachian isthmus (SEI), coronary sinus os-middle cardiac vein (CS Os-MCV) and 
the floor of CS.
Methods:Study population included 40 patients (mean age 44±19 years, 17M/23F) 
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undergoing CAb for atrioventricular reentrant tachycardia (n=22), atrioventricular nodal 
reentrant tachycardia (n=13) and atrial tachycardia (n=5). High right atrial and right 
ventricular catheters were placed in usual manner. The angle of His catheter in LAO view 
was arranged in such a way to orient the septal structures and accompanying catheters. 
CS catheters were introduced from right subclavian vein. Mapping catheters were placed 
in SEI. Coronary angiographies were performed in RAO and LAO views.
Results:In right CA dominant patients (n=32), 1-the distance between the distal right 
CA (vessel diameter 2.3±0.5 mm) and SEI was 9±6 mm in LAO-systole(s), 4±3 mm in 
LAO-diastole(d), 13±7 mm in RAO
s
 and 6±3 mm in RAOd, 2-the distance between the 
posterolateral branch of RCA (vessel diameter 1.6±0.4 mm) and CS Os-MCV was 2.9±2 
mm in LAO
s
, 2±2 mm in LAOd, 4±2.9 in RAOs and 2.7±2 mm in RAOd. In left CA dominant 
patients (n=8), the distance between the left circumflex artery (vessel diameter 2±0.4 
mm) and the floor of CS was 1.2± 0.2 mm in LAO
s
, 1.6± 0.3 mm in LAOd, 1.3± 0.2 mm 
in RAO
s
 and < 1.0 mm in RAOd. In two patients, CAb was cancelled due to the close 
proximity of the accessory pathway (one located at the CS Os and one at the posterior 
mitral valve annulus) to the coronary artery. Conclusions:Large-sized (≥ 1.5 mm) CAs 
can run close proximity (≤ 2 mm) to the CS Os-MCV in 17%, and to the floor of CS in 
22% of patients. Coronary angiography should be performed prior to Cab, planned to be 
performed at the CS Os-MCV and along the floor of CS, in order to eliminate the risk of 
potential CA occlusions.
10:00 a.m.
910-239	 Incidence,	Predictors	and	Outcomes	of	Ventricular	
Arrhythmias	During	Angioplasty	for	Acute	Myocardial	
Infarction
Jonathan P. Piccini, Jeffrey S. Berger, David L. Brown, Stony Brook University Medical 
Center, Stony Brook, NY, Duke University Medical Center, Durham, NC
Background: Ventricular arrhythmias complicate up to 20% of acute myocardial 
infarctions (AMI). However, it is unclear if these arrhythmias are associated with worse 
outcomes. We sought to identify predictors of ventricular arrhythmias following AMI and 
to determine their influence on in-hospital mortality.
Methods: We conducted a retrospective study of all patients who underwent angioplasty 
for AMI in New York State in 1998-9.
Results: Among 8,742 patients, 453 (5.2%) had VT/VF. Patients with ventricular 
arrhythmias were more likely to be white (93 vs 88%, P=0.001), have chronic kidney 
disease (2.3 vs 0.8%, P=0.001), and less likely to have diabetes (12 vs 18%, P=0.002) 
and hypertension (48 vs 56%, P=0.001). Patients with VT/VF were more likely to have 
heart failure on admission (30 vs 9.9%, P<0.001), reduced ejection fraction (31.4 ± 19.2 
vs 40.2 ± 19.9%, P<0.001) and cardiogenic shock (19 vs 3.1%, P<0.001). Independent 
predictors of VT/VF are presented in Table 1. Patients with VT/VF had a 4-fold increase 
in in-hospital mortality (16.3 vs 3.7%, P<0.001) and were more likely to experience major 
adverse cardiac events (19.1 vs 6.2%, P<0.001).
Conclusions: In this cohort of AMI patients undergoing primary angioplasty, ventricular 
arrhythmias are associated with a four-fold increased risk of in-hospital mortality. Patients 
with heart failure on presentation, cardiogenic shock, decreased ejection fraction and 
chronic kidney disease are at highest risk of developing these life-threatening arrhythmias.
Predictors of Ventricular Arrhythmias
Variable Wald Odds	Ratio 95%	Confidence	Interval P	value
CHF on admission 41.5 2.30 1.79-2.97 <0.001
Cardiogenic Shock 37.2 3.04 2.13-4.35 <0.001
EF (every 5%) 25.4 0.94 0.92-0.96 <0.001
Diabetes 13.7 0.56 0.41-0.76 <0.001
MI < 6 hours 11.5 1.45 1.17-1.80 0.001
White 6.7 1.66 1.13-2.44 0.010
Chronic kidney disease 6.1 2.47 1.21-5.08 0.013
Stent 5.2 0.76 0.60-0.96 0.022
10:00 a.m.
910-240	 Comparison	of	Baseline	Dyssynchrony	and	Acute	
Hemodynamic	Effects	of	CRT	in	Patients	with	Right	and	
Left	Bundle	Branch	Block
J. Lacy Sturdivant, Robert B. Leman, J. Marcus Wharton, Yinghong Yu, Jiang Ding, 
Shantha Arcot-Krishnamurthy, Michael R. Gold, Medical University of South Carolina, 
Charleston, SC, Boston Scientific CRM, St. Paul, MN
The benefits of cardiac resynchronization therapy (CRT) have been shown most clearly in 
heart failure (HF) patients (pts) with left bundle branch block (LBBB). In the minority of HF 
pts with right bundle branch block (RBBB), the effects of CRT are more controversial. This 
study compared acute hemodynamic effects of CRT, as well as electrical and mechanical 
measures of dyssynchrony in HF pts with RBBB or LBBB.
Methods: 12 LBBB (age 66±13yrs, QRS 185±28 ms, EF 24±8%) and 9 RBBB (age 69±9 yrs, 
QRS 162±7 ms, EF 28±5%) NYHA III pts were studied. LV dP/dt was measured invasively 
in biventricular mode with 5 AV delays. Mechanical dyssynchrony was measured via echo 
as septal to posterior wall motion delay (SPWMD) and as the time difference from opening 
of pulmonary and aortic valves (QPA-QAO); Electrical dyssynchrony was measured as the 
time difference between RV and LV depolarization (RV-LV) and as the time interval from the 
first QRS deflection on the surface ECG to the peak of the LV electrogram (QLV).
Results: RBBB pts had significantly smaller increases in LV dP/dt and electrical 
dyssynchrony measures, despite a similar degree of mechanical dyssynchrony (Table).
Conclusions: The effect of CRT on LV hemodynamic function is considerably smaller in 
RBBB than LBBB pts. The diminished benefit of CRT in RBBB may be due to a lesser 
degree of underlying electrical dyssynchrony. These results suggest that the presence 
of both electrical and mechanical dyssynchrony may be needed to achieve optimal 
hemodynamic improvement with CRT.
Results
Hemodynamic & Dyssynchrony Parameters RBBB LBBB P-value
Mean Std Mean Std
% LV dP.dt 6.08 3.97 20.16 11.40 <0.01
RV-LV 11.33 31.40 75.58 38.56 <0.001
QLV 76.57 21.47 113.14 31.66 0.03
QPA-QAO 30.89 23.43 37.10 39.26 NS
SPWMD 94.78 32.69 118.63 62.06 NS
10:00 a.m.
910-241	 Access	to	Implantable	Cardioverter	Defibrillator	Therapy	
for	Patients	with	MADIT-like	Criteria	in	Clinical	Practice
Riccardo Cappato, Gabriele Zanotto, Carlo Menozzi, Alessandro Coppola, Antonio 
Curnis, Valerio Freggiaro, Tommaso Sanna, Gianfranco Sinagra, Fabrizio Pizzetti, 
Sergio Sermasi, Giovanni Raciti, Francesco Accardi, Arrhythmias and Electrophysiology 
Center, Policlinico San Donato, Milan, Italy
Background. We sought to investigate the practice of risk assessment (RA) and access to 
cardioverter defibrillator (ICD) therapy in patients with previous myocardial infarction (MI), 
impaired left ventricular ejection fraction (LVEF), nonsustained ventricular tachycardia 
(nsVT) and inducible sustained ventricular arrhythmias.
Methods and Results. The follow-up of 1440 consecutive patients (68.9 ± 10.9 years) 
with an LVEF ≤ 40% at time of acute MI was investigated to evaluate: 1) the incidence of 
patients with a combination of LVEF ≤ 40%, clinical nsVT and inducible sustained VT or 
VF as identified by post-discharge routine RA; 2) the incidence of ICD implant following 
routine RA; and, in the same population, 3) the effectiveness of systematic RA re-evaluation 
aimed at identification of ICD candidates not or insufficiently evaluated during routine RA. 
During 33.8±13.5 months after discharge from last MI, 21.1% of patients had undergone 
non-invasive routine RA, with 0.3% undergoing programmed electrical stimulation (PES) 
and 0.1% receiving an ICD. In the same population, systematic RA re-evaluation resulted 
in 42.4% (p < 0.001 versus routine RA) of patients eligible for non-invasive RA, 2.0% 
(p<0.001) undergoing PES and 1.2%, (p<0.001) receiving an ICD. Causes preventing RA 
re-evaluation included death in 16.3%, age > 80 years in 20.3%, co-morbidity in 9.7%, other 
impediments in 6.3% and clinical sustained VT or VF in 5.0% of patients.
Conclusions. Current practice RA resulted in only 21.1% of post-MI patients with impaired 
LVEF being investigated during the first 3 years after MI with 0.1% receiving an ICD 
because of nsVT and inducible sustained VT or VF. A systematic re-evaluation of the 
same population resulted in a 2-fold increase of access to RA and 12-fold increase of 
access to ICD therapy.
10:00 a.m.
910-242	 Circadian	Variability	of	Deceleration	Capacity	of	Heart	Rate
Axel Bauer, Petra Barthel, Raphael Schneider, Elisabeth Arnoldi, Georg Schmidt, 
Deutsches Herzzentrum München, Munich, Germany
Background: Deceleration Capacity (DC) of heart rate is a novel, Holter-based risk 
predictor after myocardial infarction which has been shown to be superior to standard 
measures of heart rate variability (HRV). DC quantifies deceleration-related (quasi-
)periodicities of heart rate over 24 hours and is thought to be a measure of vagal activity. 
If so, circadian variability of DC should differ from that of global measures of HRV.
Methods: The study enrolled 1,455 survivors of acute myocardial infarction. 24-hour 
Holter recordings were performed during the second week after index infarction. During 
median follow-up of 22 months, 70 patients died. DC as well as standard measures of 
HRV were assessed over 24 hours as well as for 3-hour periods.
Results: Of all variables tested, 24-hour values of DC showed the strongest association 
with mortality (p<0.0001). DC exhibited a clear circadian pattern with maximum values 
during the night and in the early morning and minimum values in the afternoon. This 
pattern was present in both survivors and non-survivors (left panel shows median values; 
p<0.0001). In contrast, global measures of HRV such as SDNN or HRV-index exhibited 
maximum values in the morning (right panel; p<0.0001). RMSSD (reflecting vagally 
mediated short-term variability) exhibited a pattern similar to DC, but was only moderately 
associated with mortality.
Conclusions: These findings support the hypothesis that DC is a specific measure of 
vagal function which differs from global measures of HRV. 
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911-234	 Familial	Sinus	Bradycardia:	Clinical	Features	Associated	
with	a	Mutation	in	the	hyperpolarization-activated	
nucleotide-gated	channel	4	Cardiac	Ion	Channel	Pore
Eyal nof, Dina Marek, Dovrat Brass, Nathan Daskal, Hadas Lahat, Haike Reznik- Wolf, 
Eylon Pras, Michael Eldar, Michael Glikson, David Luria, Heart Institute, Chaim Sheba 
medical Center, Tel Hashomer, Israel, Department of Physiology and Pharmacology, 
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Background: The hyperpolarization-activated nucleotide-gated channel-HCN4 plays a major role 
in the diastolic depolarization of sinus atrial node cells. Mutant HCN4 channels have been found 
to be associated with inherited sinus bradycardia. We sought to investigate the clinical and genetic 
features of a family with sinus bradycardia.	
Methods: Sixteen family members were evaluated. Evaluation included a clinical questionnaire 
and Holter monitoring. Echocardiography and treadmill exercise testing were performed in 
those family members considered to be affected. Two patients underwent electrophysiological 
(EPS) testing. Genetic analysis included segregation analysis and direct sequencing of the 
exons encoding HCN4. Function analysis included expression of HCN4 Wild-type and G480R 
in Xenopus oocytes and whole cell currents were recorded using the two-electrode voltage 
clamp technique.	
Results: Eight family members (5 males) were classified as affected. All affected family members 
were asymptomatic during a long follow-up with normal exercise capacity. EPS testing performed 
on 2 affected family members confirmed significant isolated sinus node dysfunction. Segregation 
analysis suggested autosomal dominant inheritance. A missense mutation, G480R, was found in 
the ion channel pore domain of HCN4 in affected family members. Functional expression revealed 
that although there was a similarity in the reversal potential of HCN4 wild-type and G480R mutant 
channels (~-10mV), suggesting similar ion selectivity, gating was greatly altered. Mutant channels 
were activated at more negative voltages (below -85 mV) and had much slower deactivation 
kinetics compared to wild type channels (activated at -65 mV).
Conclusions: We describe an inherited, autosomal dominant form of sinus node dysfunction 
caused by a missense mutation in the HCN4 ion channel pore. The slow kinetics and the more 
negative range of activation in the mutant channels are in agreement with the reduced contribution 
of the mutated channel in physiological conditions to the If current. Despite its critical location, this 
mutation carries a favorable prognosis without the need for pacemaker implantation.
11:00 a.m.
911-237	 Macroscopic	Anatomy	Of	Atrial	Muscular	Connections	
With	The	Central	Fibrous	Body	Of	The	Aorta-	Functional	
and	Arrhythmic	Implications
Raveen R. Bazaz, University of Pittsburgh, Pittsburgh, PA
Background: Supraventricular arrhythmias (SVTs) are frequently encountered in the region 
close to the central fibrous body (CFB)of the aorta. There is little information on the relationship 
of the atrial musculature with the CFB. This study was designed to investigate this region.
Methods: Approximately 100 hearts of human, bovine, ovine and porcine origin were 
boiled to study atrial architecture. After removing all fat and connective tissue, the atrial 
were peeled of the ventricles without destroying any atrial muscle fibers.
Results: The qualitative constructions of the atria were similar between species. The 
atria had a robust connection with the CFB. Muscle bundles that were seen to insert into 
the CFB included (Figure with dissected human atrium):
1. Robust connections from the septal raphe
2. The crista terminalis and left atrial crest - either directly, or through 
interposition of the septal raphe.
3. Fibers from the left septoatrial bundle and the left posterior crest that run 
between the left and right pulmonary veins.
4. Circular muscle fibers encircling the mitral and tricuspid annuli.
Conclusions: : The atrial muscle bundle insertions into the CFB elucidated by this 
study may advance an understanding into the mechanisms and therapies for SVTs that 
emanate in this region. Insertion of dominant muscle bundles into the region of the CFB 
suggests a central role for this structure in atrial function. Whether the role is to provide 
a fulcrum/ and or an effector region for function will need investigation 
11:00 a.m.
911-238	 C-Reactive	Protein	Predicts	Mortality	in	Patients	With	
Atrial	Fibrillation
Firas H. El Sabbagh, Arthur C. Kendig, Segio G. Thal, Tushar K. Shah, David R. Van 
Wagoner, Patrick J. Tchou, Mina K. Chung, The Cleveland Clinic Foundation, Cleveland, OH
Background:	Atrial Fibrillation (AF) is associated with a 2-fold increase in mortality. We 
tested the hypotheses that markers of left ventricular (LV) or atrial remodeling predict 
mortality in patients with persistent AF presenting for cardioversion (CV).
Methods:	 Social Security Death Index was used to assess survival of all pts who 
underwent CV from 8/96 to 11/03. Demographic, clinical, echo and biomarker (CRP, BNP) 
data were subjected to univariate Cox regression analyses to determine predictors of 
mortality. Significant variables were analyzed using Cox proportional hazards model to 
determine independent predictors of mortality.
Results: Over a mean follow-up of 47±26 mos, 459 (11.5%) of 4000 pts (age 66±12 
yrs) who underwent CV died. Univariate predictors of higher mortality included older age 
(71±10 vs 66±12 yrs), male sex (12 vs 9%), black race (17 vs 11%), CAD (18 vs 8%), LV 
size (5.5±1.1 vs 5.1±1.0 cm), lower LVEF (40±16 vs 45±14%), amiodarone use (16 vs 
10%) and baseline CRP ( 34±53 vs 11±22 mg/L) and BNP ( 804±311 vs 438±452 pg/ml), 
all p<0.05. Use of Beta-blockers (8 vs 14%) and valvular heart disease (10 vs 12%) were 
associated with lower mortality,p<0.05. Cox regression analysis identified higher baseline 
CRP, lower LVEF and less VHD as significant independent predictors of mortality.
Conclusion: Markers of LV dysfunction and inflammation predict higher mortality in pts 
with AF. Future studies are of interest to determine whether treatments that target these 
factors can improve survival in AF pts.
11:00 a.m.
911-239	 Long-term	Success	of	Radiofrequency	Ablation	of	
Ventricular	Tachycardia	in	Arrhythmogenic	Right	
Ventricular	Dysplasia/Cardiomyopathy
Darshan Dalal, Jonathan Piccini, Jun Dong, Sunil Sinha, Harikrishna Tandri, Kalpana 
Prakasa, Crystal Tichnell, Cynthia James, Hugh Calkins, Johns Hopkins University 
School of Medicine, Baltimore, MD
Background:	Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C) is an 
inherited cardiomyopathy characterized by ventricular tachycardia (VT) and right ventricular 
dysfunction. Prior studies have shown that catheter-guided radiofrequency ablation (RFA) 
of VT can be performed successfully in ARVD/C patients by experienced centers. However, 
there is limited literature on the long-term success of these procedures, especially in less 
experienced centers. The purpose of this study was to evaluate the success of RFA among 
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ARVD/C patients referred by different institutions enrolled into a registry.
Methods:	The study population comprised of 16 (age 36 ± 10 years, 7 male) ARVD/
C patients, from the Johns Hopkins ARVD registry, who underwent one or more 
attempts of RFA in different institutions of the United States. Each patient underwent 
an electrophysiology study in which VT mapping and radiofrequency ablation were 
performed in an attempt to eliminate the induced VT. Medical records were reviewed and 
patients were followed up for a median duration of 17 (range 0 - 91) months. Recurrence 
was defined as the occurrence of VT subsequent to the RFA procedure documented by 
ECG, Holter monitor, or an ICD electrogram.
Results:	A total of 37 RFA procedures were performed in the 16 patients using 3D 
electroanatomic (n=9) or conventional mapping (n=28) techniques. Of these, 19 (51%), 
10 (27%), and 8 (22%) resulted in elimination of all inducible VT, only the clinical VT and 
none of the inducible VT respectively. Thirty-two (86%) procedures were followed by VT 
recurrence during follow up. The cumulative VT recurrence-free survival was 75%, 50%, 
and 25% after 1, 5, and 14 months respectively. No significant differences in the rate of 
recurrence were noted between procedures in which ablation of all, clinical, or none of 
the induced VT was achieved.
Conclusion:	Our study demonstrates a high rate of VT recurrence in ARVD/C patients 
undergoing RFA of VT. This likely reflects the fact that ARVD/C is a progressive 
cardiomyopathy that results from mutations in proteins encoding desmosomal proteins. 
Further studies are needed to define the precise role of catheter ablation in the 
management of VT in ARVD/C patients.
11:00 a.m.
911-240	 A	Dedicated	Left	Atrial	Pacing	and	Sensing	Lead	
Improves	the	Outcome	of	Atrial	Resynchronization	
Pacing	for	Atrial	Fibrillation
Rajiv Sankaranarayanan, Russell Holloway, Michael James, Taunton and Somerset 
Hospital, Taunton, United Kingdom
Background: We hypothesized that atrial resynchronization using an innovative bi-atrial 
pacemaker with a dedicated coronary sinus lead for permanent left atrial pacing and 
sensing might improve the efficacy of bi-atrial pacing for the treatment of drug resistant 
atrial fibrillation (AF). We therefore compared the outcome of patients who underwent 
atrial resynchronization using this innovative bi-atrial pacemaker versus patients who 
were treated with a conventional bi-atrial pacemaker with left and right atrial leads 
connected in tandem to a single atrial port by use of a splitter device.
Methods: 18 patients were implanted with the new bi-atrial pacemaker with a dedicated 
left atrial pacing and sensing lead (LA group) and 13 patients were implanted with a 
conventional splitter type bi-atrial pacemaker (conventional group). We compared the 2 
groups with regard to symptoms, AF duration, AF admissions and anti-arrhythmic drug 
requirement for an equal period of time pre and post-pacemaker implant (29 ± 18 months 
for LA group and 41± 20 months for conventional group).
Results: The conventional group (mean age 68 years) consisted of 9 males, 4 females and 
the LA group (mean age 69 years) consisted of 11 males, 7 females. There was a significant 
improvement in both symptoms and AF duration in 15/18 (83%) of the LA group versus 6/13 
(46%) of the conventional group (p=0.03). The improvement in median AF episodes was a 
reduction of 26 days/month (range -9 to 30) in the LA group compared to 2.5 days/month 
improvement (range -7.5 to 22.5) in the conventional group (p<0.001). There was an 80% 
reduction in mean number of admissions in LA group (2.2 ± 2.2 pre-implant and 0.4 ± 0.8 
post; p<0.001) compared to a 48% reduction in conventional group (3.3 ± 4.4 pre and 1.7 ± 
1.5 post; p=0.05). Improvement in mean number of anti-arrhythmic drugs was similar in the 
2 groups (LA group 1.9 ± 1.1 and conventional group 1.7 ± 1.8; p=0.7).
Conclusions: Atrial resynchronization for AF using a bi-atrial pacemaker with a dedicated 
coronary sinus lead enables more effective left atrial pacing and produces a better result 
in reduction of symptoms, AF duration, AF episodes and admissions for AF compared to 
conventional bi-atrial pacing.
11:00 a.m.
911-241	 Morbidity	and	Mortality	Associated	with	Device	
Generator	Replacement
Glenn M. Polin, Tracey Shannon, Steven M. Markowitz, Sei Iwai, Bindi K. Shah, Bruce 
B. Lerman, Kenneth M. Stein, Cornell University Medical Center, New York, NY
Background: Permanent pacemaker (PPM) and implantable cardioverter-defibrillator 
(ICD) pulse generators have a limited battery life, and require replacement when the battery 
is depleted. Additionally, device recalls may require consideration of premature generator 
replacement. However, there are scant data regarding the risks of this procedure.
Methods: We reviewed the baseline characteristics, 1-month, and 6-month outcomes of 
255 consecutive patients who underwent PPM or ICD generator change between October 
2003 and October 2005. Information was obtained through chart review, telephone follow-
up, and by review of the social security death index.
Results: Complete follow-up data was obtained in 241 (95%) patients (age 73±15y, EF 
44%±16%, 69% male). There were 119 PPM generator changes and 122 ICD generator 
changes. 30/241 patients (12.5%) had hospitalization/death/stroke within 1m of procedure 
(20 hospitalizations, 3 deaths, 0 strokes), pocket hematoma requiring evacuation within 1m 
of procedure (n=4), lead revision within 6m of procedure (n=2), or infection requiring pocket 
revision within 6m of procedure (n=1). Univariate predictors of this combined endpoint included 
age (79±13y vs 72±15y, p=0.02) and female sex (21.6% vs 8.4% for males, p=0.006). There 
were no differences in risk based on device type, EF, or indication for generator change (recall 
vs. battery depletion). Of the hospitalizations, 12/20 (60%) were deemed definitely related 
to the generator change, 6/20 (30%) were deemed possibly related to the procedure, and 
2 (10%) were deemed unrelated to the procedure. 3/4 patients with hematomas requiring 
reoperation were on outpatient warfarin compared with 73/237 without hematoma (p=0.1).
Conclusions: PPM and ICD generator changes are associated with significant morbidity, 
particularly in the form of hospitalization within 1m of the procedure. Risk is particularly high 
among women and in the elderly.
11:00 a.m.
911-242	 Composite	Holter-Based	Risk	Stratifier	Identifies	Low-Risk	
Postinfarction	Patients	With	Left	Ventricular	Dysfunction
Dan Wichterle, Maria Teresa La Rovere, Peter J. Schwartz, John Camm, Marek 
Malik, Department of Cardiology, Institute for Clinical and Experimental Medicine, 
Prague, Czech Republic
Background: Implantable cardioverter defibrillator (ICD) therapy has recently been 
expanded for the prevention of sudden cardiac death based on the results of SCD-HeFT trial. 
We assessed the hypothesis that combination of Holter-based risk predictors may identify 
low-risk postinfarction patients with LV dysfunction unlikely to benefit from ICD therapy.
Methods:	Heart rate turbulence after ventricular and atrial premature beats, short-term 
scaling exponent alfa, mean deceleration magnitude, and prevalent low-frequency 
oscillation of heart rate were calculated from 24-h Holter recordings in patients with 
LVEF<=35% in the population of EMIAT and ATRAMI trials. Composite risk predictor 
based on combination of risk factors, which were individually dichotomized to achieve 
high negative predictive value for cardiac events, was defined in EMIAT and validated in 
ATRAMI population. Cox proportional hazard survival analysis was performed for both 
populations with mean follow-up of 22 months.
Results: Total 143 / 444 (23.2%) and 71 / 177 (40.1%) patients belonged to low-risk group 
in EMIAT and ATRAMI trial, respectively. In low-risk group, only 5 cardiac (2 arrhythmic, 3 
non arrhythmic) deaths were observed in EMIAT and 2 events (1 nonfatal cardiac arrest, 
1 non-arrhythmic death) were observed in ATRAMI. 
Cardiac mortality in EMIAT and cardiac mortality + nonfatal cardiac arrest 
in ATRAMI
low-risk 
group
rest of 
population
hazard ratio for low-risk 
group log rank p
EMIAT (n=444) 5 / 143 (3.3%) 58 / 301 (19.3%) 0.16 0.0001
ATRAMI 
(n=177) 2 / 71 (2.8%) 16 / 106 (15.1%) 0.18 0.02
Conclusion:	 Holter-based risk stratification can identify significant proportion	 of 
postinfarction patients with LV dysfunction who are at very low risk (< 1% / year) of 
preventable death.
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912-234	 Radiofrequency	Ablation	Unmasks	Multiple	Accessory	
Pathways	in	a	Mouse	Model	of	Familial	Wolff-
Parkinson-White	Syndrome
Michael J. Giocondo, Jasvinder S. Sidhu, Keith A. Youker, Ali J. Marian, Robert Roberts, 
Dirar S. Khoury, Baylor College of Medicine, Houston, TX, The Methodist Hospital, 
Houston, TX
Background:	We previously determined in mice that PRKAG2 gene mutation, responsible 
for familial Wolff-Parkinson-White (WPW) syndrome, induces atrioventricular (AV) fibrous 
ring disruptions that result in functional and anatomical bypass tracts between the atria and 
ventricles. The objectives of this study were to determine the feasibility of using radiofrequency 
ablation in our WPW mouse model to abolish accessory pathway (AP) conduction, and 
thereby unmask bypass tract conduction through alternate AV ring disruptions.
Methods: Transgenic mice were generated by cardiac-restricted expression of the 
mutant (Arg302Gln) PRKAG2 gene with the cardiac-specific promoter alpha-myosin 
heavy chain. Twelve-lead ECG and epicardial AV ring mapping were initially performed 
in 6 mice to determine the AP location. An ablation catheter was then placed in the AV 
groove at the predicted AP site and RFA applied until either ventricular preexcitation 
ceased or the ECG morphology changed to a different pattern of preexcitation. Repeat 
epicardial mapping confirmed successful RFA, or revealed alternate pathways, which 
where targeted by further ablation.
Results: Baseline ECG demonstrated a short PR interval (8.3±1.2 ms), delta wave, and 
wide QRS complex (16.5±1.2 ms). Initial ECG delta wave vector analysis and epicardial 
mapping identified a manifest AP in the left-free-wall of 3 mice (2 anterior, 1 lateral), 
anteroseptum of 2 mice, and right-free-wall of 1 mouse. RFA disrupted 8 pathways in 
6 mice that included 2 pathways each in 2 mice (time, 16.1±4.8 s; power, 3.7±0.5 W; 
temperature, 49.6±0.9 ºC; impedance, 222.0±32.5 Ω). Successful RFA resulted in PR 
prolongation (23.5±4.2 ms), loss of delta wave, QRS narrowing (13.8±3.1 ms), and 
prolongation of the epicardial AV interval at the RFA site (5.8±1.7 ms to 24.2±4.2 ms) as 
observed over 30 min, consistent with normal AV nodal conduction.
Conclusions:	Radiofrequency ablation eliminated ventricular preexcitation in our mouse 
model of familial WPW. Ablation unmasked functional secondary pathways that correlated 
with disruptions observed histologically at various locations around the fibrous AV ring.
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912-237	 Increase	Risk	Of	Paroxysmal	Atrial	Fibrillation	
Episodes	Associated	With	Acute	Increase	In	
Ambient	Air	Pollution
Joseph Y.S. Chan, Ding Ding, Anna KY Chan, Eugene B. Wu, Gary CP Chan, Jeffery WH 
Fung, Cheuk-man Yu, The Chinese University of Hong Kong, Hong Kong, Hong Kong
Introduction: Previous studies have shown increase risk of atrial fibrillation (AF) associated 
with increase in ambient air pollution concentration (APC) in a small cohort of ICD patients.
Methods: During the study period between 1st Jan 04 to 31st March 06, 660 consecutive 
patients with PPM were followed up for occurrence of AF of longer than 1 min as recorded 
by the PPM. The time of onset of AF and the duration were noted. NO2, CO,O3, PM10, 
and SO2 concentration were measured by the local Environment Protection Department, 
these readings were used to calculate API which ranges from 0 to 500. A value of 100 is 
the short term Air Quality Objective (AQO) and level above 100 poses health hazard to 
at risk population. Using a case-crossover study method, the relationship between APC 
and occurrence of 684 episodes of AF from 76 patients were analyzed. For the same 
subject, a period of 24 hrs were defined as the hazard period (case) when AF occurred 
and compared with another matched 24 hours in the same day of the week one week 
later when no AF occurred (control).Odds ratio (OR) were calculated for each interquartile 
range (between 25th and 75th) increase in APC observed in the study period.
Results: An increase in API was associated with increase risk of AF occurrence.
Conclusions: Increase in APC is associated with higher risk of occurrence of AF in a 
population at risk. Majority of AF occurred at days with API level below 100. Scaling of API 
may need to be revised in order to serve as a better reference for health hazard. 
Table 1. Air Pollution Index API
Nitrogen 
dioxide 
NO2(µg/m3)
Carbon 
monoxide 
CO(µg/m3)
Ozone
O3(µg/
m3)
Particulate 
matter < 
10µm
PM10(µg/m3)
Sulphur 
dioxide 
SO2(µg/m3)
Minimum 13.0 6.0 98.3 4.0 11.7 1.5
25th 31.5 29.6 458.1 21.8 32.1 9.5
50th 48.0 42.6 714.2 39.1 52.4 15.9
75th 58.0 58.0 1120.2 58.6 74.8 24.7
Maximum 96.0 147.5 2934.1 161.2 195.6 111.0
Table 2.
API NO2 CO O3 PM10 SO2
OR 1.45 1.21 1.07 1.03 0.98 1.03
CI 0.33-6.36 0.75-1.95 0.99-1.15 1.03-1.01 0.97-0.98 1.02-1.05
P value 0.04 0.20 0.56 0.86 0.89 0.82
Noon
912-238	 Radiofrequency	Ablation	Of	Atypical	Atrial	Flutter	
Following	Cardiac	Surgery	Or	Atrial	Fibrillation	
Ablation---Comparison	Of	Open	Irrigation-tip	Versus	
8mm-tip	Catheters
Rong Bai, Luigi Di Biase, Dimpi Patel, Tamer S. Fahmy, Chi Keong Ching, Subramanya 
Prasad, Lucie Popova, Claude S. Elayi, Oussama M. Wazni, Jennifer E. Cummings, Robert 
A. Schweikert, J. David Burkhardt, David Martin, Thomas Dresing, Walid Saliba, Patrick 
Tchou, Mauricio Arruda, Andrea Natale, Cleveland Clinic Foundation, Cleveland, OH
Background: The efficacy of radiofrequency ablation of atypical atrial flutter (AAFL) 
remains relative low. This may be due to the complex mechanism of this arrhythmia and 
at times because of the inability to deliver sufficient energy during ablation.
Objectives: The aim of this study is to assess whether an open irrigation-tip catheter or 
an 8mm-tip catheter is more effective for ablation of AAFL in patients with prior history of 
cardiac surgery and/or catheter ablation of atrial fibrillation.
Methods: Seventy patients with AAFL following cardiac surgery/atrial fibrillation ablation 
were randomized for ablation with either an open irrigation-tip catheter (Group 1, n=36) 
or an 8mm-tip catheter (Group 2, n=34). Acute success was defined as the termination of 
AAFL by RF delivery and non-induciblity by programmed pacing at the end of procedure. 
Patients’ postoperative courses were followed-up by means of intermittent standard ECG, 
transtelephonic ECG monitoring and telephone interview. All patients underwent 48-hour 
Holter monitoring at their 3, 6 and 9 months follow-up after ablation.
Results: Acute success was achieved in 34 patients (94.4%) of Group 1 and 26 patients 
(76.5%) in Group 2 (P<0.05). As compared to the patients in Group 2, more patients in 
Group 1 remained in sinus rhythm without antiarrhythmic drug at their 90-day follow-up 
(68.8% vs 30.8%, P<0.05). After 10 months follow-up, 91.7% of the patients from Group 
1 were free of atrial tachyarrhythmias while only 58.9% of the patients from Group 2 
remained in sinus rhythm (P<0.05). The fluoroscopy time was less if an open irrigation-tip 
ablation catheter was used (P=0.05).
Conclusions: In patients with a prior history of cardiac surgery or ablation for AF, an open 
irrigation-tip catheter is superior to an 8mm-tip catheter for RF ablation of scar-related 
AAFLs. Patients ablated with an open irrigation-tip catheter appear to have less X-ray 
exposure, fewer antiarrhythmic drug uses and more favorable long-term outcome.
Noon
912-239	 Remote	Magnetic	Navigation	to	Map	and	Ablate	
Arrhythmias	in	the	Pericardial	Space
John D. Burkhardt, Walid I. Saliba, Robert A. Schweikert, Jennifer Cummings, Mandeep 
Bhargava, Andrea Natale, Cleveland Clinic, Cleveland, OH
Background: Epicardial mapping and ablation has been found to be useful for several 
arrhythmias. Navigation within the pericardial space presents distinct challenges. Remote 
magnetic navigation offers an alternative to navigating within this space.
Methods: Six consecutive patients (three with accessory pathways and three with 
ventricular tachycardia) underwent epicardial mapping using remote magnetic navigation 
and a 3-D mapping system. Five of the six had been referred for epicardial mapping due 
to multiple previously failed ablations. Two of these patients also underwent ablation in 
the pericardial space using this system.
Results: All six patients underwent successful mapping in the epicardial space using 
remote magnetic navigation via a minimally invasive subxiphoid approach. Two patients 
received ablation lesions with the remote magnetic catheter, but other catheters were 
eventually used due to limitation of power delivery with the 4mm tip. All clinical tachycardias 
in all patients were successfully ablated, although only one patient’s successful site was 
epicardial. No complications were noted from the epicardial mapping or ablation. One 
patient developed ventricular fibrillation requiring defibrillation and intubation while testing 
for inducible ventricular tachycardia.
Conclusions: Remote magnetic navigation may be successfully and safely used to 
perform epicardial mapping and ablation.
Patient Data
Patient Age Arrhythmia
Epicardial 
Mapping 
with 
magnetic 
Navigation
Ablation 
with 
magnetic 
catheter
Previous 
Ablations
Successful 
Ablation
Complications 
with epicardial 
mapping or 
ablation
1 21 WPW Yes Yes 3 Yes No
2 53 VT Yes No 0 Yes No
3 44 WPW Yes No 3 Yes No
4 19 VT Yes No 3 Yes No
5 49 WPW Yes Yes 3 Yes No
6 39 VT Yes No 2 Yes No
Noon
912-240	 Intra	-	Atrial	Conduction	Time	is	a	Major	Determinant	
of	Optimal	Atrio	-	Ventricular	Delay	in	Cardiac	
Resynchronization	Therapy
Thomas Wannenburg, Niuton S. Koide, William O. Ntim, David M. Fitzgerald, Wesley K. 
Haisty, Bryon E. Rubery, Kamron Y. Benfield, Tony W. Simmons, Wake Forest University 
Health Sciences, Winston - Salem, NC
Background: We hypothesized that intra - atrial conduction time was a major determinant 
of optimal AV delay in cardiac resynchronization therapy (CRT) and may serve as a 
surrogate for echocardiographic measurement.
Methods: We measured intra - atrial conduction time at the time of implantation of 18 CRT 
devices during sinus rhythm and during atrial pacing at 10 bpm above sinus rhythm. Intra - 
atrial conduction time was defined as the interval between the beginning of the P wave on the 
surface EKG and the earliest local atrial electrogram measured by a coronary sinus catheter 
advanced to the posterolateral mitral annulus. Optimal AV delay by echocardiography 
was determined by iterative measurement to maximize aortic time velocity integral and 
transmitral diastolic filling, and to minimize diastolic mitral regurgitation. 
Results:	Optimal AV delay correlated strongly with intra - atrial conduction time and was 
described by a linear relationship with a slope of 1.09 and an intercept of 10.6 ms (r = 0.676). 
When the slope was constrained to identity (as shown in the figure) the optimal AV delay was 
well approximated by the addition of 24ms to the measured intra - atrial conduction time.
Conclusions: Intra - atrial conduction time is an important determinant of optimal AV 
delay in CRT recipients. It is easily measured at the time of implant and measurement 
is not user - dependent. A simple formula whereby 24 ms is added to the intra - atrial 
conduction time will approximate echocardiographic optimization in most patients. 
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912-241	 Fragmented	QRS	Complexes	on	12-Lead	ECG	
Predicts	Arrhythmia	Events	in	Patient	With	Ischemic	
Cardiomyopathy
Waddah Maskoun, Mohamed Homsi, Joe Mahenthiran, Deepak Bhakta, Mithilesh K. 
Das, Krannert Institute of Cardiology, Indiana University, Indianapolis, IN
Background: We have previously shown that fragmented QRS (fQRS) without typical 
bundle branch block (BBB) is associated with myocardial scar. Myocardial scar is a risk 
factor for ventricular arrhythmia (VE) in patients with ICD. We postulate that fQRS on a 12-
lead ECG in patients (pts) with ischemic cardiomyopathy is associated with a significantly 
higher ICD therapy (shock or antitachycardia pacing) for VE than pts without fQRS.
Methods: Appropriate ICD therapy for VE and pre-implant ECGs of 110 pts with ischemic 
cardiomyopathy were studied. The fQRS was defined as various RSR patterns (rSr, 
rSR, RSr, notched R or S wave) in any two contiguous leads corresponding to a major 
coronary artery territory (figure). Pts with typical BBB were excluded (n=10).
Results: Of 100 pts (mean age: 65 ± 9 years, male: 94%, EF: 31% ± 13, median follow 
up: 32 ± 3 months), 46 pts had fQRS. 20 pts (44%) with fQRS received ICD therapy, while 
only 6 pts (11%) with no fQRS received ICD therapy (p < 0.001, RR = 5.1). fQRS was 
associated with significantly higher ICD therapy in both primary (n=30) and secondary 
indications (n=70) groups, when compared to non-fQRS group (p = 0.04 and p= 0.002 
respectively). Kaplan Meier survival analysis revealed a significantly decreased event-
free survival in fQRS group versus non-fQRS group (p <0.001). 
Conclusion: fQRS on a 12-lead ECG is a significant predictor of appropriate ICD therapy 
for VE. Presence of fQRS is associated with a significantly decreased time to first VE 
event as compared to absence of fQRS.
Noon
912-242	 Microvolt	T-Wave	Alternans	Does	Not	Predict	
Appropriate	Implantable	Defibrillator	Discharges	
or	Correlate	with	Traditional	Risk	Factors	for	
Sudden	Cardiac	Death	in	Patients	with	Hypertrophic	
Obstructive	Cardiomyopathy
Frank A. Cuoco, Byron J. Colley, III, William H. Spencer, III, Scott W. Burke, Salem N. 
Sayar, S. Luke Kusmirek, Christopher D. Nielsen, J. Lacy Sturdivant, Robert B. Leman, J. 
Marcus Wharton, Michael R. Gold, Medical University of South Carolina, Charleston, SC
Background: Microvolt T-wave alternans (TWA) is commonly used to assess arrhythmia 
vulnerability in diverse patient populations. However, the role of TWA to risk stratify for sudden 
death (SCD) among patients with hypertrophic cardiomyopathy (HCM) is unknown.
Methods: We evaluated 69 consecutive patients with HCM who underwent alcohol septal 
ablation and defibrillator (ICD) implantation for primary prevention of SCD based on traditional 
risk factors, including a family history of SCD, syncope, septal thickness ≥3cm, and abnormal 
blood pressure response during exercise. ICD shocks were classified blinded to TWA results.
Results: The mean age of the patients was 49 ± 14 years, 71% were male, and they had 
1.6 ± 0.9 risk factors for SCD. Positive, negative, and indeterminate TWA results were 
45%, 46%, and 9%, respectively. Eight appropriate ICD shocks were recorded over a 
mean follow up of 3.0 years (4 TWA negative, 4 TWA positive). Females had a greater 
proportion of negative TWA results (70% vs. 37%, p=.02). No significant relationships 
between TWA and incidence of appropriate ICD shocks or traditional risk factors were 
identified (see table). Kaplan-Meier analysis confirmed there was no significant difference 
between TWA-negative and non-negative patients for shock-free survival (p=0.75).
Conclusions: TWA does not predict appropriate ICD shocks or correlate with traditional risk factors 
for SCD in HCM, suggesting it has limited value for SCD risk stratification in this population.
Incidence of Appropriate ICD Shocks and SCD Risk Factors TWA 
Negative and Non-Negative Patients
Appropriate	
ICD	Shocks
Septal	
Thickness	
(cm)
Abnormal	BP	
Response Syncope
Family	
History	of	
SCD
TWA	
Negative 13% 2.15 44% 66% 38%
TWA	Non-
Negative 11% 2.26 48% 65% 43%
p-Value 1.00 0.35 0.79 1.00 0.80
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913-234	 A	Novel	KCNH2	Mutation	Associated	With	the	Short	QT	
Interval	of	Brugada	Syndrome:	Impaired	Deactivation	
for	the	IKr	channel
Hideki Itoh, Tomoko Sakaguchi, Wei-Guang Ding, Keiko Tsuji, Takashi Ashihara, Yuko 
Nakazawa, Hikari Jo, Takenori Yao, Makoto Ito, Hiroshi Matsuura, Minoru Horie, Shiga 
University of Medical Science, Otsu, Japan
Backgrounds:	 It has been reported that a mutation for KCNH2 can cause “gain of 
function” for IKr, which leads to the short QT syndrome characterized by sudden cardiac 
death and ventricular arrhythmia. However a KCNH2 mutation for Brugada syndrome 
with the short QT interval has been not reported.
Methods	and	Results:	A 34-year-old proband was admitted to the hospital because of 
analyses for the ECG abnormality. His electrocardiogram showed the Brugada-type ECG 
with coved-type ST-segment elevations in the right precordial leads (type 1), while the 
QT interval was interestingly shortened (QTc = 329 ms1/2). He had 2 family members with 
sudden death (50-year-old father and uncle). Though we could not detect any SCN5A 
mutations in this patient, molecular genetic studies revealed a novel mutation for KCNH2, 
which causes substitution of histidine for arginine (R1135H) in the end of the C-terminal. 
Though a 30-year-old brother was a mutation carrier, he had neither ST-segment 
elevation nor short QT interval. Voltage clamp experiments on CHO cells demonstrated 
that the mutant channels had impaired deactivation, which could cause gain of function 
for IKr and lead to shorten the QT interval. The other kinetics of mutant channels including 
the activation or inactivation states was similar to the wild-type channels.
Conclusions:	 We detected a novel missense mutation for KCNH2 in a Brugada 
syndrome with the short QT interval. This mutant causes the impaired deactivation for the 
IKr channel and could be strongly associated with life-threatening arrhythmia in Brugada 
syndrome with the short QT interval.
1:00 p.m.
913-237	 Atrial	Fibrillation	Is	a	Strong	Predictor	of	Death	and	of	
Cardiac	Events	in	Angiographied	Coronary	Patients
Thomas Marte, Christoph H. Saely, Schmid Fabian, Koch Lorena, Philipp Rein, Stefan 
Aczel, Peter Langer, Heinz Drexel, VIVIT Institute, Feldkirch, Austria, Academic 
Teaching Hospital Feldkirch, Feldkirch, Austria
Background:	No data on the prognostic impact of atrial fibrillation in angiographied 
coronary patients are available.
Methods:	 In a consecutive series of 622 patients (418 men and 204 women) who 
underwent coronary angiography for the evaluation of established or suspected stable 
coronary artery disease we evaluated electrocardiograms according to the Minnesota 
Code. Prospectively, all-cause mortality, cardiac death (including fatal myocardial 
infarction, sudden cardiac death, and death from congestive heart failure due to coronary 
artery disease) and major coronary events (including death due to coronary heart disease 
and non fatal myocardial infarction) were recorded over 4 years.
Results:	From our patients, 37 (5.9%) at baseline had atrial fibrillation, 576 (92.7%) 
exhibited sinus rhythm, and 4 (0.6%) had persistant supraventricular rhythms, and 5 
(0.8%) pacemaker rhythms. Presence of atrial fibrillation was associated with a lower 
prevalence of significant coronary stenoses with narrowing of at least ≥50% at the 
baseline angiography (adjusted odds ratio = 0.121 [95% CI 0.051-0.289], p<0.001). 
Prospectively, however, patients with atrial fibrillation were at a strongly increased risk of 
all-cause mortality (adjusted hazard ratio (HR) = 4.529 [2.070-9.911], p<0.001), cardiac 
death (HR =7.239 [2.569-20.399], p<0.001), and major coronary events (HR = 4.529 
[2.070-9.911], p<0.001).
Conclusions: Atrial fibrillation is inversely associated with the presence of angiographically 
diagnosed coronary artery disease, but is a strong predictor of death and cardiac events 
in angiographied coronary patients.
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913-238	 Midterm	Follow-up	of	Cryoballoon	Technique	in	Drug	
Resistant	Atrial	Fibrillation
Juergen Vogt, Anja Dorszewski, Johannes Heintze, Ursula Scholz, Helga Buschler, Lam 
Luong Thanh, Dieter Horstkotte, Department of Cardiology, Heart and Diabetes Center 
North Rhine-Westphalia, Ruhr University Bochum, Bad Oeynhausen, Germany
Background: In the treatment of paroxysmal atrial fibrillation (af) cryo energy is safe in 
comparison to radiofrequency energy to isolate the pulmonary veins (pv). Segmental 
isolation with both energies showed a high reconduction rate. The new cryoballoon 
ablates the pv ostium and parts of the antrum, i.e. the source of triggers and rotors in 
perpetuating af. This study reports on midterm follow-up of this new balloon technique 
with cryoenergy.
Methods: After pv angiography, isolation of all pv ostia was performed with a 28/23mm 
balloon (Arctic Front, Cryocath, Canada). With inflation the over a wire balloon occludes 
the venous ostium/antrum and freezes down to -50 to - 70 °C 6 minutes two times per 
vein with nitrous oxide. Lasso mapped rest potentials were eliminated with additional 
balloon freezes or under Lasso guidance with the 9 French Freezor Max catheter.
Results: We treated 69 patients (p) failed with class 2/1/3 drugs (19 women, mean age 
59±11 years, 61 with paroxysmal, 8 persistent af, left atrium 42±4 mm, 29 with lone af, 
26 hypertension, 14 mild structural heart disease). Mean vein diameter was 18.8±4 mm 
angiographically. With a mean number of 2.4±0.7 impulses, we could isolate 78% of the 
left pv, 77 % of the right upper and 65 % of the right lower pv with balloon only. After touch 
up of rest potentials, we isolated 100 % of all pv. Efficacy of isolation could be found 
higher with the 23 mm balloon than with the 28 mm balloon (13% necessity of touch up 
versus 34% of treated pv). The procedure time was reduced to 200±39 min, the X-ray 
burden to 35±9 min. We observed acute phrenic nerve palsy in three p with the 23 mm 
balloon. During a mid-term follow-up of 6 months, 35 (73%) of 48 p (including 6 redos) 
had no af recurrence controlled with 7-day Holter. 10 of 13 p with recurrence showed a 
marked reduction of af burden. We used no blanking time in our p.
Conclusions: The new cryoballoon technique is highly effective acutely and during follow-
up. The advantage in comparison with other innovative tools is the high cooling power, 
isolation of parts of venous antrum and a high percentage of stand alone pv isolation. 
Palsy of phrenic nerve has to be avoided due to pacing and breathing techniques and 
choice of a larger balloon.
1:00 p.m.
913-239	 Increased	Inducibility	of	Ventricular	Tachyarrhythmias	at	
the	Right	Ventricular	Outflow	Tract	in	Brugada	Syndrome.
Bertrand Pierre, Dominique Babuty, Pierre Cosnay, Cedric Giraudeau, Guillaume 
Breard, Laurent Fauchier, Centre Hospitalier Universitaire Trousseau, Tours, France
Background	: In patients with Brugada syndrome (BS), there are still controversies about 
mechanism of ventricular arrhythmia and about the prognostic value of programmed 
ventricular stimulation (PVS). Reports on the inducibility of ventricular tachyarrhythmias 
(VT) are based on studies that used different stimulation protocols limited to right 
ventricular (RV) apex. Electrical heterogeneity of the epicardium in the right ventricular 
outflow tract (RVOT) has been thought to be related to the Brugada syndrome. We 
reviewed the inducibility of VT in these patients using a uniform protocol at 2 different 
sites of right ventricle including RVOT.
Methods	:	In 67 consecutive patients (M=59, age=42±15) with ECG showing BS pattern and 
structurally normal hearts, PVS was performed in the RV apex with up to 3 extrastimuli at 3 
different cycle lengths (600, 500 and 430 ms) until 190 ms or reproducible induction of a sustained 
(>30 s) VT occurred. If a VT was not induced, the same protocol was repeated in the RVOT. The 
chronology of the protocol leaded us to assume that uniformity for both sites was associated with 
inducibility at RV apex close to 66% and inducibility at RVOT close to 33 % (hazard repartition 
between inducibility 1) at both sites 2) at RV apex only and 3) at RVOT only)
Results	:	Type 1 BS was spontaneous in 33/67 cases (49%) and provoked (drug induced) 
in the remaining 34 cases. Syncope or presyncope was present in 31/67 cases (46%). 
Late ventricular potentials were present in 33/55 patients (60%). In 22/67 patients with 
inducible VT, 14/22 (64%) were induced at RVOT whereas previous stimulation at RV 
apex was negative (95% CI 0.44-0.84, p=0.0026). Only one patient (inducible at RVOT) 
had VT during a follow-up of 34 months.
Conclusions	 : Patients with BS significantly had higher inducibility at RVOT than 
at RV apex during PVS. This may be one further explanation to the discrepancies of 
the prognostic value of PVS in BS. The underlying electrophysiological process of this 
characteristic might be of interest for the understanding of the disease. At last, the 
prognostic value of inducibility at RV apex and at RVOT should be compared in the future 
for a possible improvement of the risk stratification using PVS in BS.
1:00 p.m.
913-240	 A	Common	Limb	Involved	In	Bi-atrial	Mechanics:	
Insights	From	3D	Motion	Tracking
Raveen R. Bazaz, Yoshiya Toyoda, Pramod Bonde, Alan M. Walczak, Kenneth R. 
Hoffmann, University of Pittsburgh, Pitsburgh, PA, University at Buffalo, Buffalo, NY
Background: An understanding of the mechanics involved in atrial contraction and inter-
atrial interactions can develop targeted therapies towards atrial dysrhythmias. We sought 
to gain insights into function of the atria by 3D tracking of surgically implanted markers.
Methods: Precise surgical placement of markers was achieved in 17 adult male pigs 
under cardiopulmonary bypass. The location of markers included A: junction of a right 
pectinate and annulus; B: Junction of a left pectinate and annulus; C: crista terminalis; D: 
Left atrial crest; E; proximal Bachmann’s bundle; X: central fibrous body (CFB). Imaging 
was achieved by biplane fluoroscopy at 30 fps. The image sequences were displayed in 
an interface and the center-points of each marker manually indicated. Imaging geometry 
given by the gantry was refined with the enhanced Metz-Fencil technique. The 3D position 
of each marker at each time point was calculated using the calculated geometry and the 
indicated 2D points. Motion of the 3D points relative to other markers was determined.
Results: Data analyses revealed a dominant dynamic directionality of registered points 
towards a central point or plane. All markers were noted to get spatially closer to each other 
as well as the CFB with atrial contraction. A representative sample is shown in Fig A.
Conclusions: The results suggest a common limb involved in bi-atrial mechanics. 
Implications include directing optimal pacing therapies and locations of ablative lesions 
for atrial arrhythmia surgery 
1:00 p.m.
913-241	 Utility	of	Lead	and	Generator	Cultures	in	Managing	
Cardiac	Device	Infections
Bridget L. O’Brien, Rachel Knipe, Susan S. Kim, Eric Kessler, Kiam K. Lim, Bradley P. 
Knight, John Beshai, Michael J.D. Roberts, Deborah Moyer, Martin C. Burke, University 
of Chicago, Chicago, IL
Background: The majority of implanted cardiac device system infections requiring total 
extraction are caused by common skin flora. We investigated the utility of culturing the hardware 
removed during cardiac device infection extractions in order to tailor best antibiotic treatment.
Methods: A cardiac device infection/extraction database (n=102; mean age = 65±17 
years, range 8-92 years; 76 males) was used to compare the culture results. The 
presenting infections were separated into persistent bacteremia, pocket related or both. 
In each case, patients had blood, tissue and/or wound drainage specimens sent for 
culture. 33/102 (32%) had their successfully extracted leads sterilely packed and sent 
for culture and sensitivity testing, while 15/33 (45%) had the pulse generator also sent 
for the same testing. This culture data (n=33) was separated and compared by three 
compartments including: blood, pocket and hardware.
Results: In	2/33 (6%) patients all samples cultured were negative. Of the 31 patients with 
positive cultures, 18 (58%) had the same organism cultured in the affected compartments, 
while 12 (39%) had a different or polymicrobial culture from the hardware sample compared to 
the blood or pocket samples. Only one (3%) hardware culture was negative where the affected 
pocket culture was positive. Culturing the extracted hardware increased a microorganism 
yield by 15%. In addition to a more positive culture yield, 7/31 (23%) hardware cultures 
grew antibiotic resistant organisms not previously identified from the presenting infection 
compartment. Antibiotic resistant microorganisms were present in 20/31 (65%) cases.
Conclusions: This data suggests that sending extracted hardware for culture should be 
considered post extraction to ensure greater microbiologic yield and adequate antibiotic 
treatment. Cardiac device infections are increasingly polymicrobial and more frequently 
with antibiotic resistant microorganisms.
1:00 p.m.
913-242	 The	Characteristic	Vectorcardiographic	Changes	in	
Patients	with	Brugada	Syndrome
Andrés R. Pérez Riera, Edgardo Schapachnik, Sergio Dubner, Li Zhang, For international 
Brugada syndrome investigators, School of Medicine, ABC Santo André Foundation, São 
Paulo, Brazil, LDS Hospital, University of Utah School of Medicine, Salt Lake City, UT
Background: Patients with Brugada syndrome (BrS) are susceptible to ventricular fibrillation 
and sudden cardiac death (SCD). The clinical diagnosis is largely based on the 12-lead ECG 
changes. However, the BrS ECG pattern is often mis-identified as the simple right bundle branch 
block (RBBB) by inexperienced ECG readers. The purpose of this study was to investigate 
vectorcardiographic (VCG) changes in BrS patients with a history of syncope and aborted SCD.
Methods: The Frank system vectorcardiogram was performed on 8 symptomatic male BrS 
patients (Age 39±8.6 yrs, 6 Asian, 1 Caucasian and 1 mulatto) with coved type ST elevation 
and T wave inversion, namely the type-1 BrS ECG pattern. The orientation and morphology of 
QRS and T loops were analyzed for frontal and horizontal planes (FP and HP), respectively.
Results: 1. The right end conduction delay (RECD) defined as 15 or more dashes very 
close to each other was present in all subjects. In those BrS cases RECD is located in 
the right superior quadrant in FP, and right posterior quadrant in HP, which corresponds 
to the right ventricle outflow tract (RVOT).
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2. None of the BrS cases showed typical RBBB VCG patterns, such as glove finger, 
located in the right anterior quadrant of truncus or the pre-divisional region.
3. In all cases the initial QRS vector from 10 to 20 ms was heading left and downward. 
And the vector of the 40 to 60 ms shifted rapidly from left to right in both FP and HP.
4. The T loop was rounded in the 3 cases with intermittent type 1 BrS ECG pattern.
Conclusions: Differed from simple RBBB, the right end conduction delay identified in 
Brugada syndrome patients with coved ST elevation is a disease-specific VCG presentation. 
Therefore, VCG evaluation can increase the diagnostic accuracy. Our findings suggest that 
the RVOT regional delay of both depolarization and repolarization may have contributed the 
characteristic QRS-ST-T pattern on V1 and V2 in Brugada syndrome.
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914-237	 Mechanisms	of	Recurrent	Atrial	Fibrillation	After	Left	
Atrial	Radiofrequency	Ablation	Guided	By	Complex	
Electrograms
Thomas C. Crawford, Aman Chugh, Eric Good, Al Wimmer, Sujoya Dey, Krit Jongnarangsin, 
Frank Pelosi, Jr., Frank Bogun, Fred Morady, Hakan Oral, University of Michigan, Ann Arbor, MI
Background: The mechanisms of recurrent atrial fibrillation (AF) after electrogram-
guided ablation (EGA) that only targets complex electrograms characterized by a short 
cycle length and/or continuous electrical activity have not been described.
Methods: A repeat ablation was performed in 36 patients (59±8 years old) for recurrent 
paroxysmal (20) or chronic AF (16) 10±4 months after EGA. During the initial EGA complex 
electrograms were targeted using a focal approach without creating a predetermined set of 
lesions or isolating the pulmonary veins (PVs). During repeat ablation, all PVs and superior vena 
cava (SVC) were mapped with a circular catheter in addition to the left atrium (LA) and right 
atrium (RA) during spontaneous (22) or induced episode of AF (14). Ablation was performed to 
eliminate all drivers of AF until AF became noniducible or all mappable targets were ablated.
Results:	Among the 36 patients, there was ≥1 driver tachycardia in ≥1 PVs in 17/20 (85%) 
patients with paroxysmal and 13/16 (81%) with chronic AF (P=0.09), specifically within the left 
superior PV (21), left inferior PV (19), right superior PV (19), and right inferior PV (20). In 15 
patients only PV drivers were found. The mean cycle length of the PV driver tachycardias was 
151±28 ms when the cycle length in the coronary sinus was 191±32 ms (P<0.001). Additional 
drivers were found in the SVC in 3, LA in 11, RA in 7, coronary sinus in 3, crista terminalis 
in 1, and left atrial appendage in 1. During application of RF energy AF converted to sinus 
rhythm in 12 patients and AF converted to atrial flutter (AFL) in 4. Four patients had immediate 
recurrence of AF (IRAF). In 20 patients AF became non-inducible. Left AFLs utilizing mitral 
isthmus (13), LA roof (9), and elsewhere in the left atrium (6) were also targeted in 25 patients. 
AFL had developed or converted from AF after the initial ablation procedure in 18 patients or 
was inducible during the repeat procedure in 22 patients. At a mean follow-up of 7±1 months 
66% of the patients were free form recurrent AF or atrial flutter.
Conclusions: Recurrence of AF after EGA is usually due to residual PV tachycardias. All PVs 
should be mapped during the initial procedure and potential PV drivers should be ablated.
2:00 p.m.
914-238	 Unique	Electrophysiological	Characteristics	of	“Irregular”	
Atypical	Atrioventricular	Nodal	Reentrant	Tachycardia
Kiyoshi Otomo, Keita Handa, Tadafumi Nanbu, Yasutoshi Nagata, Kikuya Uno, Yoshito Iesaka, 
Division of Cardiology, Cardiovascular Center, Tsuchiura Kyodo Hospital, Tsuchiura, Japan
Background Atrioventricular (AV) nodal reentrant tachycardia (AVNRT) usually shows a 
constant 1:1 AV relationship. Atypical AVNRT has been reported to sometimes exhibit transient 
variations in AV relationship during tachycardia; however, the incidence and electrophysiological 
characteristics of atypical AVNRT exhibiting variable AV relationships have not been fully 
elucidated. This study was performed to assess the incidence and electrophysiological 
characteristics of atypical AVNRT with variable AV relationship.
Methods	The electrophysiological and ablation data were reviewed in consecutive 53 patients 
(pts) who underwent catheter ablation for atypical AVNRT.
Results Among 67 atypical AVNRTs induced in 53 pts, 8 AVNRTs (12%) induced in 8 pts (15%) 
exhibited persistent episodes of continuous and simultaneous variations in the A-H, H-A, A-A 
and H-H intervals (variations: 139±82, 185±132, 94±80, and 232±104 msec, respectively) and 
Wenckebach A-H block during uninterrupted tachycardia without a change in the retrograde 
atrial activation sequence (“irregular	AVNRT”), while the other 59 AVNRTs (88%) induced in 
45 pts presented a constant AV relationship (“regular	AVNRT”: slow-slow/fast-slow=28/31). 
The tachycardia cycle length was significantly shorter (312±74 versus 380±102 msec; p=0.037) 
and pts’ mean age was significantly younger in irregular AVNRT than in regular AVNRT (35±15 
versus 47±16 years; p=0.024). Radiofrequency ablation (4±3 times) to the earliest retrograde 
atrial activation site (proximal coronary sinus/left inferoseptum/right inferoseptum=4/1/3 patients) 
eliminated the retrograde slow pathway conduction in 7 pts (88%) and rendered the tachycardia 
non-inducible in all 8 pts (100%).
Conclusion The variations in the AV relationship during irregular AVNRT would be attributable 
to the short tachycardia cycle length that gave rise to unstable conduction in the reentrant circuit 
and Wenckebach block in the lower common pathway. The left-sided ablation was required to 
eliminate tachycardia inducibility in about 2/3 of the pts, suggesting that the participation of the 
leftward AV nodal pathway is common in this entity.
2:00 p.m.
914-239	 Is	the	Heart	Close	Enough	to	the	Skin	Surface	of	the	
Chest	Wall	to	Allow	a	Taser®	to	Potentially	Cause	
Ventricular	Fibrillation?
Peter S. Rahko, University of Wisconsin Shool of Medicine and Public Health, Madison, WI
Background: Electromuscular disabling devices (EMDs) deliver high current, short 
duration pulses that cause temporary strong muscle contraction. Current devices fire a 
dart 9 mm long. In our most recent study of swine (weight 53-69 kg), a dart tip as far as 8 
mm from the epicardial surface caused ventricular fibrillation (VF). Adding dart length of 9 
mm, a heart up to 17 mm below the skin might receive enough current to cause VF.
Methods: To estimate distance from epicardial surface to chest wall we performed 2-D 
echocardiograms in 150 consecutive adults. While standing, 10 beats of images were 
acquired in parasternal and apical positions. Images were analyzed to determine the 
shortest linear distance from sector origin (skin surface) to epicardial surface.
Results: Average age was 54±13 years, height 171±10 cm, weight 80±19 kg and body 
mass index (BMI) 27.6±6.4, and 71 were men. In the parasternal view, average skin to 
heart distance was 32.1±7.9 mm (range 12.3-58.4 mm); in the apical view 31.3±11.3 mm 
(range 10.4-75.7 mm). Skin-to-heart distance and BMI were correlated: apical r=0.55 and 
parasternal r=0.57 (p<0.0001). In the table, skin-to-heart distances are grouped by BMI. 
BMI range ≤20 20.1-24.9 25-29.9 >30
Apex skin to heart (mm)* 18.8±6.3 25.7±6.4 32.3±10 39.9±11.7
Range (mm) 10.4-31.8 15.6-50 12.7-75.7 19.0-71.9
Parasternal skin to heart (mm)* 22.6±5.6 27.9±59 32.4±5.8 39.1±7.5
Range (mm) 12.3-34.2 18.4-41.4 18.7-45.2 27.4-58.4
Weight (kg)* 52±7 67±9 83±15 102±16
n≤17mm/n in BMI group 5/10 3/47 1/53 0/40
(Data mean ± std. dev.) *=p<0.00001 by ANOVA
Conclusion: In these adults, skin-to-heart distance falls within a distance that could 
cause VF in 9/150 (6%), if the dart penetrates soft tissue. Skin-to-heart distance is highly 
related to body habitus. To minimize the potential for VF, users of EMDs should avoid 
direct aim at the heart, particularly in individuals with a low BMI.
2:00 p.m.
914-240	 Influence	of	Cardiac	Resynchronization	Therapy	
on	the	Prognostic	Power	of	NT-BNP	in	Patients	
with	Heart	Failure	Charactersised	by	Cardiac	
Dyssynchrony:	A	Substudy	of	the	CARE-HF	Trial
Rudolf Berger, Fruhwald Friedrich, Fahrleitner Astrid, Tavazzi Luici, Freemantle Nick, 
Cleland G.F. John, Pacher Richard, Medical University of Vienna, Vienna, Austria, 
University of Hull, Kingston upon Hull, United Kingdom
Background: In the Cardiac Resynchronization in Heart Failure (CARE-HF) study cardiac 
resynchronization therapy (CRT) reduced morbidity and mortality in patients with chronic heart 
failure and markers of cardiac dyssynchrony. Recently, NT-BNP has emerged as new gold 
standard for the prognostic evaluation of heart failure patients. We evaluated the influence of 
cardiac resynchronization therapy on the prognostic power of NT-proBNP in CARE-HF.
Methods: A total of 813 heart failure patients were enrolled and followed for a mean 
of 37.4 months. Using multivariate analyses, the ability of baseline clinical variables 
including NT-proBNP to predict various clinical outcomes in patients assigned either to 
CRT or the control group was investigated.
Results: NT-BNP predicted all-cause mortality (p<0.0001), sudden death (p=0.0025) 
and death from pump failure (<0.0001). Stratifying patients according to the median NT-
proBNP and to CRT treatment-allocation, all-cause mortality was 12% if <median+CRT, 
21% if <median+control-group, 30% if ≥median+CRT, and 41% if ≥median+control-group. 
In a simple multivariate model including NT-proBNP, CRT treatment and an interaction 
term (NT-proBNP*CRT), NT-proBNP retained its prognostic power for all-cause mortality, 
sudden death, and death from pump failure (interaction term n.s.). Patients with below 
median NT-proBNP had similar absolute and somewhat greater relative reduction in 
mortality compared to those with above levels.
Conclusions: This substudy demonstrated that NT-proBNP retains its prognostic value 
in heart failure patients independent of treatment with CRT-treatment; individuals with 
high NT-BNP at baseline show poorer outcomes, irrespective of the treatment group. It is 
possible that patients with less advanced heart failure have as great or greater modifiable 
risk as those with more severe heart failure.
2:00 p.m.
914-241	 Single	Center	Experience	with	Complications	Due	to	
Two	Manufacturers’	Recent	Device	Advisories
Michael S. Goldstein, Erica Zado, Joshua M. Cooper, Andrea M. Russo, David Lin, 
Edward P. Gerstenfeld, Sanjay Dixit, David J. Callans, Francis E. Marchlinski, Ralph J. 
Verdino, University of Pennsylvania, Philadelphia, PA
Background: Manufacturer recalls have plagued the field of implantable cardiac rhythm 
management devices over the past two years. Medtronic issued an advisory regarding 
their Marquis ICD and CRT-D devices in February 2005. Guidant reported 10 advisories 
for potential failures of 26 models of ICD, CRT-D, and PPM devices from 6/2005 to 6/2006. 
We have previously reported our experience with the Medtronic advisory, replacing 51 
of 173 followed devices (29%) with a complication rate of 11.8% (4% requiring device 
revision). Guidant advisories encompassed devices with a wider range of implantation 
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dates, different reported incidences of failure, and different suggestions for remedy. We 
sought to review our experience with the Guidant advisory, and to determine if experience 
gained from the Medtronic advisory influenced practice patterns and clinical outcomes of 
patients in our group of twelve electrophysiologists
Methods: Advisory devices were replaced in patients who were pacemaker dependent, 
had ICDs implanted for secondary prevention, had received prior appropriate ICD therapy, 
or preferred generator replacement (GR) after risk counseling. Chart reviews and follow 
up data on this cohort were compiled.
Results: At our institution 644 affected Guidant devices were implanted and 456 were 
followed in our practice. Thirty-two (7%) of the 456 patients underwent GR. We identified 
four pts (12.5%) who experienced procedural complications: 2 pocket hematomas (one 
requiring an inpatient stay for re-anticoagulation), one LV lead dislodgement into the main 
coronary sinus requiring subsequent lead revision, and a pocket infection requiring device 
explantation. Device revision was required in 2/32 pts (6.3%). For patients who have not 
undergone GR, no untoward events have been noted secondary to device malfunction.
Conclusions: Complications associated with GR remain consistent across different 
advisories; however a smaller percentage of patients underwent GR with the most recent 
series of advisories. Based on our findings, the risks of GR favor a conservative approach.
2:00 p.m.
914-242	 Tako-tsubo	Syndrome	And	Acute	Coronary	Syndrome:	
Are	They	Really	Different	Entities?	ECG	Analysis
Antonio Pinero, Borja Ibanez, Felipe Navarro, Pedro Marcos-Alberca, Miguel Orejas, 
Juan Benezet.Mazuecos, Jose Manuel Rubio, Jeronimo Farre, Funfacion Jimenez Diaz-
Capio, Madrid, Spain, Mount Sinai School of Medicine, New York, NY
Tako-tsubo sindrome (TSS) ECG has been said to be similar to that of anterior wall MI, 
however coronary arteries in TSS show no narrowing. The etiology is still unknown. Recently, 
based on the presence of ruptured atherosclerotic plaques on LAD IVUS examination, it 
was postulated that TSS could be an anterior MI with early spontaneous reperfusion.
To test this hypothesis, we compared the ECG of 20 TSS patients (Pts) with that of 40 
consecutive anterior wall MI Pts (20 with spontaneous reperfusion (spont rep): TIMI 3 on initial 
angiography , and 20 with instrumental reperfusion (instr rep): LAD occluded on angiography)
RESULTS	Admission ECG showed pathological Q waves in 45% of TSS, 22% in spont rep 
and 65% in the instr rep, disappearing in a 90%, 50%, and 8% respectively. The ST was 
elevated in 85%, 50%, and 100%.
The ECG evolved to negative T waves in 90% of the Pts in all 3 groups. However on days 2, 
and 3 the T waves were deeper in Pts with TSS and spont rep (the sum of the T waves voltage 
is shown on left picture). QT interval was longer in TSS and spont rep (right picture).
Differences were statistically significant only between TSS and instr rep Pts (both for T 
waves voltage [p=0.02], and for QT interval [p<0.05])
CONCLUSIONS	 ECG of tako-tsubo syndrome is very similar to that of anterior 
AMI Pts with spontaneous reperfusion (high rate of Q wave disappearance, deeper 
negative T waves, and longer QT interval). This support the hypothesis that tako-
tsubo syndrome could be a form of anterior wall AMI with early spontaneous
reperfusion of LAD
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915-234	 Human	Ventricular	Scar	Derived	Fibroblasts	Conduct	
Electrical	Current	Over	Short	Distances;	An	In	Vitro	
Study	of	Functional	Cell-Cell	Coupling	Revealing	Slow	
Conduction	and	Block.
Daniël A. Pijnappels, Martin J. Schalij, Dirk L. Ypey, Arti A. Ramkisoensing, John van 
Tuyn, Twan A. de Vries, Robert J. Klautz, Ernst E. van der Wall, Arnoud van der Laarse, 
Douwe E. Atsma, Department of Cardiology, Leiden University Medical Center, Leiden, 
The Netherlands, Department of Thoractic Surgery, Leiden University Medical Center, 
Leiden, The Netherlands
Background: Scar formation after myocardial infarction is associated with slow 
conduction and conduction block, and increased risk of arrhythmias. Decreased electrical 
coupling is difficult to assess at cell-cell level in vivo. Therefore we developed an in vitro 
model to study the electrical conduction capacity of human ventricular scar fibroblasts 
(hVSFs) over increasing distances.
Methods:	Neonatal rat cardiomyocytes (CMCs) were cultured in multi-electrode mapping 
arrays (60 electrodes), resulting in a spontaneously and synchronously beating monolayer. 
After 2 days, a central conduction block was created by abrasion of a channel either 250-
300 or 300-350 μm wide, dividing the monolayer in two asynchronously beating CMC 
syncytia. Then, either 50x103 DiI-labeled hVSFs, 50x103 DiI-labeled CMCs or no cells 
(control), were applied in the channel. Immunostaining was performed for Connexin40 
(Cx40), Cx43, Cx45, and for SCN5A, encoding for fast sodium ion channels involved in 
excitability. Intracellular measurements were performed to determine excitability.
Results:	After 24 h, electrical conduction between the two CMC syncytia was restored 
by hVSFs only in channels <300 μm (240±20μm, n=6), with a conduction velocity (CV) 
οf 1.1±0.5 cm/s across the hVSFs. In contrast, no restoration occurred in channels >300 
μm (320±25 μm, n=6, p<0.01), associated with persistent asynchronously beating CMC 
syncytia. Electrical conduction was restored after application of CMCs, measuring a CV 
of 15.8±1.2 cm/s, which is comparable to CV across syncytia of CMCs. Immunostaining 
was positive for Cx43 and Cx45 between adjacent hVSFs and CMCs, Cx40 staining 
was rarely observed. SCN5A staining was highly expressed in CMCs, only very sparse 
in hVSFs. No hSVFs were found to be excitable (n=7), in contrast to CMCs (n=12, 
p<0.01).
Conclusions: Human ventricular scar derived fibroblasts have limited conduction 
capacities, resulting in slow conduction or conduction block between two syncytia of 
cardiomyocytes. This typical electrotonic interaction of hVSFs results from functional gap 
junctions and lack of excitability. This model can provide insights in genesis of arrhythmias 
from a cellular point of view.
3:00 p.m.
915-237	 Role	of	Multimodality	Imaging	in	the	Evalution	of	
Patients	Undergoing	Pulmonary	Vein	Antral	Isolation	
for	Atrial	Fibrillation	-	the	ROTEA	Study.
Margaret Park, Ronan J. Curtin, Boris S. Lowe, Hean Y. Ong, Gardar Sigurdsson, 
Susan E. Jasper, Sri Sola, Wael A. Jaber, Paul Schoenhagen, Andrea Natale, Allan L. 
Klein, Cleveland Clinic, Cleveland, OH
Background: Multimodality cardiac imaging is needed for procedural planning and 
detection of complications in patients undergoing pulmonary vein antral isolation 
(PVAI) for atrial fibrillation. We are prospectively studying the potential roles of multi-
detector row computed tomography (MDCT), transesophageal (TEE), and intracardiac 
(ICE) echocardiography in patients undergoing PVAI in the Role Of Transesophageal 
Echocardiography in Atrial fibrillation (ROTEA) study.
Methods: Patients enrolled in the study underwent TEE and MDCT before and 3 months 
after PVAI. ICE was used peri-procedurally. MDCT was used to characterize PV anatomy, 
and measure pulmonary vein size. TEE and ICE measured PV velocities by pulsed wave 
Doppler. Evidence of hemodynamically significant pulmonary vein stenosis on TEE 
at 3 months was defined as pulmonary vein inflow velocities > 1 m/s with evidence of 
turbulence and reduced flow variation.
Results: To date 27 patients (mean age 55 yrs, 26 male) have enrolled in the study 
and 16 have completed 3 month follow-up post PVAI. There was possible left atrial 
appendage thrombus in 5 patients by MDCT, which was confirmed by TEE in 1 case. 
MDCT demonstrated the pulmonary veins in all cases and identified abnormal PV 
anatomy in 12 patients. TEE identified 2 left and 2 right pulmonary veins in all cases 
and recognized 5 of 5 separate right middle pulmonary veins. Doppler interrogation by 
TEE was successful in 165 of 172 (96%) pulmonary veins. All 27 patients had normal PV 
velocities (< 1 m/s) by TEE prior to PVAI. 1 patient had a large interatrial hematoma near 
the orifice of the right inferior PV on post ICE interrogation. No patient had > 50% PV 
stenosis on MDCT at 3 months. However, 3 patients developed mild (20-45%) stenoses 
in 4 pulmonary veins. Evidence of hemodynamically significant stenosis was seen in only 
one of the 4 pulmonary veins by TEE at 3 months (30% stenosis by MDCT).
Conclusions: Preliminary results from the ROTEA study suggest that MDCT is the 
gold standard for the assessment of pulmonary vein anatomy and stenosis in patients 
undergoing PVAI. ICE and TEE can play a complimentary role in the evaluation of 
pulmonary vein anatomy and functional evaluation of pulmonary vein stenosis.
3:00 p.m.
915-238	 Three-Month	Cumulative	Incidence	of	
Thromboembolism	and	Bleeding	After	Periprocedural	
Anticoagulation	Management	of	Non-Valvular	Atrial	
Fibrillation	Patients:	A	Single	Center	Retrospective	
Cohort	Study.
Waldemar E. Wysokinski, Robert D. McBane, II, Paul R. Daniels, Scott C. Litin, Ryan A. 
Meverden, David Hodge, John A. Heit, Mayo Clinic, Rochester, MN
Background: Patients with non-valvular atrial fibrillation (AF) often require temporary 
interruption of warfarin for an invasive procedure. There are few data regarding 
the incidence of thromboembolism (TE) and bleeding related to peri-procedural 
anticoagulation management of such patients, especially with low molecular weight 
heparin (LMWH) bridging therapy.
Methods: In a retrospective cohort study (1997-2003), the 3-month cumulative incidence 
of TE and bleeding was assessed for all AF patients referred for periprocedural 
anticoagulation management. Warfarin was stopped 4-5 days prior to the procedure. 
Decisions to bridge with LMWH were individualized based on the estimated risks of TE 
and bleeding. All events were centrally adjudicated.
Results: Among 391 patients (mean age 74±9.5; 33% women) with AF (79 paroxysmal), 
31% had prior stroke/TIA. While patients with prior stroke/TIA were more likely to receive 
bridging LMWH (p=0.02), the stroke risk (as assessed by CHADS-2 score) did not 
differ significantly for patients receiving (2.2±1.4) vs. not receiving (2.0±1.4) LMWH . 
The 3-month cumulative incidence rates of TE and bleeding were low and did not differ 
significantly by management type (Table). One death related to major bleeding occurred 
in the LMWH group.
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Conclusions: The 3 month event rate was low. Although TE rates did not differ by 
management strategy, bleeding was twice as common in the LMWH group. These 
findings question the need for periprocedural bridging LMWH therapy in AF patients.
COMPLICATIONS No LMW-H LMW-H
N 217 174
Cerebral Ischemia 1 (0.5%) 2 (1.2%)
Myocardial Infarction 2 (1.0%) 1 (0.6%)
Major Bleeding 3 (1.5%) 6 (3.6%)
Minor Bleeding 5 (2.4%) 10 (6.0%)
3:00 p.m.
915-239	 Hibernating	Myocardium	Leads	to	an	Upregulation	
in	Nerve	Growth	Factor	and	Partial	Subendocardial	
Sympathetic	Denervation
Vladislav Ovchinnikov, John M. Canty, Jr., James A. Fallavollita, University at Buffalo, 
Buffalo, NY, VA WNY Health Care System, Buffalo, NY
Background:	 Inhomogeneity in sympathetic innervation is a substrate for sudden death 
(SD). This also occurs in hibernating myocardium but the extent of denervation and the role 
of nerve growth factor (NGF) as a potential mediator of nerve sprouting are unknown.
Methods/Results: Pigs chronically instrumented with an LAD stenosis developed 
hibernating myocardium characterized by regional dysfunction (wall thickening, 2.5 ± 0.2 
vs. 6.0 ± 0.4 mm in remote myocardium, p<0.01) with reduced subendocardial flow (0.90 ± 
0.07 vs. 1.12 ± 0.06 in remote ml/min/g, p=0.05) without infarction. Subendocardial samples 
obtained at elective termination or immediately after spontaneous VT/VF and SD, were 
compared to shams. By immunohistochemistry, sympathetic nerve density was moderately 
reduced. Partial denervation was confirmed by a 42% reduction in tyrosine hydroxylase 
(TH) and a 38% reduction in tissue norepinephrine. In contrast, NGF was regionally 
increased (Table). While these changes were confined to hibernating myocardium, there 
were no quantitative differences in animals that developed spontaneous SD.
Conclusion:	 In contrast to denervation associated with infarction, hibernating 
myocardium is characterized by a partial loss of sympathetic nerves. Although the 
degree of denervation does not predict SD, the regional increase in NGF in hibernating 
myocardium suggests a role for nerve sprouting in ischemic dysfunctional regions as a 
substrate factor for SD, similar to that described with infarction.
Tissue	Norepinephrine	
(ng/g)
Relative	Protein	(LAD/
Rem)
n LAD Remote TH NGF
Hibernating 9 1051 ± 182* 1673 ± 126 0.53 ± 0.14* 1.41 ± 0.18*
Sudden	Death 8 1006 ± 221* 1805 ± 279 0.63 ± 0.17* 1.59 ± 0.33*
Sham-Operated	
Controls 8 1753 ± 43 2000 ± 157 0.83 ± 0.10 1.07 ± 0.12
* p<0.05 LAD vs. remote
3:00 p.m.
915-240	 Endothelial	Dysfunction	Improves	Following	
Biventricular	Pacing	And	Identifies	Responders	To	
Cardiac	Resynchronization	Therapy
M. Obadah N. Al Chekakie, Tyler Fugate, Joanna Tomaszewski, Thomas Gavigan, 
Cynthia Finn, Jean Del Priore, Peter Santucci, Niraj Varma, David J. Wilber, Martin 
Matsumura, Joseph G. Akar, Loyola University Medical Center, Maywood, IL, Lehigh 
Valley Hospital, Allentown, PA
Background: Cardiac resynchronization therapy (CRT) improves functional capacity 
and decreases mortality in patients with heart failure. However, current guidelines do not 
adequately identify potential responders to CRT. Endothelial dysfunction is a hallmark of 
heart failure and is associated with increased mortality. We hypothesized that endothelial 
dysfunction improves following CRT and can predict response to CRT.
Methods: Assessment of brachial artery flow mediated dilatation (FMD), a measure of 
endothelial function, was performed pre-implantation (FMD0) and 14 days post-implant 
(FMD14) in patients (n=23, 18 males, age 66.5±14.6 yrs) undergoing CRT (LVEF 21±7%, 
QRS duration 163±20 ms). Patients were NYHC III-IV [ischemic cardiomyopathy 15/23 
(65%)] and were on a stable medical regimen with no change during the study period. Pre- 
and post-implant FMD as well as the extent of FMD change (ΔFMD0-14) were compared 
between responders and non-responders (assessed clinically by symptoms and NYHC).
Results: When the cohort was divided by clinical response to CRT, there were 11/23 
patients (48%) who were determined to be responders (12/23 non-responders). Baseline 
FMD was 3.4±4.9% in responders and 9.7±3.4% in non-responders (p<0.01). Following 
CRT, FMD increased to 8.4±7.5% in responders (p<0.05 compared to baseline) but did 
not changes in non-responders (6.7±6.3%, p=NS). ΔFMD0-14 was significantly higher in 
responders compared to non-responders (4.7±6.1% versus -3.1±7.0%, p=0.01). A baseline 
FMD level of 4.5% had a positive predictive value for response of 100%, and a negative 
predictive value of 85.7%. Pts with ischemic and non-ischemic cardiomyopathy had similar 
FMD0 (6.7±5.2% vs 6.7±5.4%, p=0.99) and ΔFMD0-14 (-3.3±9.3% vs 2.2±6.5%, p=0.24).
Conclusions: Endothelial function improves in heart failure following CRT, independent 
of other therapy. Heart failure patients with severe endothelial dysfunction as measured by 
FMD will likely respond to CRT while those with normal baseline FMD are likely to be non-
responders. Baseline endothelial function predicts response to CRT with high sensitivity 
and specificity. Larger randomized studies are needed to address this observation.
3:00 p.m.
915-241	 Defibrillation	Thresholds	and	Safety	Profiles	with	
Cardiac	Resynchronization	Therapy	Devices	Are	
Similar	To	Standard	Implantable	Cardiac	Defibrillators.
Byron Judson Colley, III, Anbukarasi Maran, Federick Funcke, Frank A. Cuoco, Jr., John 
L. Sturdivant, Robert Leman, Marcus Wharton, Michael R. Gold, The Medical University 
of South Carolina, Charleston, SC
Background: It is common clinical practice to implant high output defibrillators (ICD) 
in patients undergoing cardiac resynchronization therapy (CRT) due to concerns of 
elevated defibrillation thresholds (DFT). However, a detailed evaluation of DFTs among 
pts receiving ICD with CRT (CRT-D) devices has not been performed previously.
Methods: DFT and clinical data were collected in 600 pts undergoing initial implantation 
with a standardized defibrillation protocol. Comparisons were performed between CRT-D 
implants and pts undergoing routine ICD implant (single or dual chamber). The DFT was 
measured with step down protocol starting at 15 J (delivered energy), with subsequent 
inductions at 10 and 5 J until first shock failure.
Results: The study included 300 CRT-D and 300 ICD pts. The demographics for each 
group were similar (Table 1). CRT-D pts have a more advanced heart failure class, larger 
left ventricular mass and diameter, a lower ejection fraction, and a wider QRS (p<0.05). 
There was no significant difference in the DFTs between CRT-D and standard ICD 
groups (10.4±5.3J v. 10.1±5.7, p=0.64). The proportion of pts with elevated DFTs (>15 
J) were similar between groups (8.3% vs 10%, respectively). No patient had respiratory, 
neurologic or cardiac complications of DFT testing.
Conclusions: Despite clinical differences in the CRT-D group, DFTs are similar 
compared with standard ICD implantations and high output devices are rarely needed. 
Defibrillation testing can be performed safely in this cohort.
Table 1: Demographics and Variables
CRT ICD p	Value
Age	(avg)
Male	(%)
65(+/-11)
75.0
64(+/-13)
76.7 p=ns
CHF	class	(avg)
Ischemic	(%)
2.9(+/-0.4)
68
2.4(+/-0.7)
68
p<0.05
p=ns
LV	mass	(gm)
LVIDD	(cm)
EF	(measured)
352(+/-125)
6.9(+/-1.2)
25(+/-8)
317(+/-117)
6.3(+/-1.0)
33(+/-12)
p<0.05
Height	(in)
Weight	(lb)
GFR	(ml/min)
68(+/-4)
189(+/-42)
61(+/-22)
68(+/-4)
189(+/-44)
63(+/-29)
p=ns
Amiodarone	(%) 15 16 p=ns
DFT	>	15J	(%) 8.3 10 p=ns
3:00 p.m.
915-242	 Prevalence	and	Significance	of	an	Isolated	Long-QT	
Interval	on	a	12-lead	EKG	in	Elite	Athletes
Sandeep Basavarajaiah, Mathew Wilson, Greg Whyte, Ajay Shah, Sanjay Sharma, University 
Hospital Lewisham, London, United Kingdom, Kings College hospital, London, United Kingdom
Background: Congenital Long QT syndromes (LQTS) are relatively rare but a recognised 
cause of sudden cardiac death (SCD) in young athletes. Many individuals with congenital 
LQTS are asymptomatic and SCD may be the first presentation. The prevalence and 
significance of an isolated Long QTc (LQTc) interval on the 12-lead EKG in asymptomatic 
athletes has never been reported. Its identification represents a dilemma, since the 
diagnosis of congenital LQTS calls for permanent disqualification from competitive sports.
Methods: Between 2002 and 2006, 1400 elite asymptomatic athletes aged between 
14-35 years (mean 20.26 ± 5.40) underwent 12-lead EKG as a part of pre-participation 
screening programme. Nine hundred and seventy five (69.64%) were male and and 425 
(30.35%) female athletes. The QT interval was measured using callipers and corrected 
for the heart rate using Bazett’s formula (QTc). Athletes with LQTc (>440ms in males and 
>460ms in females) were investigated further with 24-holter monitor and an exercise 
stress test. All athletes with a LQTc were offered genetic testing and their first-degree 
relatives were offered a 12-lead EKG.
Results: Out of 1400 athletes, 6 (0.42%) (5 males and 1 female) athletes had LQTc 
interval. The QTc interval ranged from 460-580msec. Two males and one female athlete 
had QTc interval >500ms. None had a family history of syncope or SCD. Subsequent 
Holter monitoring did not reveal polymorphic ventricular tachycardia, but exercise stress 
testing demonstrated paradoxical prolongation of the QTc during the recovery phase in 2 
(33%) of these athletes. Both had a QTc > 500 msec and 1 had first degrees relatives with 
a LQTc on EKG and was gene positive for LQT1. None of the other athletes had family 
members with EKG abnormalities and the genetic results on these athletes for known 
LQT mutations have proved negative so far.
Conclusion:	 The prevalence of an isolated LQT on the ECG in asymptomatic athletes 
is 0.42%. One third of our athletes with a LQT had other phenotypic manifestations 
of the disorder and their QTc interval > 500msec was highly suggestive of LQTS. Our 
results indicate that the finding of an isolated LQTc is rare in athlete and warrants detailed 
investigation for congenital LQTS.
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916-234	 QRS	Complex	Fragmentation	As	Independent	Risk	
Factor	For	Secondary	Cardiac	Event	In	Patients	With	Q	
Wave	Myocardial	Infarction.
Grzegorz M. Pietrasik, Wojciech Zareba, Patricia Severski, Arthur J. Moss, University Of 
Rochester Medical Center, Rochester, Ny
Background: Fragmented QRS could be recognized on ECG independently of Q wave 
identification. Fragmented QRS complex is defined as alternation of QRS morphology 
(<120ms) with different RSR’ patterns: additional R wave, notching S wave, or >1 R’ 
wave. We aimed to compare prognostic value of fragmented QRS complex patterns of 
ECG changes in patient diagnosed Q wave MI.
Methods: 465 patients diagnosed with Q wave MI were followed prospectively and 
resting 12 lead ECG 2 month after index event were analyzed for the presence of 
significant fragmented QRS complexes. Unstable angina, nonfatal MI or cardiac 
death were considered as combined endpoint.
Results: There were four major patterns of ECG changes: 136 patients (30%) with 
only Q wave, 188 (42%) patients with both fragmented QRS and Q waves, 65 patients 
(14%) with no Q waves and no QRS fragmentation and 65 (14%) patients with only QRS 
fragmentation. In last two groups, significant Q waves on index event ECG disappeared.
Presence of fragmented QRS only on surface ECG 2 months post-Q wave MI was associated 
with 98% higher risk of combined endpoint: unstable angina, nonfatal MI or cardiac death (hazard 
ratio 1.98, 95% CI 1.08-8.16, p=0.035, adjusted for diabetes mellitus and history of angina 1 
month prior to event). Patients with this QRS abnormality had slightly higher frequency of ischemia 
on nuclear exercise stress test (23%) in comparison to remaining groups (only Q wave - 13%, Q 
wave and fragmented QRS - 11% and no Q wave and no QRS fragmentation -14%, p=0.10).
Conclusions: Presence of QRS fragmentation on 2 month follow-up ECG was associated with 
higher risk of UA, nonfatal MI or cardiac death in patients previously diagnosed as Q wave MI.
These finding might indicate that QRS fragmentation requires further attention as a 
prognostic parameter in identifying higher risk coronary patients.
4:00 p.m.
916-237	 The	Atrial	Vulnerability	Parameters	in	Lone	Atrial	
Fibrillation	Patients	with	Subclinical	Hypothyroidism	
-	A	New	Entity	in	Idiopathic	Atrial	Fibrillation?
Rie Komiya, Norihiro Komiya, Shinji Seto, Katsusuke Yano, Nagasaki University 
Hospital, Nagasaki, Japan
Background: Thyroid function is one of the important influential factor on atrial vulnerability. 
Subclinical hypothyroidism (SHT) is a very common disorder that may decrease the cardiac 
performance and alter electrical and structural conditions. We exam whether STH and lone atrial 
fibrillation (LAF) coexist and evaluated atrial vulnerability parameters in LAF patients with SHT. 
Methods: Thyroid function and atrial vulnerability parameters were evaluated in 
consecutive 100 LAF. The following atrial vulnerability parameters were assessed 
quantitatively: abnormal right atrial electrogram (AAE), effective refractory period (ERP), 
maximal conduction delay (MCD) between high lateral RA and distal coronary sinus, 
maximal duration of fractionated atrial activity on right appendage (MFAA). 
Results: SHT group (TSH <4.0 IU/ml and normal FT3 and FT4) was observed 10 patients 
(10%) in our LAF patients. The other patients had normal TSH, FT3, and FT4 (Normal 
group). The clinical characteristics and atrial vulnerability parameters of SHT and Normal 
groups are shown as Table. There is significant correlation between the CRP and MCD 
(r= 0.42, P< 0.05), and MFAA (r=0.55, P< 0.05). 
Conclusions: Surprisingly, SHT shares 10% in LAF patients. Moreover, this group of 
patients showed a unique electrophysiological feature. This suggests that LAF with 
SHT can be categorized as a subgroup, more increase the conduction delays in atrium. 
Thyroid hormone replacement could be an effective therapy in this particular entity.
The clinical characteristics and atrial vulnerability parameters of two 
groups (mean +/- SD)
SHT group Normal group P value
N (M/F) 10 (3/7) 90 (55/35)
Age 61.7 +/- 13.5 57.0 +/- 14.3 NS
Free T3 (pmol/L) 3.89 +/- 0.90 3.87 +/- 0.57 NS
TSH (microIU/mL) 5.20 +/- 1.53 1.74 +/- 1.30 P < 0.001
Incidence of AAE (%) 66 41 P < 0.05
ERP (ms) 203 +/- 39 209 +/- 32 NS
Maximum CD (ms) 95 +/- 42 66 +/- 20 P < 0.05
MFAA (ms) 37 +/- 33 20 +/- 25 P < 0.05
CRP (mg/dl) 1.66 +/- 0.30 0.47 +/- 0.11 P < 0.05
4:00 p.m.
916-238	 Outcome	After	Third	Atrial	Fibrillation	Ablation:	
“Whittling	Away”	vs.	“Too	Much	Already!”
David Lin, Erica S. Zado, Edward P. Gerstenfeld, Sanjay Dixit, Joshua M. Cooper, Ralph 
J. Verdino, Andrea M. Russo, David J. Callans, Francis E. Marchlinski, University of 
Pennsylvania Health System, Philadelphia, PA, Anguilla
Background: The need for repeat ablation procedures for atrial fibrillation (AF) is common. 
Despite repeat procedures, success has not been uniform. Additional procedures for 
recurrent AF should be evidence based.
Methods: To gain insight into the effectiveness of repeat ablation, we analyzed the 
observations during procedure and subsequent clinical outcome in 29 consecutive 
patients (pts) undergoing a third (27 pts) or fourth (2 pts) RF ablation for recurrent AF. 
Prior ablation consisted of proximal pulmonary vein (PV) isolation plus targeting of non-
PV triggers of AF that could be provoked with isoproterenol (ISO) or cardioversion (CV).
Results:	Reconnection was documented in all 4 PVs in 19 pts, 3 PVs in 7 pts, 2 PVs in 
2 pts, and 1 PV in 1 pt. No triggers for AF could be provoked with high dose ISO and CV 
of AF in 4pts. PV triggers initiating AF (11 pts) or frequent PV APDs (3 pts) were identified 
in 14 pts (48%) from reconnected PVs. Non PV targets were provoked and targeted in 
14 pts and included focal atrial tachycardias (AT) in 3 pts, reproducible APDs (from fossa 
ovalis, mitral annulus (MA), Eustachian ridge, superior vena cava, and epicardial CS) in 
8 pts and MA flutter in 3 pts. PV isolation with entrance and exit block and no additional 
provokable triggers of AF with 20mcg of ISO and CV with and without ISO was achieved 
in all pts. Three patients underwent their first MA isthmus line. No complications occurred. 
Follow-up in the 25 pts who are >3mos after ablation (average 14 months) showed no AF 
off antiarrhythmic drugs (AAD) in 17 pts (68%), no AF on AAD in 6 pts (24%) and rare AF 
in 1 pt . Only one patient had recurrent AF.
Conclusions:	 Our experience in pts undergoing repeated AF ablation suggests 1) 
Provocative maneuvers can identify appropriate ablation targets with reconnected 
PVs common and PV triggers for AF and/or AT noted in approximately half of the pts. 
2) Ablation using objective endpoints of PV isolation and targeting non PV provokable 
triggers results in acute prevention of trigger provocation and long term AF control; and 3) 
the data supports the role of repeated AF catheter ablation procedures in eliminating AF 
and PV reconnection as the cause of most AF recurrence.
4:00 p.m.
916-239	 Acute	Efficacy	and	Safety	of	Closed	Loop	Irrigated	Tip	
Catheter	Ablation	for	VT	after	Failed	Standard	4	mm	RF	
Ablation:	Benefit	of	a	Dual	Catheter	Approach
Michael P. Riley, Erica S. Zado, Fermin Garcia, Rupa Bala, David J. Callans, Edward P. 
Gerstenfeld, Sanjay Dixit, David Lin, Joshua Cooper, Francis E. Marchlinski, University 
of Pennsylvania Health Systems, Philadelphia, PA
Standard 4 mm tip RF ablation for VT is frequently limited with respect to power delivery 
and efficacy. Inducible VT frequently persists despite detailed characterization of the 
substrate and/or VT circuit using electroanatomic (EA) sinus rhythm and entrainment 
mapping with CARTO. We hypothesized that a closed cooled tip RF ablation catheter 
(Chilli) added via separate vascular access could be positioned adjacent to the 
CARTO catheter to provide more effective RF delivery at important anatomic and 
electrophysiologic sites. Methods: We report acute results in 158 VT procedures during 
which, after failed 4mm standard RF ablation due to persistent inducible VT and/or failure 
to deliver power >25 Watts (W), Chilli was used for RF application. All patients underwent 
detailed EA mapping to characterize the substrate using the 4 mm CARTO catheter. The 
combined CARTO and Chilli catheters, coupled with the EA mapping information were 
used to facilitate EA targeting, track lesion deployment and optimize energy delivery. 
Results: RF ablation at output >30 W (range 30-50 W) was achieved with Chilli in all. 
By confirming adjacent Chilli/Carto catheter tips on biplane fluoroscopy, all Chilli RF 
lesions were tracked in detail on CARTO substrate/activation maps to facilitate ablation 
of EA targets. Following RF application with Chilli programmed stimulation (up to triple 
extrastimuli) in 142 of the procedures identified no VT in 55 (39%) or only fast VT (<300 
ms) in 39 (27%). Clinical VT remained inducible in 14 (10%). The remainder had inducible 
non-clinical VT at cycle lengths >300ms. Major complications occurred with 4 procedures: 
CVA/TIA 1, tamponade 1, acute heart failure 2. Vascular access complications occurred 
in 5 procedures. Conclusions: In VT ablations limited by inadequate power delivery 
using the 4mm standard CARTO catheter, a closed loop irrigated tip catheter can be 
used to effectively increase RF power delivery. This dual catheter approach, combining 
Chilli and CARTO catheters, facilitates EA targeting and optimizes lesion deployment and 
tracking. The increased efficacy in eliminating VT and low complication rate using this 
approach provides an important ablation strategy to improve VT control.
4:00 p.m.
916-240	 Surgical	Excision	Of	Bachmann’s	Bundle	Does	Not	
Impact	The	P	Wave	Duration	In	Normal	Sinus	Rhythm.
Raveen R. Bazaz, Yoshiya Toyoda, Pramod Bonde, University of Pittsburgh, Pittsburgh, PA
Background:	Bachmann’s bundle (BB) is widely accepted to be the most important 
structure mediating left atrial activation. Current mapping techniques have revealed other 
inter-atrial breakthroughs including those seen in the atrial septum. Post-BB interruption 
increase in P wave duration after epicardial pacing is reported, however, data about effect 
of BB ablation on P wave morphology in normal sinus rhythm (NSR) is not available. We 
aimed to elucidate the influence of BB excision on P wave duration in NSR.
Methods: Under cardiopulmonary bypass, BB was surgically excised from 
left atrium to right atrium in adult male pigs. Both pre-bypass and post-bypass 
electrocardiograms were recorded.
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Results: The P wave duration measured in lead III in was 85±10 ms; both pre and 
post BB excision. The figure below has representative examples (A and B). P wave 
morphology changes such as a small terminal negative deflection and a double-humped 
P wave could be noted.
Conclusions: There is no change in the P wave duration in NSR after surgical excision 
of BB- this suggests that BB is not the primary conduit mediating left atrial activation. This 
information is important in advancing the understanding inter-atrial communication and 
has clinical relevance in the field of optimal atrial pacing. 
4:00 p.m.
916-241	 Synchronizing	Transthoracic	Shocks	for	VF	to	the	
Surface	ECG	does	not	Improve	Defibrillation	Success
Karen M. Darragh, Ganesh Manoharan, Cesar Navarro, Simon J. Walsh, J. D. Allen, 
John Anderson, Jennifer A. Adgey, Royal Victoria Hospital, Belfast, United Kingdom, 
Queen’s University, Belfast, United Kingdom
Background: Optimization of defibrillation is important to improve efficacy and minimize 
post-shock sequelae. Previous work has suggested an improvement in shock success 
when shocks are delivered on the upslope of a VF wave. We investigated the efficacy 
of transthoracic defibrillation success using a novel biphasic defibrillator which delivers 
shocks synchronised to the upslope of the surface ECG.
Methods: VF was induced repeatedly in ten pigs. Shocks were delivered from a 50%-tilted 
biphasic defibrillator in synchronised (sync) or non-synchronised (non-sync) mode via self-
adhesive pads following 30 seconds of VF. Energy settings of 50, 70, 80 and 100J were 
randomly tested. VF amplitude, impedance and shock outcome were recorded and analysed.
Results: A total of three hundred shocks were delivered. Sync shocks were delivered on 
the upslope of the VF wave in 99% of cases. Results are shown in Table 1. There was 
also no significant difference in shock success between non-sync shocks delivered on the 
upslope and those delivered elsewhere (p=0.764). High amplitude VF was found in 12% 
of shocks with no increase in shock success compared to medium or low amplitude VF 
(p=0.281; sync shocks only, p=0.958).
Conclusion: The novel defibrillator used in this study was able to consistently deliver 
shocks on the upslope of the VF wave but did not show an improvement in shock success. 
There was also no association between VF amplitude and shock success regardless of 
shock synchronisation.
Table 1. Shock Success
Delivered Energy Synchronised Shocks Non-Synchronised Shocks p Value
50J 0% 3% 1.0
70J 3% 16% 0.108
80J 34% 29% 0.622
100J 63% 65% 0.878
4:00 p.m.
916-242	 New	Ecg	Pattern	In	Young	Patients	With	Polymorphic	
Catecholaminergic	Ventricular	Tachycardia	
Leonid M. Makarov, Tatiana A. Kyrileva, Vera N. Komoliatova, Svetlana N. Chuprova, 
Moscow Inst. Pediatry and Surgery, Moscow, Russian Federation
Background: Polymorphic cathecholaminergic ventricular tachycardia (PCVT) is an 
uncommon, dangerous arrhythmia in children and young patients without evidence heart 
diseases. The aim of this study was to define peculiarities of the rest ECG during sinus rhythm 
in patients (pts) with PCVT as possible marker for early detection of the pts with PCVT.
Methods: PCVT was diagnosed in 20 pts 3 - 17 years (10,6 ± 3,4), 11 boys, 9 girls. 10 
(50%) pts had been previously treated as epilepsy. Evidence heart diseases, long QT 
syndrome, syndrome Brugada, digoxin toxity were excluded for all pts.
Results: All children were underwent 12 chanel rest ECG and 24 hr Holter monitoring 
(HM).For the first time VT was detected during Holter monitoring in 12 (60%), on rest 
ECG in 6 (30%) and during exercise test in 2 (10%) pts. For all pts was typically sinus 
bradycardia to compare normal limit for sex and age. 13 pts had a a short PR interval 
(SPRI) - 0,11 sec or less (age 7,4 ± 2,4, boy/girls - 7/6), without other signs of WPW 
syndrome, 7 (age 8,9 ± 3,7, boy/girls - 4/3) - a normal PR interval (NPRI). All CPVT 
pts had syncope (4,9 ± 3,7 per year in SPRI vs 2,6 ± 2,0 per year in pts with NPRI), 6 
- aborted sudden death (all with SPRI), 2 pts with SPRI suddenly died. Heart rate (HR) 
and Circadian index (ratio mean HR bpm during awake to mean HR during sleep by 
results of HM) were 56,3 ± 8,7 vs 78,1 ± 2,8 bpm and 1,69 ± 0,09 vs 1,4 2 ± 0,18 (p= 
0,009) respectively SPRI vs NPRI. Also QTc < 350 ms and supraventricular tachycardia 
were detected only in pts with SPRI - 4 (30,8%) and 7 (53,8%) pts respectively. We had 
detected SPRI pattern in some other description of the cases of PCVT, but not marked 
by authors as typical for this arrhythmia (Reid et al. 1975, Eisenberg et al. 1995, Fisher 
et al. 1999 and other), that allow for us decide that SPRI and PCVT is a more freguent 
association that it was considered before.
Conclusions: Combination of bradycardia and short PR interval is a new ECG patterns 
or syndrome inside groupe of pts with PCVT. Young patients with epilepsy or uncertain 
syncope with bradycardia and short PR on rest ECG need in exclusion of PCVT by 
repetitivy HM and exercise tests.
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917-234	 Autonomic	Nervous	Function	Abnormalities	in	Patients	
With	Brugada	Syndrome
Anna Kostopoulou, George N. Theodorakis, Maria Koutelou, Efthimios G. Livanis, 
Athanassios Theodorakos, Themos Maounis, Dimitrios Th Kremastinos, Dennis V. 
Cokkinos, Onassis Cardiac Surgery Center, Athens, Greece
Background: The purpose of this study was to evaluate autonomic function in patients (pts) with 
Brugada syndrome with a head-up tilt-test (HUT) and sympathetic innervation of the heart assessed 
by I-123 metaiodobenzylguanidine (MIBG) single photon emission tomography (SPECT).
Methods: The study included 15 pts with the Brugada syndrome, mean age 40±7.7 years. 
Eleven pts had an implanted defibrillator. All pts underwent a HUT with clomipramine 
challenge whereas the I-123 MIBG-test was performed in 13. The myocardium uptake 
was studied in 6 segments (anterior, posterior, inferior, septum, lateral from the short 
axis and apex from long vertical axes) using a 5-point scale (0=normal, 1= moderately 
diminished, 2=intermediately diminished, 3=severely diminished and 4=no uptake).
Results: Ten pts (66.67%) had a positive HUT during the 8.6±4.3 min of the test. All pts 
with a positive HUT showed abnormal uptake of I-123 MIBG with a mean score of 6.3±2.5. 
Reduced uptake was noted mainly in the inferior, posterior wall and apex. Five pts (33.3%) 
had a negative HUT. There was a significant difference in MIBG scores between the two 
groups (6.3±2.5 in positive HUT vs 1.8±2.9 in negative HUT, ANOVA p=0.015).
Conclusions: The results of this study support the presence of autonomic abnormalities 
in a subgroup of pts with the Brugada syndrome. These abnormalities are expressed as 
abnormal responses to head-up tilt-testing and areas of sympathetic denervation in the 
left ventricle. It is therefore possible that many syncopal episodes in pts with Brugada 
syndrome have a neurocardiogenic origin.
9:00 a.m.
917-237	 Intraoperative	Cooled-tip	Radiofrequency	Linear	Atrial	
Ablation	to	Treat	Permanent	Atrial	Fibrillation
Thomas Deneke, Krishna Khargi, Markus Fritz, Thomas Lawo, Peter H. Grewe, Laif I. 
Bösche, Turgut Brodherr, Bernd Lemke, Axel Laczkovics, Andreas Mügge, University 
Heart Center Bochum - BG Clinic Bergmannsheil, Bochum, Germany
Background: Atrial fibrillation (AF) surgery has become more engaged in every-day practise 
of cardio-surgical centres. The cut-and-sew technique still remains the gold standard with 
superior efficacy. Is an intraoperative approach using cooled-tip endocardial radiofrequency 
energy to induce linear atrial lesions (SICTRA) safe and effective in treating AF?
Methods: 230 patients (mean EUROSCORE 6.4, AF duration 7years) presenting 
with permanent AF (>1 year, 1 failed cardioversion) and the need for cardiac surgery 
were included. In addition to the cardio-surgical procedure concomitant SICTRA was 
performed. In 120 patients the ablation pattern was restricted to the left atrium alone. 
Follow-up constituted of ECG, holter-ECG and echocardiography.
Results: Cardio-surgical procedures were mitral valve surgery in 97, aortic valve 
replacement in 30, bypass surgery in 79 including 25 patients with additional mitral 
valve surgery and combined procedures in 24. During the mean follow-up of 26months 
178 patients (77%) converted to sinusrhythm (SR) without postoperative antiarrhythmic 
medication. At discharge 30%, at 3 months 61%, at 6 months 77% and after 12 months 
76% of patients were in stable SR. Biatrial contraction was documented in 82% of patients 
in SR. In patients with a SICTRA procedure restricted to the left atrium conversion rates 
were not significantly different compared to a biatrial approach (80% versus 78%, p=0.47). 
The type of cardio-surgical procedure did not influence 12-month conversion.
30-day-mortality was found to be 4% (10/230) mainly due to cardiac insufficiency. 
Histopathology revealed 24% of all lesions to be histologically non-transmural but only 
4% (10/230) of patients developed sustained regular atrial arrhythmia.
Conclusions: SICTRA safely and effectively restores stable sinusrhythm in 77% of 
patients with permanent AF undergoing open heart surgery. A biatrial contraction can be 
restored in 82%. Rhythm conversion is not influenced by treatment of the right atrium or 
the performed cardio-surgical procedure. Sustained regular atrial arrhythmia occur in 4% 
although intraoperative ablation lesions are often non-transmural.
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917-238	 B-type	Natriuretic	Peptide	And	Recurrence	Of	Atrial	
Fibrillation	After	Electrical	Cardioversion:	A	Prospective	
Study	With	One-year	Follow-up.
Antonio Varveri, Barbara Magris, Vincenzo Pasceri, Claudio Pandozi, Luca Santini, 
Gerardo Ansalone, Marina Vitillo, Sebastiano La Rocca, Massimo Santini, Cardiology 
San Filippo Neri Hospital, Rome, Italy
Background B-type natriuretic peptide (BNP) has been associated with atrial fibrillation (AF), 
but it is unknown whether BNP may predict risk of recurrence after electrical cardioversion.
Methods Sixty-two consecutive patients with successful electrical cardioversion for 
persistent AF were enrolled, with a mean follow-up of 12±6 months. BNP levels were 
divided into tertiles (T): T1=18.1-84.6 pg/dl, T2=85.1-168.4 pg/dl, T3=168.9-1114 pg/dl.
Results Patients with AF recurrence had higher BNP levels (226±209 vs. 116±86 
pg/dl p=0.04), larger left ventricular diameter (57±9 vs. 50±13 mm p=0.04), lower left 
ventricular ejection fraction (45±18 vs. 51±9 p=0.10) and larger left atrial diameter (51±7 
vs. 45±6 mm p=0.001). Recurrence rate at 6 months was 33% for T1, 65% for T2 and 
71% for T3 (p= 0.02 for T1 vs. T2 or T3). In a multivariate Cox proportional hazard model, 
including age, gender, ejection fraction, end diastolic ventricular volume, left atrial size, 
use of amiodarone and BNP levels, only higher BNP levels (T2 or T3 vs T1) and larger left 
atrial diameter (>40 mm) were significantly associated with higher risk of AF recurrence, 
Hazard Ratio (HR) 1.87; 95% CI, 1.01-3.25 for BNP T2 or T3 vs. T1 and HR 3.83; 95% 
CI, 1.06-13.6 for atrial diameter respectively.
Conclusions Low BNP levels may identify patients with lower risk of AF recurrence after 
successful cardioversion.
9:00 a.m.
917-239	 Genotype-Phenotype	Aspects	Of	Type-2	Long-QT	
Syndrome
Samit Shah, Vinit Amin, John Castle, Ilan Goldenberg, Arthur J. Moss, Scott McNitt, 
Coeli Lopes, Wojciech Zareba, Jennifer L. Robinson, Slava Polonsky, University of 
Rochester Medical Center, Rochester, NY
Background Type-2 Long QT syndrome (LQT2) is caused by mutations involving the 
HERG-encoded cardiac potassium channel. In the present study we evaluated the risk 
associated with mutations located within prespecified domains of the HERG gene.
Methods The independent contribution of mutation domains to the development of 
LQTS-related cardiac events was assessed in 440 LQT2 patients enrolled in the US 
portion of the International LQTS Registry.
Results: The transmembrane domain was shown to be associated with a significantly 
higher rate of cardiac events as compared to the N-term and the C-term regions (Figure). 
Consistently, after adjustment for gender, QTc and beta-blocker therapy, the transmembrane 
domain was associated with highest risk (HR=2.45, P<0.001), whereas no significant 
difference was shown between the N- and C-terminus regions (p=0.17). Further analysis of 
specific regions within the N- and C-terminus domains showed that the PAS (Per-Arnt-Ser) 
region of the N-terminus domain and the non-cNBD (cyclic nucleotide binding domain) 
region of the C-terminus domain were independently associated with a respective 74% 
(p=0.041) and 69% (p=0.0.039) increase in the risk of LQTS related cardiac events during 
follow-up as compared with the cNBD region of the C-terminus domain.
Conclusions - This large genotype-phenotype study indicates that in LQT2, mutations 
located in distinct domains of the potassium channel confer a different risk of LQTS-
related cardiac events during long-term follow-up. 
9:00 a.m.
917-240	 Hemodynamic	Effects	Of	Post-extrasystolic	Pacing	
With	Bi-ventricular	Stimulation
Tamás Szili - Török,, Berthold Stegemann, Zsolt Török, Rudas Laszlo, Bakken Research 
Center, Maastricht, The Netherlands, Goki Budapest, Budapest, Hungary
Background: Cardiac resynchronization therapy is an accepted electrical therapy for 
systolic heart failure. Post-extrasystolic potentiation has been suggested as another 
potential electrical therapy to improve ventricular systolic function. Post-extrasystolic 
potentiation (PESP) is a well established property of cardiac muscle whereby premature 
stimulation of the ventricle increases the contractility of successive cardiac beats.
PESP pacing has been applied using the intrinsic or single site ventricular activation in 
the past. As the need for ventricular pacing in heart failure population is more frequent, 
we studied PESP with bi-ventricular stimulation in this study.
Methods: Fifteen patients with systolic symptomatic heart failure were studied acutely. 
Left ventricular and arterial pressures were recorded and analyzed offline. Pacing leads 
were transvenously placed in the high right atrium, right ventricular septum and the left 
lateral wall. Bi-ventricular pacing was delivered without (BV) and with right ventricular 
paced extrasystoles (BVPP). Extrasystoles were delivered after every cardiac beat within 
10 ms after the end of the ventricular refractory period. Atrial pacing was delivered to 
avoid the strong rate drop associated with BVPP.
Results: Changing form BV to BVPP we observed the following: heart rate decreased 
19% (81.8 ± 14.9 to 66.5 ± 10.2 bpm ( P <0.001 )), left ventricular maximal dp/dt increased 
21% (1059.7 ± 459 to 1282 ± 611 mmHg/s (P < 0.001)) and arterial end diastolic 
decreased by 3.3 mmHg (56.1 ± 10.2 mmHg to 52.8 ± 10.2 mmHg (P < 0.001)).
Contractility during CPT increased at high and low ventricular pacing rates and showed a 
minimum contractility at a heart rate 25% below the intrinsic rate.
Conclusion: Adding BVPP to bi-ventricular pacing was feasible. Left ventricular 
contractility increased and the mechanical heart rate dropped as expected. The observed 
increase in contractility could however not compensate for the drop in heart rate causing 
a decrease in arterial end diastolic pressure. BVPP may have positive hemodynamic 
effects in a at elevated heart rates.
9:00 a.m.
917-241	 Blood	Urea	Nitrogen	Levels	and	the	Risk	of	Sustained	
Ventricular	Arrhythmias	and	Sudden	Cardiac	Mortality	
in	Patients	with	Left	Ventricular	Dysfunction.
Ilan Goldenberg, Arthur J. Moss, Wojciech Zareba, Scott McNitt, University of Rochester 
Medical Center, Rochester, NY
Background:	Renal disease, as defined by glomerular filtration rate (GFR) <60 per 
minute per 1.73 m2, is associated with a substantial increase in the risks cardiovascular 
morbidity and mortality. Blood urea nitrogen (BUN) has been suggested to more closely 
estimate cardiorenal pathophysiology. We hypothesized that BUN may be useful to 
identify patients at a high-risk for sustained ventricular tachycardia/fibrillation (VT/VF) 
and sudden cardiac death (SCD).
Methods: The relationship between BUN and the risk of appropriate implantable 
cardiovertr defibrillator (ICD) therapy for VT/VF or SCD was evaluated in 1223 patients 
enrolled in the Multicenter Automatic Defibrillator Implantation Trial-II.
Results: Multivariate analysis in non-ICD treated patients showed that 1.0 mg/dL 
increments in BUN were independently associated with a respective 3.5% increase in 
the risk of SCD (p<0.001); the findings persisted after further adjustment for either serum 
creatinine or GFR. In the ICD group, BUN >25 mg/dL was identified an independently 
associated with a 63% increase in the risk of VT/VF or SCD (p=0.02). Similar findings 
were observed among patients without renal disease; in this subset of patients, elevated 
BUN maintained a 2.1-fold increase in the risk of VT/VF or SCD (p=0.025), and was 
associated with a significantly higher rate of this end point (Figure).
Conclusions:	Elevated BUN identifies arrhythmic risk in patients with left ventricular 
dysfunction independently of the presence of renal disease. 
9:00 a.m.
917-242	 Non-Linear	Analysis	of	Heart	Rate	Variability	
During	Recovery	from	Treadmill	Testing	Predicts	
Cardiovascular	Prognosis
Frederick E. Dewey, James V. Freeman, David Hadley, Jonathan Myers, Victor F. Froelicher, 
Palo Alto VA Health Care System, Palo Alto, CA, Cardiac Science, Bothwell, WA
Background: We have recently shown that greater short-term (rMSSD) and high 
frequency heart rate variability (HF HRV) during recovery from exercise treadmill 
testing are associated with increased cardiovascular mortality. At rest, very high rMSSD 
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and HF HRV reflect non-respiratory sinus arrhythmia (NRSA), which is manifested in 
greater values of the non-linear heart rate variability parameter SD1/SD2. Accentuated 
sympathovagal antagonism, which is present during initial recovery from exercise, has 
been shown to contribute to NRSA. We aimed to evaluate the prognostic power of SD1/
SD2 and its correlation with rMSSD and HF HRV during recovery from exercise.
Methods: We evaluated 1335 subjects (95% male, mean age 58) who were referred for 
exercise treadmill testing between 1997 and 2004 at the Palo Alto VA Medical Center. The 
SD1/SD2 ratio was quantified by Poincare plot of successive R-R intervals for the first 
two minutes of recovery from exercise. Multivariable Cox survival analysis was used to 
evaluate the prognostic power of SD1/SD2 after adjusting for potential confounders (Duke 
Treadmill Score, heart rate reserve, heart rate recovery, and clinical risk factors). The 
relationship between SD1/SD2 and HF HRV and rMSSD was evaluated by Spearman-
Rank correlation.
Results: During the 5.0 year mean follow-up, 133 subjects died and 53 of these deaths 
were due to cardiovascular (CV) causes. The SD1/SD2 ratio was significantly higher 
in non-survivors than in survivors (median 0.58 vs. 0.27, respectively, p<0.001). After 
adjusting for confounders, SD1/SD2 > 0.59 was associated with a hazard ratio of 1.9 
(95% confidence interval 1.3-2.8, p < 0.001) for all-cause mortality and 2.6 for CV mortality 
(95% confidence interval 1.4-4.6, p = 0.001). The SD1/SD2 ratio was highly correlated 
with rMSSD and HF HRV during recovery (r = 0.9 and r = 0.7, respectively, p < 0.001).
Conclusions: Increased SD1/SD2 ratios during recovery from clinical treadmill testing 
are significantly associated with both increased CV mortality and greater short-term and 
HF HRV. Sinus arrhythmia not due to respiration may be implicated in the development of 
unstable rhythms and CV death in periods of increased sympathovagal antagonism.
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918-234	 A	Constitutively	Activating	Mutation	of	Gα
s
	in	
Outflow	Tract	Tachycardia	Increases	L-type	Ca2+	
Channel	Activity	
Geoffrey W. Abbott, Gianina Panaghie, Jie Dai, Trine Krogh-Madsen, David J. Christini, 
Bruce B. Lerman, Weill Medical College of Cornell University, New York, NY
Background: We previously identified a novel somatic missense mutation (W234R) 
in the guanosine triphosphate (GTP) binding domain of the guanine nucleotide binding 
protein Gα
s
 in a patient with resting repetitive monomorphic ventricular tachycardia (VT). 
The tachycardia was cyclic AMP-dependent, originating from a focal source in ventricular 
outflow tract. The somatic mutation elevated basal intracellular cyclic AMP levels 16-
fold, consistent with constitutive activation. We hypothesize that this form of VT is due 
to cAMP-mediated intracellular Ca2+ overload and triggered activity. To this end, we have 
initiated studies to examine effects of this mutation on basal L-type Ca2+ channel activity.
Methods: Cardiac L-type Ca2+ channel subunits (α1, β2a and α2-δ) were transiently co-
expressed with wild-type or W234R Gα
s
 in Chinese Hamster Ovary cells, and effects of 
the mutation on basal channel function were assessed using whole-cell voltage clamp. 
BaCl2 (20 mM) was included in the bath solution as a surrogate charge carrier for CaCl2. 
A human ventricular cell mathematical model was then adapted to incorporate effects of 
the somatic mutation on L-type Ca2+ current observed here, and also a 2.5-fold increase 
in peak SR Ca2+ release and a leak equivalent to 1% of the peak release in control - 
consistent with features previously observed with chronically elevated PKA levels.
Results: Co-expression of cardiac L-type Ca2+ channel subunits with mutant (W234R) 
Gα
s 
increased mean peak current density by 48 ± 15 % compared with wild-type 
Gα
s
 (p < 0.05). In a human ventricular cell model, this results in normal initial SR 
Ca2+ release but then a secondary release about 600 ms after the action potential 
upstroke, increasing cellular Ca2+ efflux through the Na+/Ca2+ exchanger, resulting in 
an increase in inward current leading to membrane depolarization and the generation 
of a delayed afterdepolarization (DAD).
Conclusions: These data are consistent with the hypothesis that constitutively activating 
mutant W234R Gα
s 
significantly increases basal intracellular Ca2+ via increased L-type 
Ca2+ channel activity, suggesting a mechanism by which this somatic mutation can result 
in DAD-mediated triggered activity.
10:00 a.m.
918-237	 Magnesium	Therapy	for	the	Acute	Management	of	Atrial	
Fibrillation:	A	Meta-Analysis
Orhan Onalan, Eugene Crystal, Amin Daoulah, Ching Lau, Alexander Crystal, Ilan 
Lashevsky, University of Toronto, Toronto, ON, Canada
Background: effects of Magnesium (Mg) on the heart suggest that it might be effective 
in the treatment of AF working for both rhythm and rate control. Methods: Randomized 
controlled trials (RCT) comparing intravenous Mg with placebo or antiarrhythmics for 
acute management of AF were included. Nine electronic databases from the earliest 
possible dates through June 2005 and abstract books from eight cardiovascular meetings 
held in the last 10 years were searched for relevant trials. The primary outcome was 
success rate in achieving ventricular rate control or rhythm control where available.
Results: Nine trials (n=562) met the inclusion criteria. All trials included patients with AF 
who had a ventricular rate ≥100 bpm. A predefined criterion for rate control was available 
in five trials (< 100 bpm in 4 trials and < 90 bpm in 1 trial). Conversion rates were reported 
in all trials. Duration of follow-up was ≤ 24 hours in all trials. When compared to placebo 
(n=125), Mg use (n=133) was more effective in achieving rate control (61% vs. 39%, OR 
2.97, 95%CI 1.78 to 4.97) without heterogeneity between studies (I2=0, p=0.58). In four 
studies including 273 patients, Mg treated patients had similar conversion rates (26% 
vs. 20%) as compared to placebo treated patients (OR 0.98 95%CI 0.26 to 3.64). In two 
studies (n=101) comparing Mg with CCBs, Mg was more effective than control group 
in restoration of sinus rhythm (57% vs. 17%, OR 6.34, 95%CI 2.41 to 16.66) without 
heterogeneity between studies (I2=0, p=0.49). Overall, either rate (<100 bpm) or rhythm 
control were achieved respectively in 87% of patients treated with Mg and versus 51% 
in placebo group (p< 0.0001). Both major side effects and study withdrawals due to any 
reason in the Mg group were not different from placebo group.
Conclusions: Intravenous Mg administration may be an effective and safe strategy for 
the acute management of AF.
10:00 a.m.
918-238	 Orally	Administered	Vanoxerine	,	a	Cardiac	
Multichannel	Blocker,	Terminates	Atrial	Flutter	and	
Prevents	Its	Reinducibility	in	the	Canine	Sterile	
Pericarditis	Model
Ivan Toma Cakulev, Kyungmoo Ryu, Celeen Khrestian, Antonio E. Lacerda, Arthur M. 
Brown, Albert L. Waldo, Case Western Reserve University, Cleveland, OH
Background: Antiarrhythmics that block multiple cardiac ion channels (amiodarone-like) 
have not been shown to terminate atrial flutter (AFL) acutely after oral dosing. We tested 
the hypothesis that oral dosing of vanoxerine (V), a cardiac sodium, calcium and potassium 
channel blocker, will quickly terminate atrial flutter (AFL), and prevent its reinduction.
Methods: Five dogs with sterile pericarditis received oral doses of V starting
at 90mg, followed by 180mg and 270mg given 1hr apart.Blood was obtained at baseline, 
every 30 min, at AFL termination, and 1 hr after the 270 mg dose to obtain plasma V 
concentrations. In 4 dogs, the first dose of V was given after sustained AFL (>10min) 
was reproducibly induced. One dog (#5) had only induced, nonsustained (<2 min) 
atrial fibrillation (AF) . We performed electrophysiologic (EP) studies at baseline, and 
after V administration to measure atrial excitability, refractoriness (ERP) and conduction 
time (CT) during pacing from the right atrial appendage, Bachmann’s bundle, and the 
posteroinferior left atrium from epicardial electrodes at pacing drive cycle lengths (CLs) 
of 400, 300 and 200 ms.
Results: In 4 AFL episodes, oral V: 1) terminated all episodes after an average of 111 
min (range 75-180 min) after the first dose was administered; sustained AFL was not 
inducible after termination; 2) mean V plasma level at AFL termination was 84 ng/ml, with 
a narrow range of 76-99ng/ml. In dog #5, nonsustained AF was no longer inducible at a V 
plasma level of 75 ng/ml; 3) significantly prolonged the atrial ERP at 300ms (125 to 151 
ms p=0.025) and 200ms (115 to134 ms; p=0.04), but not at 400 ms pacing CL; 4) did not 
significantly change atrial excitability thresholds; 5) did not significantly prolong atrial CT, 
or any ECG parameters (PR and QT intervals, QRS complex duration).
Conclusions: Orally administered V: 1) effectively terminated AFL
and rendered it noninducible; 2) suppressed inducibility of nonsustained AF; and 3) increased 
atrial ERP at shorter pacing CL but had no effect at longer pacing CL. These effects occurred 
over a similar time course, and at very consistent plasma drug level, suggesting that V is an 
effective frequency dependent oral drug to treat AFL and AF acutely.
10:00 a.m.
918-239	 N-3	Polyunsaturated	Fatty	Acids	and	Major	
Arrhythmic	Events:	A	Meta-analysis	of	Randomized	
Controlled	Trials.
Laurent Fauchier, Bertrand Pierre, Guillaume Breard, Caroline Grimard, Noura Zannad, Pierre 
Cosnay, Dominique Babuty, Centre Hospitalier Universitaire Trousseau, Tours, France
Background: N-3 polyunsaturated fatty acids (omega-3 PUFAs) are thought to reduce 
risk of sudden death, possibly by reducing susceptibility to cardiac arrhythmia. However, 
recent studies in the field gave conflicting results with lack of significance on primary 
endpoints. In order to reevaluate the possible benefit of omega-3 PUFAs with a sufficient 
power in statistical analysis, we performed a metaanalysis of trials on the endpoint 
of major arrhythmic events defined as sudden death or appropriate therapy by an 
implantable cardioverter defibrillator (ICD).
Methods: A systematic review of controlled trials with omega-3 PUFAs was performed. 
Data sources included Medline, Embase, Cochrane central register of controlled trials, 
and hand search. Predefined criteria were used to select controlled clinical trials. Eligible 
studies had to be randomized, controlled, parallel-design human trials with use of omega-
3 PUFAs that collected data on major arrhythmic events as defined above. Data were 
extracted for patients’ characteristics, interventions, quality of trials, and rates of events.
Results: Eight studies with 14208 patients were included in the analysis. Five studies 
investigated the use of omega-3 PUFAs in patients with coronary artery disease and 3 in 
patients with an ICD. Major arrhythmic events occurred in 656 patients (306 with sudden 
death and 356 with appropriate therapy by ICD). Overall, the use of omega-3 PUFAs 
was significantly associated with a decreased risk of major arrhythmic event compared 
to control (relative risk 0.71, 95% confidence interval 0.60 to 0.84, p<0.0001). Omega-
3 PUFAs decreased both the risk of therapy delivered by ICD (relative risk 0.71, 95% 
confidence interval 0.55 to 0.92, p=0.008) and the risk of sudden death (relative risk 0.73, 
95% confidence interval 0.58 to 0.92, p<0.0001) compared to control.
Conclusions: Despite some negative results in recent studies, we found in a large 
number of patients that use of omega-3 PUFAs was significantly associated with a 
decreased risk of major arrhythmic events compared to control in patients with coronary 
artery disease or with an ICD.
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918-240	 Worsening	Left	Ventricular	Function	Per	se	is	
a	Predictor	of	Left	Ventricular	Dyssynchrony	
Independently	of	QRS	Duration:	Insight	Into	Cardiac	
Resynchronization	Therapy	Indication
Mitsuaki Takami, Masaki Fujita, Youhei Gen, Yuzuru Yanbe, Hiroshi Ohira, Takashi 
Shimabukuro, Naoki Sakakibara, Takehiko Keida, Toho University Ohashi Medical 
Center, Tokyo, Japan
Background:	There is increasing evidence that QRS duration (QRSd) is an inadequate 
indicator of left ventricular (LV) dyssynchrony and is a poor marker in patient selection for 
cardiac resynchronization therapy (CRT). We hypothesized worsening LV function per se 
was a predictor of LV dyssynchrony independently of QRSd.
Methods:	315 patients presenting various QRSd (80 to 200ms) and LV ejection fraction 
(LVEF: 5 to 83%) underwent ECG-gated myocardial perfusion SPECT applying novel 
software capable of segmental LV volume analysis. The data sets were computed 
to produce time-volume curves for the 5 lateral and 5 septum segments (figure). 
A dyssynchrony index (DI) was calculated using the following formula: |mean time to 
minimum volume of 5 lateral segments - mean time to minimum volume of 5 septum 
segments| x 100/RR interval. The LVEF and the QRSd were subjected to a multiple linear 
regression model with the DI as the dependent variable.
Results:	DI increased with worsening LV function (LVEF>50% n=103, 2.33+2.70; LVEF 
35-50% n=83, 3.66+3.92; LVEF<35% n=129, 6.88+8.87). In multivariate analysis, 
reduction in LVEF predicted increase in DI in patients with severe and mild LV dysfunction 
(LVEF<35%, p=0.012; LVEF 35-50%, p=0.026; LVEF>50%, p=NS). Meanwhile, increase 
in QRSd did not predict increase in DI in any of LVEF strata.
Conclusion:	Unlike increase in QRSd, worsening LV function per se was a predictor of 
increase in LV dyssynchrony. This may again emphasize that QRSd is a poor marker in 
patient selection for CRT.
10:00 a.m.
918-241	 Comparison	of	Complication	Rates	Between	
Outpatient	and	Inpatient	Implantation	of	Cardiac	
Resynchronization	Therapy	Devices
George Kantis, Aneesh Tolat, Joseph Dell’Orfano, Ellison Berns, Diane Dodson, Neal 
Lippman, Saint Francis Hospital, Hartford, CT, University of Connecticut School of 
Medicine, Hartford, CT
Background: Patient management following implantation of cardiac resynchronization 
implantable defibrillators (CRT-D) varies among institutions. Post-CRT-D implant care 
frequently includes at least one night of inpatient hospitalization, intended to minimize 
the risk of postoperative complications. However, outpatient CRT-D implantation may 
offer an equally safe alternative with the added benefit of cost savings and less hospital 
resource utilization.
Methods:	We compared the complications rates of 100 consecutive patients who were 
implanted with a CRT-D device and discharged home the same day as surgery with 
65 patients who underwent CRT-D device implantation and were hospitalized for one 
or more days following surgery. Patients who could not be implanted with a coronary 
sinus lead were referred for epicardial lead placement and excluded from analysis. All 
implantations occurred at a single institution from 2004-2005. Patients were analyzed 
on an intention to treat basis. Complications were defined as: any lead dislodgement, 
pocket hematoma, infection, and cardiac perforation with tamponade. The minimum post-
operative follow up was 2 months.
Results:	165 CRT-D implants were performed at our institution, with no deaths occurring 
in the first 60 days following the procedure. The mean ejection fraction of each group was 
20%. Of the 100 outpatient CRT-D implants, 12 (12%) had a complication vs. 9 (13.8%) 
inpatients (p=NS) over a mean follow-up period of 9.2 months [range 2-26 months]. The 
most frequent complication in both groups was lead dislodgement with 5 (5%) occurring 
in the outpatient group and 5 (8%) occurring in the inpatient group. Coronary sinus lead 
dislodgement was the most common type of lead dislodgement occurring in 2 (2%) 
patients from the outpatient group and 2 (3%) patients from the inpatient group.
Conclusions: Outpatient CRT-D implantation complication rates are similar to those 
found for inpatients. CRT-D can be performed safely on an outpatient basis.
10:00 a.m.
918-242	 Effect	of	Beta-Blockade	on	the	Association	Between	
Cardiac	Autonomic	Dysfunction	and	Inflammation	in	
Type	1	Diabetic	Patients
Gaetano A. Lanza, Dario Pitocco, Alfonso Sestito, Eliano P. Navarese, Gregory A. 
Sgueglia, Pasquale Santangeli, Fabio Infusino, Giovanni Ghirlanda, Filippo Crea, 
Università Cattolica del Sacro Cuore, Rome, Italy
Background: Abnormal cardiac autonomic function and increased markers of inflammation are 
findings detectable in a sizeable proportion of patients affected by type 1 diabetes mellitus, and are 
both associated with worse clinical conditions and outcome. Recent experimental data suggest 
that inflammatory reactions can be modulated by the activity of the autonomic nervous system.
We aimed at assessing the relationship between cardiac autonomic dysfunction and 
inflammation in patients with type 1 diabetes, and whether beta-blocker therapy might 
improve both abnormalities in these patients.
Methods: We studied 49 patients with type 1 diabetes (age 50.5±11 years, 33 men). 
Serum levels of high-sensitivity C-reactive protein (CRP), as a marker of inflammation, 
and frequency-domain heart rate variability (HRV) on 24-hour Holter monitoring, as a 
measure of cardiac autonomic function, were assessed in all patients.
Results: Twenty-one patients with depressed HRV were subsequently randomized to 
receive atenolol (50 mg daily) or no beta-blockade. HRV and CRP were reassessed after 
3-4 weeks from randomization. An inverse correlation was found between CRP levels and 
HRV parameters, with the highest r coefficient shown with low frequency (LF) power (r=-
0.39; P=0.005). On multivariate logistic regression analysis only low LF power (P=0.027) 
and higher triglucerydes levels (P=0.45) were independent predictors of high (>3 mg/L) 
CRP serum levels. HRV parameters improved significantly in patients treated with atenolol, 
but not in the no-atenolol group. Furthermore, CRP levels decreased in the beta-blockade 
group, but not in the no-beta-blockade group (P=0.04 for changes between groups).
Conclusions: In type 1 diabetic patients, serum CRP levels are significantly associated 
with depressed HRV; the favourable effects of beta-blockade on both HRV parameters 
and CRP serum levels suggest that autonomic nervous system can be a significant 
modulator of inflammation.
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919-234	 Mechanism	of	Fever-aggravation	of	ST	Elevation	and	
Arrhythmognesis	in	a	Canine	Tissue	Model	of	Brugada	
Syndrome
Hiroshi Morita, Douglas P. Zipes, John Lopshire, Shiho T. Morita, Jiashin Wu, Krannert 
Institute of Cardiology, Indiana University School of Medicine, Indianapolis, IN
Background:	 Fever promotes ST elevation and polymorphic ventricular tachycardia 
(VT) or ventricular fibrillation in Brugada syndrome. However, the mechanism is unclear. 
We evaluated the hypothesis that elevated temperatures promoted arrhythmogenesis 
by modulating functional dynamics of right ventricular electrophysiological activity in an 
experimental canine model of Brugada syndrome.
Methods: We optically mapped 256 channels of action potentials (APs) on the epicardial 
(epi) or transmural surfaces of 27 arterially perfused canine right ventricular tissues at 36.5 
and 40 °C. We induced Brugada-type ECG with pinacidil, pilsicainide, and terfenadine 
(2.5, 5, and 2 μmol/L, respectively).
Results:	 We observed intraepi dispersion of AP duration (APD) and reversal of 
transmural gradient of APD (longest in epi) in association with manifest Brugada-type 
ECG at 36.5 °C. Elevated temperature (40° C) shortened APDs and reduced the phase 
1 notch of epi APs (APD: 36.5 °C 253 ± 39; 40 °C 220 ± 30 ms, p<0.01; epi phase 1 
notch width: 36.5°C 108 ± 25; 40°C, 82 ± 27 ms, p<0.01). Prominent phase 2 domes of 
epi APs frequently led to spontaneous premature ventricular activations (PVAs), which 
conducted to surrounding regions having shorter APDs (phase 2 reentry). Longer epi 
APDs at 36.5 °C frequently blocked reentry although promoted PVA, while shortened epi 
APDs at 40 °C facilitated reentrant VT (occurrence of VT: 36.5°C 8%; 40°C 23%, p<0.05). 
During bradycardia (cycle length: CL=2000ms), J-ST elevation with negative T wave was 
observed in transmural ECG. Rapid pacing (CL=500 ms) eliminated the dome of epi 
APs and enhanced J-ST elevation and eliminated negative T wave at each temperature 
(width of J wave at 40°C : 29±7 ms at CL=2000 ms; 127±34 ms at CL=500 ms; p<0.01). 
Blocking the transient outward current, Ito, with 4-aminopyridine (1 mmol/L) reduced J-ST 
elevation and eliminated the PVA and reentry at each temperature.
Conclusions:	 Fever induces APD shortening and facilitates reentrant ventricular 
arrhythmias. Changes in AP during fever and tachycardia aggravate ST elevation and 
VT in Brugada syndrome.
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919-237	 Tachycardiomyopathy	in	Patients	with	Persistent	
Atrial	Flutter
Stephen Pizzale, Anthony Tang, Michael Gollob, Robert Lemery, Martin Green, David H. 
Birnie, University of Ottawa Heart Instittue, Ottawa, Canada
Introduction: Tachycardiomyopathy (TCM) is important to recognize as the left ventricular 
(LV) dysfunction is partially or wholly reversible. Previously it has been considered to be 
a rare cause of cardiomyopathy (CM). Furthermore there are some patients with TCM 
superimposed on underlying fixed CM. There is little data on predictors of reversibility of 
LV dysfunction in these patients. This latter point is particularly relevant in the current era 
of primary prevention ICD implantation. Potentially there is a group of patients who may 
not require ICD implantation if LV function improves after reversal of tachycardia.
Our aims were: (1) To look at the incidence of TCM in patients undergoing ablation for 
persistent atrial flutter (AFl). (2) To analyze predictors of reversibility of CM in patients 
with AFl and LV dysfunction.
Methods: We performed a retrospective analysis of all consecutive patients who 
underwent successful ablation for persistent AFl from 1998 to 2006 at our institution. 
LV function was quantified before and after ablation. Mean Ventricular Response (VR) 
during AFl was assessed from holter monitors or as the mean VR on all available ECGs. 
Addional clinical variables were recorded for mulit-variate analysis.
Results: 111 patients met the inclusion criteria for this study. 28/111 (25.2%) patients were 
identified as having CM. 16/28 (57.1%) of those patients showed significant improvement 
in their LV function post ablation. Hence the overall incidence of TCM was 16/111 (14.4%) 
patients. In 12/16 (75%) patients the LV function improved to normal. 19 patients had 
a baseline LV ejection fraction <35% and thus were potential ICD candidates. 10/19 
patients improved to >35% post ablation. In multivariate analysis average VR during AFl 
was the only independent predictor of reversible CM (p=0.0128).
Conclusions	
1. TCM is common in patients with persistent AFl. We found that 14% of our cohort had 
reversible LV dysfunction. Furthermore in patients with CM and persistent AFl 16/28 
(57.1%) had some degree of TCM.
2. The only independent predictor of reversible LV dysfunction in patients with CM and 
persistent AFl was VR during AFl. However it should be noted that the mean VR in 
patients with TCM was only 112.
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919-238	 Clinical	And	Echocardiographic	Measures	Governing	
Embolic	Destination	In	Atrial	Fibrillation.
Waldemar E. Wysokinski, David Hodge, Tanya Petterson, Robert D. McBane, II, Mayo 
Clinic, Rochester, MN
Background: More than 200,000 ischemic strokes registered annually in United States 
are directly attributed to atrial fibrillation (AF). There are few data regarding predictors 
of thromboembolism to other arteries in AF. Within the last 10 years, 33,152 unique AF 
patients from the 6 state region (MN, IA, IL, ND, SD, WI) were evaluated at Mayo Clinic 
Rochester. Of these, 6,164 had AF related thromboembolic complications. Ischemic 
strokes (98%) vastly outnumbered embolic peripheral arterial occlusions (2%). The aim 
of this study was to define clinical and echocardiographic characteristics distinguishing 
patients suffering peripheral (AFPE) compared to cerebral (AFS) thromboembolism.
Methods: In a retrospective case-control study, clinical and transesophageal 
echocardiographic (TEE) variables for AFPE patients were compared to a random 
sample of AFS patients.
Results: AFPE (74±11 years) were older than AFS patients (68±13 years; p=0.01). 
CHADS-2 scores were low for both groups. Although many CHADS variables were more 
common in AFPE (Table), prior stroke was nearly twice as common in the AFS group. Both 
structural and functional echocardiographic variables stand out among AFPE patients.
Conclusions: Acute symptomatic peripheral embolization is extremely rare compared 
to cerebral embolization in AF patients. The greater overall infirmity in AFPE patients 
defined by clinical and echocardiographic measures may offer insight into mechanisms 
governing embolic destination.
Variable AFPE (n=72) AFS (n=100) P-value
CHF 25% 11% 0.016
Hypertension 85% 59% 0.0003
Age>75 yrs 51% 32% 0.01
Diabetes 28% 22% 0.38
Stroke/TIA 31% 54% 0.0001
CHADS-2 score 2.5±1.1 2.3±1.3 0.49
LVEF<30% 13% 4% 0.038
Spontaneous echo contrast 47% 23% 0.0009
Left atrial thrombus 29% 10% 0.0013
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919-239	 Features	of	Ventricular	Tachyarrhythmias	in	Patients	
with	Brugada	Syndrome
Li Zhang, Bortolo Martini, Ningning Zhuang, Jeffrey L. Anderson, Joseph B. Muhlestein, 
Peter Weiss, Donald Lappe, G. Michael Vincent, For international Brugada syndrome 
investigators, LDS Hospital, Intermountain Healthcare, Univ. of Utah School of 
Medicine, Salt Lake City, UT, Boldrini Hospital, Thiene, Italy
Background: Unlike common ventricular arrhythmias seen in the general population, 
ventricular tachycardias (VT) in Brugada syndrome (BrS) patients have a high tendency 
to degenerate into ventricular fibrillation (VF). This study, therefore, investigated the 
features of ventricular tachyarrhythmias in BrS.
Methods:	The ECG records documenting VT/VF were evaluated in 31 BrS pts whose ethnic 
background was Asian in 55%, Caucasian 40% and Latino 5%. Among BrS pts, 76% had a 
history of syncope, 20% cardiac arrest and 16% sudden death. A family history of syncope or 
sudden death was seen in 21%. An internal cardioverter-defibrillator (ICD) was implanted in 
62%. The ECG of VT/VF was studied for rate, morphology and ventricle of origin.
Results: 1. The VT rate was 258±44 bpm and 87% showed degeneration into VF. In 
cases of spontaneous VT/VF and VT/VF induced by Class IC sodium channel blockers, 
78% showed the shortest coupling interval (CI, 325±58 ms) in V1 and the longest CI 
(410±98 ms) in V6. “R-on-T” phenomena was found in 75%.
2. In this cohort of BrS, 13% (n=4) VT was monomorphic; the majority was polymorphic, 
which generally immediately degenerated into VF.
3. In 10% (n=3) VT originated from the left ventricle (LV), including 1 monomorphic VT 
caused by a fever, and 2 VT cases originating from both the LV and right ventricle (RV), 
induced by vasospasm and EP study, respectively.
4. In 90% VT/VF arose exclusively from the RV, including 16/31 from the RV outflow tract 
and 11/31 from the RV inflow tract or apex.
Conclusions:	Ventricular tachycardia in Brugada syndrome is characterized by a right 
ventricular origination, rapid rate, polymorphic wave forms and a high tendency to 
degenerate into ventricular fibrillation.
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919-240	 What	Programmed	Atrioventricular	Delay	is	Needed	to	
Minimize	Pacing	For	Any	Given	Baseline	PR	Interval:	
How	Much	Longer	is	Long	Enough?
Bruce A. Koplan, Kellie Chase Berg, Stacia Merkel, Christopher Mullin, Brigham and 
Women’s Hospital, Boston, MA, Boston Scientific, St. Paul, MN
Introduction: Sinus node dysfunction patients may require a pacemaker. Since RV pacing may 
be detrimental in some patients, what programmed AV delay can provide support but minimize 
pacing? Methods: In the ULTRA Study, 489 patients received a pacemaker with pre-implant PR 
interval measured. Based on PR interval, patients were divided in 4 groups: low (60-159 ms), 
medium (160-199), high (200-259), very high (260-480). Device programming and % RV pacing 
were collected at first follow-up. After exploratory graphical analyses, regression models were fit 
to evaluate what AV delay minimized RV pacing in the 4 groups. Models for fixed and minimum 
dynamic AV delay had polynomial terms and max dynamic AV delay had linear terms. Results: 
Mean RV pacing was 45.4±40.3% (n=395). For patients programmed to fixed AV delay, minimal 
RV pacing and corresponding AV delays were 3.7% at 260 (n=14) in the low PR interval group, 
0% at 300 (n=28) in the medium group, 24.8% at 270 (n=28) in the high group, and 9.6% at 
270 (n=6) in the very high group. For dynamic AV delay, minimal RV pacing occurred at a 
max of 300 where RV pacing was 22.4% (n=72), 13.2% (n=110), 25.3% (n=99), and 83.1% 
(n=21), respectively. Predicted RV pacing was lowest with minimum dynamic AV delays of 170 
(16.5%, n=72), 215 (19.9%, n=110), 205 (33.2%, n=99), and 200 (36.9%, n=21), respectively. 
Conclusion: In order to minimize RV pacing in sick sinus patients, AV delay must be set greater 
(up to 70ms) than baseline PR interval; even in patients with normal (<200ms) PR intervals. 
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919-241	 Shock-Free	Survival	in	Patients	with	Hypertrophic	
Obstructive	Cardiomyopathy	and	Implantable	
Defibrillators	following	Alcohol	Septal	Ablation
Frank A. Cuoco, Byron J. Colley, III, William H. Spencer, III, Scott W. Burke, Salem N. 
Sayar, S. Luke Kusmirek, Christopher D. Nielsen, J. Lacy Sturdivant, Robert B. Leman, J. 
Marcus Wharton, Michael R. Gold, Medical University of South Carolina, Charleston, SC
Background: Alcohol septal ablation (ASA) is becoming increasingly common for treatment 
of patients with hypertrophic cardiomyopathy (HOCM). ASA reduces symptoms and outflow 
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tract obstruction, but concern has been raised that this therapy is proarrhythmic because 
iatrogenic scar formation that may lead to ventricular arrhythmias (VT/VF).
Methods: We analyzed 123 consecutive patients with HOCM who underwent ASA and 
had an ICD for primary prevention of sudden cardiac death (SCD) based on traditional 
risk factors, including a family history of SCD, syncope, septal thickness ≥3cm, and 
abnormal blood pressure response during exercise. Data from ICD shocks were collected 
and verified as appropriate if they treated VT/VF.
Results: The mean age of the patients was 48 ± 15 years, 66% were male, and they had 
a mean of 1.5 ± 0.9 risk factors for SCD. Nine appropriate ICD shocks were recorded 
over a mean follow up of 2.9 years. Using Kaplan-Meier survival analysis, the estimated 
event rate was 2.8% per year over three years (see figure). There were no statistical 
differences in demographics or SCD risk predictors between patients who did and not 
receive appropriate shocks.
Conclusions: The annual rate of appropriate ICD discharges following ASA is low and 
less than that reported previously (4-6%) for primary prevention of SCD in HCM. In fact, 
ASA may reduce VT/VF by relieving outflow tract obstruction and promoting reverse 
remodeling. Finally, traditional SCD risk factors did not predict ICD shocks in this cohort.
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919-242	 ECG	Characteristics	Prior	to	the	Onset	of	Ventricular	
Tachycardia/Fibrillation	in	Patients	with	Brudaga	
Syndrome
Li Zhang, Ningning Zhuang, Bortolo Martini, Jeffrey L. Anderson, Joseph B. Muhlestein, 
Donald Lappe, G. Michael Vincent, For international Brugada syndrome investigators, 
LDS Hospital, Intermountain Healthcare, Univ. of Utah School of Medicine, Salt Lake 
City, UT, Boldrini Hospital, Thiene, Italy
Background: Patients with Brugada syndrome (BrS) often display distinct ECG features 
under Class IC sodium channel blockade, especially before the onset of ventricular 
tachycardia/fibrillation (VT/VF). We aimed to characterize the ECG features of BrS 
patients prior to the onset of VT/VF, which may help understand the genesis of VT/VF 
in this entity.
Methods: ECGs of 31 BrS pts (age 43±14 yrs, 24 M) with documented VT/VF were 
analyzed for P-QRS-T intervals and morphologies prior to the onset of VT/VF and 
compared to the control stage.
Results: 1. Heart rate was 68±10 bpm, PR 167±32 ms, I° AVB in 16%, left QRS axis in 
47% and 16% with left anterior fascicular block.
2. Besides the coved ST elevation, the right end conduction delay (RECD), defined 
as right divisional Purkinje block, was shown in V1 of all pts, V2 67% and aVR 33%, 
respectively. The predivisional RBBB appeared in 55%.
3. Prior to VT/VF, the V1 QRS amplitude was reduced in 71% of pts. The low QRS 
amplitude was also in limb leads (52%). In V1-2 the QRS morphology and duration were 
all significantly different prior to VT/VF vs. control stage. 
4. QTc (446±34 ms) and Tpeak-end (143±38 ms) were the longest in V2, with QTc≥470 
ms in 33%.
Table 1. Right Precordial QRS Alterations Prior to the Onset of VT/VF. 
*p<0.01 by paired T test
V1-2 QRS ms S wave mV R’ wave ms R’ wave mV
Prior to VT/VF 173±30* 0.4±0.5* 78±34* 0.5±0.3*
Control stage 106±21 0.7±0.4 33±26 0.1±0.1
Conclusions: Conduction abnormality is prominent in Brugada syndrome. The alteration 
of QRS complex, RECD and lengthening of QT and Tpeak-end in V1-2 prior to VT/VF 
suggests worsening delayed regional activation in right ventricle may have contributed 
to the genesis of VT/VF besides the increased repolarization disparity in Brugada 
syndrome.
